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AIM: Sarocpenic obesity is a national concern within the United States because this 
metabolic syndrome is tied with reduced mobility and quality of life. Both obesity and aging 
are associated with insulin-resistance, chronic low-grade inflammation and muscle weakness. 
Skeletal muscle regeneration is a process that involves the coordinated effort of myogenic 
regulatory factors (MRFs), inflammatory signaling, and extracellular matrix (ECM) 
remodeling for optimal regeneration. It has been demonstrated that obesity and aging have a 
reduction in muscle regeneration. It has not been examined if sarcopenic obesity will further 
reduce muscle mass and the regenerative process. The purpose of this study was to determine 
how sarcopenic obesity alters inflammatory signaling and extracellular remodeling in mouse 
skeletal muscle. METHODS: One hundred two male C57BL6/J mice (4 weeks old) were 
randomly assigned to either a high fat diet (HFD, 60% fat) or normal chow. Both young (3 
months old) and aged mice (22-24 months old) were injected with either PBS or bupivacaine. 
Muscles were excised 3 or 21 days after injection.  RESULTS: Mean cross-sectional area 
was reduced by 26% in aged HFD mice. The aged lean mice had 9% greater mean cross-
sectional area 21 days following muscle damage but no changes were observed in aged HFD. 
Aged mice had nearly 2-fold collagen III content than young mice. P-STAT3/STAT3 was 
reduced by 82% in the aged HFD mice in the TA. NF-κB was 3-5 fold greater in the aged 
HFD mice compared to the aged lean mice in the gastrocnemius and the TA. There was a 
main effect of injury to reduce collagen I and III content in aged injured, and a main effect of 
diet with a decrease of collagen I, collagen III, and MMP-9 gene expression in aged HFD 
mice 3 days following muscle damage. CONCLUSION: Sarcopenic obese mice have 
reduced cross-sectional area than aged mice along with increase collagen III content and basal 
  
alterations in MyoD, ECM proteins, and inflammation gene expression. During skeletal 
muscle regeneration sarocopenic obese mice had dysregulated inflammatory signaling and 
reduced ECM gene expression. These data suggest further impairment in the regenerative 
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REVIEW OF LITERATURE 
 Sarcopenic obesity is a metabolic syndrome that is rising in the United States and 
around the globe due to the increased rate of obese adults (Villareal, Apovian, Kushner, & 
Klein, 2005). This is alarming to several health organizations because roughly a third of older 
adults are obese yet little is known about symptoms and health risks involved in this 
population (Batsis et al., 2013; Flegal, Carroll, Kit, & Ogden, 2012). Moreover, there are 
several devastating symptoms that are linked with sarcopenia alone that may lead to poor 
quality of life, increased healthcare cost, and increase mortality rate. Functional independence 
is necessary for older adults to complete daily life tasks without assisted living. If older adults 
do not need to rely on aides and medications related to physical movement there would be a 
substantial reduction in disability associated healthcare cost (Bowne, Russell, Morgan, 
Optenberg, & Clarke, 1984).  
 Skeletal muscle regeneration is a process that occurs following damage after physical 
activity or exercise and has been investigated with sarcopenia and obese populations because 
it is necessary for skeletal muscle repair and growth. Skeletal muscle regeneration relies on a 
coordinated effort from inflammation, myoblast proliferation and differentiation 
(myogenesis), and ECM remodeling. It has been heavily supported in the literature that 
exercise can be beneficial in functional movement, reduction in body weight, and muscle 
growth (Kraemer et al., 1999; Rubenstein et al., 2000; Shumway-Cook, Gruber, Baldwin, & 
Liao, 1997). Certainly, the overall objective for sarcopenic obese individuals is to increase 
lean mass and reduce fat free mass because both sarcopenia and obesity are associated with 
reduced regenerative capacity in skeletal muscle, insulin resistance, systemic low-grade 
2  
inflammation, and altered ECM remodeling (Barrett-Connor, 1990; Gregor & Hotamisligil, 
2011; Hotamisligil et al., 1996).  Nevertheless, both sarcopenia and obesity contribute to 
reduced mobility which may prevent sarcopenic obese individuals in participating in 
resistance training and aerobic activity. The literature review for this topic will focus on 
sarcopenic obesity and skeletal muscle regeneration. The major areas of focus in muscle 
regeneration for this dissertation are 1) myogenesis 2) the inflammatory response and 3) the 




To better understand sarcopenic obesity both obesity and sarcopenia have to be clearly 
defined. Obesity is a metabolic disease involving excess adipose tissue that increases health 
risk. It is most commonly measured by body mass index (BMI). Individuals with a BMI 
within 25-30 kg/m2 are considered overweight whereas individuals that have a BMI ≥ 30 
kg/m2 are classified as obese. Measuring body fat percentage and Hip-Girth ratio are 
alternative methods to examine obesity. Classifying obesity is important because there are 
several health risk associated with the metabolic disease such as high blood pressure, systemic 
low-grade inflammation, and insulin resistance (Barrett-Connor, 1990; Gregor & 
Hotamisligil, 2011; Hotamisligil et al., 1996). Over time obesity can lead to pathological 
disease. Hence, obese individuals are more at risk for cardiovascular disease, diabetes, and 
stroke (Barrett-Connor, 1990; Steppan et al., 2001; Van Gaal, Mertens, & De Block, 2006).  
Within skeletal muscle specifically obese individuals exhibit delayed muscle regeneration, 
muscle fibrosis, increased advanced glycation of end products that is related to muscle 
stiffness that can negatively impact mobility (Akhmedov & Berdeaux, 2013; L. A. Brown et 
al., 2015; Gaens, Stehouwer, & Schalkwijk, 2013). 
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Sarcopenia was first defined by Rosenberg in 1989 as an age-related decline in muscle 
mass (Rosenberg, 1989). In the past few decades it has been redefined as progressive age-
related loss of muscle mass and associated muscle weakness (Lynch, 2011). There are many 
documented symptoms that are related to the loss of skeletal muscle mass including increase 
risk of falls, muscle frailty, decrease mobility, and reduced strength (Rubenstein et al., 2000; 
Shumway-Cook et al., 1997). In clinical research however the definition of sarcopenia is 
broader in scope. Individuals that suffer from certain disease and illnesses that have similar 
symptoms may be classified as sarcopenic. For the objective of this dissertation, Rosenberg’s 
definition will be used to examine sarcopenic obesity.  
The occurrence of sarcopenia in older adults is usually initiated in the fifth decade 
(Janssen, Heymsfield, & Ross, 2002). It is around this time that it is assumed that majority of 
the population will suffer from this disease. In a clinical setting sarcopenia is measured by the 
reduction in muscle mass, muscle strength, and/or physical performance (Stenholm et al., 
2008). The most common clinical equipment and testing for sarcopenia are DXA, handgrip 
strength, and usual gait speed (Stenholm et al., 2008). While there are several types of 
measurements to classify sarcopenia by decline in muscle mass, it is well accepted that a loss 
in muscle grip strength of 40% would be sarcopenia (Choong & Mak, 1991; Stenholm et al., 
2008). Although other studies have diagnosed sarcopenia by 2 standard deviations below or 
lower quintiles of muscle mass compared to young adults (Stenholm et al., 2008). In the 
literature a 30-50% loss of muscle mass is most common in older adults 50-80 year old 
(Lynch, 2011). Older adults who suffer from sarcopenia are also more susceptible to a 
reduction of size in type II muscle fibers than type I fibers (Muscaritoli et al., 2010). Thus, 
there is drastic decline in strength physical performance. Older adults with sacropenia will 
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also have a reduction in protein turnover, which may partially be involved with the reduction 
in muscle quality (Proctor, Balagopal, & Nair, 1998). It has been examined in older adults that 
there is roughly a 50% reduction in muscle stem cells or satellite cells that are needed in the 
muscle regeneration process. Although, satellite cells are important for muscle fiber repair and 
growth there are many factors involved that may impact the regenerative capacity (Conboy et 
al., 2005). Whether these symptoms or underlying mechanisms are involved in sarcopenic 
obesity is not very well known. 
Sarcopenic obesity can be defined as the age-related decline in mass while excessive 
adipose tissue is preserved or gained (Santilli, Bernetti, Mangone, & Paoloni, 2014). It has 
been reported that sarcopenic obesity is more closely associated with metabolic syndrome 
than either disease alone (Lim et al., 2010). This is due to the evidence discovered in 
numerous studies linking both sarcopenia and obesity to increase mortality and metabolic 
diseases (J. C. Brown, Harhay, & Harhay, 2014; Fried et al., 2001; Stenholm et al., 2008). 
This is troubling to sarcopenic obese individuals because the combination of the two co-
morbidities could be more damaging to skeletal muscle integrity, repair, and function, but it’s 
classification as a metabolic syndrome is milder because it is less understood. It has been 
suggested that both sarcopenia and obesity may work synergistically to negatively impact 
mobility, mortality, and metabolism (Fried et al., 2001; Proctor et al., 1998; Rejeski, Marsh, 
Chmelo, & Rejeski, 2010). Recent investigations examining sarcopenic obesity have reported 
reductions of muscle loss that is not based solely muscle mass decline (Santilli et al., 2014). It 
has also been reported that sarcopenic obese individuals have altered muscle composition due 
to fat infiltration in the muscle (Santilli et al., 2014). Excessive fat infiltration in skeletal 
muscle has been linked to a decline in muscle quality and physical performance (Santilli et al., 
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2014). Systemic low grade inflammation is also exhibited in sarcopenic individuals and may 
be of more concern then sarcopenic or obese individuals. Chronic signaling of inflammatory 
cytokines has been reported to promote muscle wasting and apoptosis. The pro-inflammatory 
cytokine serum IL-6 is associated with excess adipose tissue while TNF-α is inversely related 
with total muscle mass (Cesari et al., 2005; Schaap, Pluijm, Deeg, & Visser, 2006). 
 
Sarcopenic obesity Animal model 
 
There are very few published studies investigating sarcopenic obese mice and 
therefore the animal model is relatively new. From a clinical standpoint obese mice that 
exhibit muscle wasting by disease or genetic modification have been examined (Nilsson et al., 
2013). The common model used are middle aged mice and rats that have a deletion of the 
leptin gene. As a result these mice will gain excessive body fat due to higher rates of food 
consumption. A more physiological model to examine sarcopenic obesity is diet-induced 
obesity in old mice. In this model the C57BL/6 strain is given a western or high-fat diet to 
mimic the excessive calories consumed in western countries. These mice will be kept on this 
diet until tissue extraction for biochemical analysis. Tissue extraction in these mice will take 
place at 18-24 months of age which would be the human equivalent of 56-69 years old. The 
current studies in the literature using this model are predominately focused on heart and liver 
tissues. There have been a few investigations in sarcopenic obese muscle, but the majority of 
these studies are in human models where cellular mechanisms are overlooked.  
Myogenesis 
 
 Once muscle damage occurs from physical activity or exercise, the muscle will have to 
repair and remodel. This process is known as skeletal muscle regeneration. One aspect of 
muscle regeneration is the formation of muscle tissue through stem cells, which is termed 
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myogenesis. There are several phases that are involved with myogenesis including satellite 
cell (SC) activation, myoblast proliferation, myoblast differentiation, and fusion to the 
myofiber. SC cells are muscle progenitor cells that have the capability to proliferate and 
differentiate into myoblasts. Moreover, SC activity is tightly regulated by transcription factors 
or myogenic regulatory factors (MRF) that will bind to the E-Box region of the DNA 
sequence (Satoh, Araki, & Satou, 1996). At rest almost all SC cells are localized under the 
basement membrane beneath the basal lamina and nearly all SC cells will express the 
transcription factor paired box homeotic gene 7 (Pax7).  
Upon skeletal muscle damage, quiescent satellite cells will become activated and the 
majority of the population will express Pax7 and myogenic differentiation (MyoD). MyoD is 
a basic helix-loop-helix transcription factor that is expressed during myoblast proliferation 
and differentiation and is important for myogenic commitment. Upon, SC activation nearly all 
cells will express MyoD within 24 hours (Zammit et al., 2002). Once MyoD expression is 
upregulated, SC cells will begin to co-express the MRF myogenic factor 5 (Myf5), which is 
necessary for proliferation of myoblast (Grefte, 2011). In fact, MyoD is tightly regulated by 
Myf5 as well as Pax3 and Six homeoproteins (Relaix et al., 2013).  
It has been demonstrated that growth factors and cytokines may also be involved with 
the regulation of MyoD (Engert, Berglund, & Rosenthal, 1996; Serrano, Baeza-Raja, 
Perdiguero, Jardi, & Munoz-Canoves, 2008). There are also several negative regulators of 
MyoD including myostatin and TGF-β signaling that are necessary too for myogenesis so that 
myoblasts can enter the later stages to ultimately lead to myofiber repair and growth (Langley 
et al., 2002). Chronic activation of these signals, however, can be very detrimental to the 
regenerative process (Burks & Cohn, 2011). Myoblast proliferation will reach its peak about 
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2-3 days after injury and will transition into myoblast differentiation to form myotubes. At 
this point Pax7 will be downregulated and the myoblast will express MyoD, myogenic factor 
4 (myogenin), and in some cases Myf5. The expression of both MyoD and myogenin has been 
reported as early as 12 hours, although the peak of myogenin is around 3 days (Rantanen, 
Hurme, Lukka, Heino, & Kalimo, 1995).  
Myogenin is a MRF that is essential for the initiation of terminal differentiation and 
fusion (Yin, Price, & Rudnicki, 2013). Myogenin is also involved with the regulation of the 
contractile proteins myosin and actin to restore muscle function (Benchaouir et al., 2007). 
Moreover, myogenin can repress Pax7 expression to promote its major functions (Olguin, 
Yang, Tapscott, & Olwin, 2007). It has recently been discovered that myogenin expression 
can be regulated by MyoD (Gillespie et al., 2009). Because binding is essential for MRFs to 
promote their function, they can be negatively regulated by proteins that do not allow them to 
bind to the E-box region. Ids are a group of proteins that will take the place of MRFs and 
heterodimerize with E proteins at the E-box (Yin et al., 2013). This will allow the cessation of 
myogenesis following muscle damage. Thus, MRFs are essential in muscle repair and 
recovery from muscle damage and are tightly regulated by numerous proteins that are 
localized in the muscle tissue. 
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Inflammatory response and Skeletal muscle 
The inflammatory response is regarded as the first responders during skeletal muscle 
regeneration. As such, non-resident phagocytes and other inflammatory proteins will migrate 
to the site of injury. Moreover, these inflammatory proteins will be involved in the early 
stages of repair including clearance of necrotic tissue, myoblast proliferation, and 
differentiation. As muscle regeneration continues there is a shift in function to focus on 
migration, fusion, and remodeling of the musculature. Anti-inflammatory proteins will 
regulate these processes and macrophages will secrete these proteins to facilitate these 
changes. Hence, inflammation has a regulatory role all throughout muscle regeneration.  
It has been reported in numerous metabolic and pathological diseases that expression and 
concentration of these inflammatory proteins and signals are altered that will negatively 
impact the regenerative capacity of skeletal muscle tissue. More specifically, sarcopenic 
obesity has been classified as metabolic syndrome that reduces regenerative capacity and 
leads to skeletal muscle loss. Therefore, it is imperative to identify the changes in the 
inflammatory response so that future interventions and therapeutics can be utilized to optimize 
skeletal muscle regeneration in sarcopenic obese individuals. 
 
Phagocytes & Cytokines 
 
Upon skeletal muscle damage there have been several cytokines observed in the 
skeletal muscle that are upregulated. Interleukin-6 (IL-6) and tumor necrosis factor alpha 
(TNF-α) have been examined extensively in regards to muscle regeneration because they are 
necessary for optimal regeneration and have many regulatory functions (S. E. Chen et al., 
2005; T. A. Washington et al., 2011; Zhang et al., 2013). IL-6 is a pleiotropic interleukin 
protein that is a part of the IL-6 family. During infection or injury IL-6 is upregulated to 
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promote an immune response that will protect against pathogens and cellular damage. Upon 
skeletal muscle regeneration specifically, IL-6 will be secreted by resident and infiltrating 
macrophages which will promote a pro-inflammatory response. It has been well documented 
that IL-6 can function as anti-inflammatory myokine when secreted by muscle cells (Petersen 
& Pedersen, 2005). In addition, IL-6 is secreted by over 20 other cell types and common 
mesenchymal cells to perform diverse functions (Croker et al., 2003; Kamimura, Ishihara, & 
Hirano, 2003). At the onset skeletal muscle damage, IL-6 will bind to its signaling receptor 
glycoprotein 130 (gp130), which will activate a signaling cascade that ultimately results in 
cell growth, proliferation, and differentiation. Once gp130 is activated, Janus kinase (JAK) 
will bind to membrane proximal region of the receptor and gp130 will be phosphorylated 
(Croker et al., 2003; Heinrich et al., 2003). Phosphorylation of gp130 allows signal 
transducers and activators of transcription (STAT) to dock on Src Homology 2 (SH2) of the 
tyrosine kinase JAK1. Once phosphorylated, STATs will form dimers and translocate to the 
nucleus where the will function as transcription factors along with other proteins to regulate 
cell function. IL-6 signaling leads to dimerization of predominately STAT3 (Tyr705) along 
with STAT1.  
IL-6 signaling will increase exponentially upon infection and/or trauma thus there are 
multiple inhibitors and phosphatases responsible for the deactivation and degradation of IL-6. 
Specifically, examining myotoxin induced muscle damage IL-6 has been observed on average 
to increase 10–fold 48 hours following damage (Hirata et al., 2003). It has been established 
that both PIAS and SOCS can suppress IL-6 activity to control its function (Croker et al., 
2003; Heinrich et al., 2003). It has also been reported that the upregulation of IL-6 at the onset 
of regeneration increases myoblast proliferation and differentiation and is necessary for the 
10  
regenerative process (Kamimura et al., 2003; Toth et al., 2011; Zhang et al., 2013). However, 
it appears that the overexpression of basal IL-6 in skeletal muscle has been implicated in 
muscle pathological disease states such as DMD, cachexia, and myopathies (Iwase, 
Murakami, Saito, & Nakagawa, 2004; Lundberg, Brengman, & Engel, 1995). IL-6 is one of a 
few cytokines that are observed in nearly all obese individuals that will exhibit low-chronic 
grade inflammation. However, these individuals may have a reduction in muscle IL-6 at rest 
and a blunted response of IL-6 expression in muscle a few days following muscle damage (J. 
C. Brown et al., 2014).  
In aging individuals it appears that basal levels of IL-6 in skeletal muscle are similar to 
younger adults while levels of skeletal muscle IL-6 expression may be different following 
exercise (Hamada, Vannier, Sacheck, Witsell, & Roubenoff, 2005; Pedersen et al., 2004; 
Przybyla et al., 2006). A few studies reported a significant upregulation of skeletal muscle IL-
6 following muscle damage (Pedersen et al., 2004; Przybyla et al., 2006). In contrast, Hamada 
and colleagues observed a significant increase of skeletal muscle IL-6 mRNA expression in 
younger adults, but did not find any differences in IL-6 mRNA expression following exercise 
in older adults (Hamada et al., 2005). Whether IL-6 expression is blunted in older adults 
remains unclear. Moreover, the fate of IL-6 is uncertain in older adults. It is not known if IL-6 
signaling is leading towards an anti-inflammatory response by STAT3 activation or a pro-
inflammatory immune response. When IL-6 is membrane bound to the IL-6 receptor (IL-6R), 
it will activate STAT3 and have anti-inflammatory effects. This is referred as classical IL-6 
signaling. IL-6 trans signaling occurs in chronic inflammatory disease states and leads to 
activation of the immune system (Kishimoto, 2006). Thus, IL-6 signaling needs to be further 
explored in aging and sarcopenic obese adults. 
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TNF-α is a pro-inflammatory cytokine that is a member of the TNF family and is known 
for its role as a pro-apoptotic gene. In classical signaling, the TNF-α ligand will bind to either 
TNFR1 or TNFR2 transmembrane receptor. A major target of TNF-α, Nuclear Factor-κB 
(NF-κB), is involved with promoting apoptosis in various cells including muscle cells. NF-κB 
has multiple isoforms, which are involved with different outcomes of the cell. Typically in 
skeletal muscle the p50/p65 heterodimer will be activated and will lead to cellular apoptosis. 
Because TNF-α is a pro-apoptotic cytokine and is necessary for skeletal muscle regeneration 
it has been examined for its involvement of damaged tissue (S. J. Chen et al., 1999). 
Pathological and metabolic diseases have demonstrated that increased levels of chronic 
systemic TNF-α expression are involved with muscle wasting (Argiles, Busquets, Toledo, & 
Lopez-Soriano, 2009; Cai et al., 2004; Tisdale, 1997). Chronic systemic inflammation is also 
found in aging and obese populations as well (Chmelar, Chung, & Chavakis, 2013; Gregor & 
Hotamisligil, 2011). Far less is known about TNF- α signaling at basal levels and during acute 
regeneration in skeletal muscle. In human studies with various exercise interventions both 
TNF-α has been reported as either no change or upregulated in elderly skeletal muscle 
compared to younger adults (Peake, Della Gatta, & Cameron-Smith, 2010). Thus, IL-6 and 
TNF signaling are crucial components in the skeletal muscle regeneration process with 
distinct roles. Furthermore, alterations in these cytokines can have a negative impact on 
regenerative capacity and should be further examined in sarcopenic obese populations.  
 
Recruitment and infiltration of phagocytes 
 
One process involved with the initial inflammatory response during skeletal muscle 
regeneration is infiltration of phagocytes (Kharraz, Guerra, Mann, Serrano, & Munoz-
Canoves, 2013; Kragstrup, Kjaer, & Mackey, 2011; Serrano et al., 2008; Thornell, 2011; 
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Yang et al., 2012). Non-resident phagocytes play a predominant role in phagocyte recruitment 
and plasma proteins to remove damaged tissue and repair skeletal muscle (Zhang et al., 2013). 
Resident macrophages perform these functions as well, but to a lesser extent. At the onset of 
muscle damage, resident macrophages located at the epimysium and perimysium connective 
tissue will secrete muscle cytokines that will serve as a chemoattractant to phagocytes and 
plasma proteins to the site of damage (De Bleecker & Engel, 1994). These recruited 
phagocytes will remove necrotic tissue and aid in the repair and remodeling of the skeletal 
muscle tissue. Neutrophils are the first phagocytes to infiltrate the endothelium to the site of 
injury. Their role in regeneration is not completely understood in skeletal muscle but they 
may take partial responsibility in removing damaged tissue and facilitating myoblast 
proliferation (Cassatella, 1999). After 48 hours neutrophils are downregulated whereas 
macrophage infiltration is increased. Macrophages are activated monocytes that phagocytose 
microbes and damage tissues and are necessary in the muscle regeneration response (Kharraz 
et al., 2013). The recruitment of neutrophils and monocytes (non-activated macrophages) is a 
coordinated response between several specific ligands and receptors.  
Recruitment of phagocytes and inflammatory cells is a multi-step process that has been 
studied extensively in the immune response. Furthermore, phagocyte recruitment in regards to 
muscle damage is an emerging field in the muscle regeneration process. Cytokines, 
chemokines, integrins, and adhesion molecules are important proteins in the recruitment 
process. Adhesion molecules are a group of proteins that are involved with recruiting 
circulating phagocytes for infiltration into the skeletal muscle tissue. Naïve neutrophils and 
monocytes have receptors that correspond with selectins and integrins that will bind with 
specific ligands on the endothelium. The sheer force of blood will cause the phagocytes to roll 
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on the endothelium wall until the muscle cytokine, which serves as a chemoattractant, 
recognizes a chemokine receptor on the immune cell. Afterwards, a conformational change 
will take place on an integrin, which is a cell surface protein that is involved with cell-cell 
adhesion. The β2 integrin will change from a low to high confirmation and tether the 
phagocyte near the site of damage. The tethering of the phagocyte will lead towards 
infiltration into the extracellular matrix, then towards damaged skeletal muscle tissue. Each 
phagocyte has a specialized β2 heterodimeric integrin that is involved with migration and may 
explain for the difference in regulation. The integrin located on neutrophils is called 
lymphocyte function-associated antigen 1 (LFA-1) whereas macrophages integrins are called 
macrophage-1 antigen (Mac-1 or αMβ2). Intercellular adhesion molecule 1 (ICAM-1) is an 
adhesion molecule and a member of the immunoglobulin family that binds with LFA-1 and 
Mac-1 (Dearth et al., 2013). ICAM-1 consist of five extracellular domains, a transmembrane, 
and cytoplasmic tail (Gahmberg, Tolvanen, & Kotovuori, 1997). The extracellular 
immunoglobulin domain, CD11b, has been implicated as an essential domain for binding to 
β2 integrins (Gahmberg et al., 1997).  
The induction of adhesion molecules have been investigated in skeletal muscle growth, 
regeneration, and disease. Dearth and colleagues investigated ICAM-1 in a muscle overload 
animal model, because ICAM-1 interacts with β2-integrins that is needed for macrophage 
infiltration during muscle damage. The authors suggested that the overexpression of the 
ligand ICAM-1 may be beneficial during muscle regeneration to improve the migration of 
immune cells (Dearth et al., 2013). Sonnet examined whether ICAM-1 is expressed upon 
muscle regeneration and its functional role in skeletal muscle (Sonnet et al., 2006). The 
researchers discovered that not only was ICAM-1 expressed in muscle upon regeneration, but 
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that it is involved in the survival of macrophages (Sonnet et al., 2006). De Bleecker and Engel 
examined ICAM-1 and its expression in myopathies associated with chronic inflammation 
(De Bleecker & Engel, 1994). They reported an upregulation of ICAM-1, which was 
associated with an increase of cytokines in the muscle. Thus, ICAM-1 may have supported the 
chronic influx of macrophages to the site of muscle damage that could alter inflammation 
signaling.  
Whether or not these alterations occur in aging or obese population have yet to be 
explored. Previously mentioned older adults and obese individuals exhibit chronic systemic 
low grade inflammation, but there inflammatory profile may be reduced in skeletal muscle. It 
has been observed in skeletal muscle of obese mice that macrophage count is reduced a few 
days following injury (Nguyen, Cheng, & Koh, 2011). Moreover, it appears that inflammatory 
cytokines are reduced in skeletal muscle of obese mice and that cytokine secretion is blunted 
at the onset of muscle damage (L. A. Brown et al., 2015). Yet, it has not been investigated if 
adhesion molecules may be responsible for the reduction of inflammatory signaling in obese 
or aging skeletal muscle. This process warrants further investigation in obese, aging, and 




Macrophages serve many functions to assist in the regenerative process of skeletal 
muscle. The two primary functions are, a) removing damaged or necrotic tissue, and b) 
repairing and remodeling. The function that a macrophage will perform is dependent on the 
phenotype and the changing of the functional state is referred as macrophage polarization. M1 
macrophages are known as classically activated macrophages that will remove 
damaged/necrotic tissue. In contrast, M2 macrophages (alternatively activated macrophages) 
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are partially responsible for the repair process (Zhang et al., 2013) (Figure1-1). M2 
macrophage subsets include M2a, M2b, and M2c which are mediated by cytokines, hormones, 
and signals and are based on the state of the cell (Martinez & Gordon, 2014). M2a 
macrophages are mediated by IL-4 and IL-13 and primarily function to kill parasites and 
protect against allergic reactions (Martinez & Gordon, 2014). M2b macrophages are mediated 
by toll-like receptor ligands and immune complexes and serve as immunoregulatory 
macrophages (Martinez & Gordon, 2014). Finally, M2c macrophages are mediated by IL-10 
and TGF-β and are involved in matrix deposition and tissue remodeling (i.e. muscle damage 
from injury) (Martinez & Gordon, 2014). No matter the phenotype, macrophages will secrete 
cytokines that promote their function. The homeostatic balance between the two phenotypes is 
key for optimal skeletal muscle regeneration (Rigamonti & Zordan, 2014). In a normal 
response to muscle damage after an exercise bout, initially M1 macrophages will be expressed 
during regeneration followed by a phenotypic switch towards M2 macrophage expression. If 
the balance between the phenotypes are modified, it may result in less optimal muscle 




Figure 1-1. Macrophage Polarization. Adapted from Cellular and molecular biology by A. K. 
Abbas, A. H. H. Lichtman, S. Pillai, 2011, . Philadelphia, PA: Elsevier Saunders. Copyright 
2011. 
 
The adaptive immune system is primarily responsible for regulating macrophage 
phenotype. After damage occurs to the skeletal muscle tissue, dendritic cells will present the 
damaged peptides to T lymphocytes. The T lymphocytes will recognize the damaged tissue 
with the T cell receptor and will begin the differentiation to either a TH1 or TH2 cells. TH1 
cells will secrete IFN-γ, which dictates a pro-inflammatory response by M1 macrophages. M1 
macrophages will secrete pro-inflammatory cytokines such as IL-6, IL-1β, and TNF-α. IL-6 
will signal through the JAK2/STAT3 pathway leading to cell survival of monocytes, T-
lymphocytes, and B-lymphocytes. TNF-α and IL-1β will signal through the NF-κB pathway. 
This response is necessary in the inflammatory response because it promotes acute 
inflammation and stimulates the adaptive immunity. M1 macrophages appear to be 
upregulated during myoblast proliferation and may aide in myoblast proliferation (Toth et al., 
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2011). Toth and colleagues wanted to determine whether or not IL-6 played a role in muscle 
regeneration because skeletal muscle cells secrete IL-6 after damage around the same time 
point myoblast begin proliferation (Hiscock, Chan, Bisucci, Darby, & Febbraio, 2004; Toth et 
al., 2011). STAT3 is a downstream target of IL-6 known to increase expression c-Myc (Kiuchi 
et al., 1999). Increased c-Myc expression induces proliferation in myoblast cells (Z. Li et al., 
2012). Toth found that induction of STAT3 by IL-6 occurred in the nuclei of human satellite 
cells following eccentric contraction (Toth et al., 2011). Overall, classical activation of M1 
macrophages are required for the earlier response in regeneration. 
Conversely, TH2 will mediate anti-inflammatory cytokines such as IL-13 and IL-14 
that will facilitate a change from M1 to M2 expression. M2 macrophages will promote wound 
repair and ECM remodeling. To date, IL-10 and TGF-β are the most understood anti-
inflammatory cytokines secreted by M2 macrophages. TGF-β has many functions in skeletal 
muscle regeneration, the most important being skeletal muscle repair. TGF-β commonly 
signals through Smad proteins and promotes growth of collagen, fibroblast, and increases in 
matrix proteins. In addition, TGF-β will reduce the activation of neutrophils and 
macrophages. IL-10 is a negative feedback regulator of M1 macrophages that signals through 
JAK1 and TYR2/STAT3 signaling. It can also be signaled by regulatory T cells that are 
involved with suppressing the immune response. Nevertheless, IL-10 is partially involved in 
bringing expression of inflammation back to baseline levels. Regulation of the switching 
between the two phenotypes is still not well understood and requires further investigation. M2 
macrophages may also promote myoblast differentiation (Sakaguchi et al., 2014). One study 
focused on the function of M2 macrophages 3-5 days post muscle damage in vitro and in vivo. 
The study observed that in vitro, differentiating myoblast in M2 macrophage media 
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upregulated differentiation markers, myogenin and MyHC (Sakaguchi et al., 2014). They 
concluded that M2 macrophages may need to be further explored in terms of differentiation 
but may be necessary for the differentiating phase of muscle regeneration (Sakaguchi et al., 
2014). 
The balance between M1 and M2 macrophages is very delicate in the regeneration 
process. Prolonged expression in either macrophage phenotype can lead to a suboptimal repair 
in skeletal muscle fibers (Villalta et al., 2009; Yang et al., 2012). Yang and colleagues 
reported distinct differences between lean and obese mice in the ratio between M1/M2 
macrophage expressions (Yang et al., 2012). They included SIRT1 knockout (MSKO) mice in 
their experiment because it is a master regulator of metabolism and inflammation (X. Li, 
2013; Yang et al., 2012). They found that deletion of SIRT1 switched M2 alternative 
macrophages activation to M1 classical activation. They also found increases in total M1 
macrophages expressed in adipose tissue in MSKO mice (Yang et al., 2012). An imbalance of 
M2/M1 is also not favorable in certain tissues. Prolonged expression of M2 occurs in 
muscular dystrophies (Yang et al., 2012). Villalta noticed that during muscle regeneration that 
there was a severe reduction in M1 expression in mdx mice (Villalta et al., 2009). After 
further investigation, it appeared that M2 macrophages inhibit the expression of M1 
macrophages. Thus, individuals that suffer from muscular dystrophies may benefit from 
therapies that improve M1 macrophages early in the regeneration process (Villalta et al., 
2009). 
In conclusion, the balance between M1 and M2 macrophages is essential in 
regenerating skeletal muscle fibers. M1 macrophages will be upregulated first to promote the 
removal of damage necrotic muscle tissue. Afterwards, anti-inflammatory M2 macrophages 
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will assist in the repair and remodeling of muscle tissue. Prolonged responses in both M1 and 
M2 macrophages have been shown to negatively impact repair of skeletal muscle tissue. Thus, 




Extracellular matrix of skeletal muscle 
 
The extracellular matrix (ECM) provides structural support to skeletal muscle and is 
comprised of several proteins that serve a variety of functions in skeletal muscle such as 
repair, growth, remodeling, and stability. The earliest experiments described the ECM as only 
a structural protein to support functional movement and resist tension from stress. Yet, in the 
past few decades this notion has been disproven through deeper investigation. Studies 
examining localization of dormant SC cells, growth factors, myokines, and resident 
macrophages that are involved in the regenerative process have discovered that these proteins 
all reside in the basement membrane of the ECM. Hence, following studies have uncovered 
physical interactions with ECM proteins and proteins involved with skeletal muscle 
regeneration. Furthermore, upon mechanical stress ECM proteins will initiate the regenerative 
process and the inflammatory proteins that reside in the ECM will assist in the regulation of 
ECM remodeling for optimal regeneration. Thus, the extracellular matrix is more than just a 
structural protein for muscle, it is essential in muscle repair and is involved with other 
processes that are necessary for muscle function.  
The extracellular matrix requires tight regulation because it is comprised of several 
proteins that all perform diverse functions in numerous processes. It has been demonstrated in 
metabolic and pathological diseases that the ECM will be dysregulated and reduce the 
regenerative capacity of skeletal muscle. The major consequence in altered ECM is skeletal 
muscle fibrosis, which can be defined as improper healing of connective tissue leading to scar 
tissue formation. As a result of fibrosis there is a reduction of force transmission (muscle 
weakness) and stability of the muscle (excessive muscle stiffness) as well as sub-optimal 
muscle regeneration upon damage. Thus, it is essential to know about the components that 
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comprise the ECM and understand the remodeling process upon muscle damage to identify 
potential problems in regenerating muscle of sarcopenic obese individuals. 
 
ECM structure and function 
 
The ECM is localized in several areas of skeletal muscle with a varied distribution of 
extracellular proteins to best suit its function (Light & Champion, 1984). The most outer layer 
of the ECM is referred as the epimysium, which is the sheath that covers the entire belly of 
the muscle and extends to the tendon. Collagen accounts for nearly a quarter of the connective 
tissue in the epimysium that is predominately collagen I and has minor amounts of collagen 
III (Light & Champion, 1984). The ECM that covers the surrounding muscle bundles along 
with the blood vessels and nerves is the perimysium. Collagen comprises nearly all of the 
connective tissue content in the perimysium and is predominately Collagen I with a minor 
amount of Collagen III and trace amounts of Collagen V (Light & Champion, 1984). Lastly, 
there is the endomysium that covers each individual muscle fiber and is in direct contact of 
the basement membrane where quiescent SC cells reside. The blood vessels and nerves will 
actually extend into the endomysium. The endomysium is comprised predominately of 
collagen I and collagen III fibrils and accounts for half of the connective tissue content (Light 
& Champion, 1984). Macrophages, adipocytes, and fibroblast cells are all localized in the 
endomysium and are involved in the skeletal muscle regeneration process. Overall, skeletal 
muscle ECM makes up about 5% of the skeletal muscle dry weight and is comprised of 
collagens, glycoproteins, glycoaminoglycans, and proteoglycans (Light & Champion, 1984; 
Schiaffino & Partridge, 2008). 
 
Collagens are the most abundant proteins in the human body that are highly diverse in 
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composition (Myllyharju & Kivirikko, 2004). The collagen family is composed of 3 
polypeptide α chains that are coiled into a triple helix configuration that allow them to be 
structural proteins by nature (Schiaffino & Partridge, 2008). Collagens are rich in glycine, 
proline, and hydroxyproline. The proline in collagen is responsible for maintaining the 
formation of helical orientation of each alpha chain. Glycine is essential in the structure of 
collagen because of its size. Glycine is the only amino acid that can fit in the interior of the 
helical collagen structure. All collagens have at least one rod-like collagen domain and one 
noncollagenous domain. Collagen structures have tensile strength and elastic properties that 
allow functional movement in mammals whereas noncollagneous proteins in the ECM 
provide compressive strength. Collagen fibrils are synthesized by fibroblasts and are usually 
made up of 2 or more collagen isoforms. To date there are over 45 genes that code for 28 
isoforms of collagen (collagen type based on domain structure homology) that have been 
discovered in human tissue and organs (Mecham, 2011) (Table 1-1). Collagen types I-III, V, 
and XI are fibril forming collagens that are 285 kDa and provide tensile strength to the 
skeletal muscle (Table 1-1). Collagen I and III are the most abundant fibrillar collagens in 
skeletal muscle (Purslow & Duance, 1990). The composition of the basement membrane 








Type Class Distribution     
I Fibrillar dermin, bone, tendon, ligament 
II Fibrillar cartilage, vitreous  
III Fibrillar skin, blood vessels, intestine 
IV Network basement membranes  
V Fibrillar bone, dermis, cornea, placenta 
VI Network bone, dermis, cornea, cartilage 
VII 
Anchoring 
fibrils dermis, bladder  
VIII Network dermis, brain, heart, kidney 
IX FACIT cartilage, cornea, vitreous 
X Network cartilage   
XI Fibrillar cartilage, invertebral disc 
XII FACIT dermis, tendon  
XIII MACIT endothelial cells, dermis, eye, heart 
XIV FACIT bone, dermis cartilage  
XV MULTIPLEXIN capillaries, testis, kidney, heart 
XVI FACIT dermis, kidney  
XVII MACIT hemidesmosomes in epithelia 
XVIII MULTIPLEXIN basement membrane, liver 
XIX FACIT basement membrane  
XX FACIT cornea   
XXI FACIT stomach, kidney  
XXII FACIT tissue junctions  
XXIII MACIT heart, retina   
XXIV Fibrillar bone, cornea   
XXV MACIT brain, heart, testis  
XXVI FACIT testis, ovary   
XXVII Fibrillar cartilage   
XXVIII - dermis, sciatic nerve   
 
Table 1-1. Types, class, and composition of collagen. Adapted from Collagen: basis of life 
from S. Jain, H. Kaur, G. Pandav, A. Dewan, and D. Saxena, 2014, Universal Research 
Journal of Dentistry, 4, p.1. Copyright 2014 by Wolters Kluwer Medknow Publications. 
 
Collagen I is the most abundant form of fibrillar collagen in the human body that has been 
extensively researched in skeletal muscle biology. Collagen I is made up of nearly 1,000 
amino acids and is composed of two α1(I) chains and one α2(I) chain. Collagen I is known as 
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the thickest collagen fibrils (~ 400 kDa) in mammals. Upon, injury the COL1A1 gene is 
upregulated to increase collagen turnover at the site of injury. 
Collagen III has been examined less extensively as collagen I within skeletal muscle. One 
of the earliest findings of collagen III in skeletal muscle was documented in 1977 by Bailey’s 
meat science laboratory (Duance, Restall, Beard, Bourne, & Bailey, 1977). Collagen III is 
composed of three α1(III) chains. Similar to COL1A1, the COL3A1 gene is upregulated after 
muscle damage and is regulated by similar growth factors and myokines, but differences in 
upregulation may occur in traumatic injury and disease. Processing of collagen I and III are 
very similar, but several differences do exist in the post-translational steps during procollagen 
formation inside the fibroblast (Fleischmajer, MacDonald, Perlish, Burgeson, & Fisher, 1990). 
During post-translational modifications, Collagen III will lose a carboxy propeptide and then 
amino peptide, which is reversed in collagen I processing (Fessler, Timpl, & Fessler, 1981). 
Collagen III and I will actually share similar cleavage sites during post-translational 
modifications but use different proteinase specific enzymes (Morikawa, Tuderman, & 
Prockop, 1980). Collagen III is considered an incomplete processed collagen because the 
enzymes involved in processing leave a C-telopeptide and partially processed N-propeptide 
(Mecham, 2011). Thus, collagen III is a thinner collagen fibril that can withstand more 
deformation compared to collagen I. Flesichmajer and colleagues observed that collagen I 
with increasing diameter lack amino propeptides, whereas collagen III fibrils, which do not 
grow keep the amino propeptide on the surface (Fleischmajer et al., 1990). The amino 
propeptide specifically prevents the formation of thick collagen III fibrils. 
It has been suggested that collagen III is essential for fibrillogenesis, processing of 
collagen I and determination collagen I diameter (Liu, Wu, Byrne, Krane, & Jaenisch, 1997). 
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It is well known that collagen fibrils are made up of at least two collagen fibrils and that 
collagen III is co-localized in all collagen I tissues in humans (Liu et al., 1997; Mecham, 
2011). Liu et al., discovered that COL3A1 knockout mice had a reduction of collagen fibrils 
and disorganized fibrils (Liu et al., 1997).  
The synthesis of collagen is an important aspect of collagen turnover that takes place in 
many cell types including fibroblasts, myofibroblast, osteoblasts, fibroadipocytes, adipocytes, 
macrophages, mast cells, plasma cells, and leukocytes. These cells will reside on collagen 
fibers and will regulate collagen remodeling and turnover via cell-cell interactions (Kjaer, 
2004; Schiaffino & Partridge, 2008). Alterations in these cell populations can interfere with 
collagen structure and direct cell-cell interactions. For example, in hypertrophic obesity 
preexisting adipocytes will expand. The expansion of these cells will forcibly push collagen 
fibrils to the side. 
Fibril forming collagen synthesis involves many steps usually starting with mechanical 
stress. Upon mechanical load the ECM will serve as scaffold for the adhesion of cells that are 
mediated by glycoproteins, proteoglycans (PG), and integrins (Brakebusch, Bouvard, Stanchi, 
Sakai, & Fassler, 2002; Ingber et al., 1994; Kjaer, 2004). The interaction between the ECM 
and particular adhesion molecules will activate cellular signaling pathways (MAPK, PKC, 
NF-κB) and rearrangement of the cytoskeleton (Burridge & Chrzanowska-Wodnicka, 1996; 
Chiquet, Matthisson, Koch, Tannheimer, & Chiquet-Ehrismann, 1996; Reynolds et al., 2000). 
Concurrently, the glycosaminoglycan (GAG) side chains on PGs will be able to bind specific 
growth factors and present these factors to their respected receptor (i.e. TGF-β, IGF-1, FGF, 
VEGF) (Kjaer, 2004). The ECM can also release growth factors that is dependent on the level 
of mechanical stimulation (Kjaer, 2004). These growth factors will serve as transcription 
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factors and are responsible for the upregulation of collagen genes. Afterwards, translation of 
procollagen will take place in the endoplasmic reticulum of the fibroblast. Then the alpha 
chains are folded and procollagen will go through a series of posttranslational modifications 
before it is stable. The assembling of procollagen, conversion to collagen, and cross-linking of 
collagen fibrils are all major steps that finalize collagen processing. Collagen degradation 
involves specializes proteases known as matrix metalloproteinases (MMP) and will be 
discussed later in this section. 
Glycoproteins are another population of proteins in the ECM that are made up of an 
oligosaccharide chain and polypeptide side-chains. Fibronectin is one of the most researched 
glycoproteins in the ECM that is abundant in skeletal muscle. Fibronectin is a large (440 
kDa), fibril, adhesive glycoprotein that has a soluble, insoluble, and cell surface form. 
Fibronectin is responsible for binding to collagen as well as other important ECM proteins to 
assist in cell adhesion and migration (Kjaer, 2004; Mecham, 2011). More specifically, 
fibronectin will bind with collagen type I and III between residue 775 and 776 (Kleinman, 
Martin, & Fishman, 1979). This is important in regards to activated satellite cells that will 
need to migrate and interact with other cell types. Fibronectin will bind to integrins located on 
ECM proteins to activate several signaling pathways. It is evident that fibronectin is involved 
with the regenerative process because of its high affinity for denatured collagens (Jilek & 
Hörmann, 1978). Fibronectin is also classified as a fibrillogenesis organizer which is 
important process in ECM remodeling. Assembly of collagen fibrils with fibronectin require 
interactions with integrins and other collagen fibrils (Kadler, Hill, & Canty-Laird, 2008; Mao 
& Schwarzbauer, 2005). It has been demonstrated that the blocking of integrins on fibronectin 
will inhibit collagen fibril assembly. 
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The ECM in skeletal muscle is also comprised with several proteoglycans (PG) that have 
many distinct functions. PGs can be described as a specialized class of glycoproteins that are 
heavily glycosylated. All PGs are carbohydrate-rich soluble polyanions that are attached to a 
protein and glycosaminoglycan (GAG) chain (Scott, 1990). Glycoaminoglycans (GAGs) are 
long branched heteropolisacchrides that have repeating dissachaarides units with one or both 
sugars containing a sulfate group. The rigidity in GAGs structure assist in structural integrity 
of the ECM while allowing cell migration to take place. GAGs are highly negative molecules 
that bind and organize water molecules while repelling other negative molecules. This 
property of GAG allows lubricating fluid in joints. The most noted PGs that have been 
discovered in muscle are decorin, biglycan, and versican. One of the major roles of PGs in the 
ECM is to link collagen fibrils (Scott, 1990).  
Decorin is a small leucine rich proteoglycan (SLRP) named after its ability to decorate the 
collagen fibers (Mecham, 2011). Its major functions involve the assembly of collagen fibrils 
and the protection of the collagen from collagenases. Specifically, decorin works as a steric 
barrier that will prevent collagenase from accessing their cleavage site in most scenarios 
(Mecham, 2011). A reduction of decorin in tendons leads to larger diameter collagen fibrils 
and structurally abnormal fibrils (Ameye et al., 2002; Danielson et al., 1997). Decorin will 
bind and interact with fibril collagens and inhibit cell growth. The deletion of decorin slows 
bone growth and possibly skeletal muscle growth (Xu et al., 1998). Decorin can also bind 
with growth factors that regulate ECM proteins through binding with cell surface receptors. In 
addition, decorin signaling will lead to intracellular signaling (Mecham, 2011). Decorin has 
been classified as an antifibrotic reagent because it will bind and inactivate TGF-β (Kjaer, 
2004). MMPs will cleave decorin when bound to TGF-β to activate TGF-β activity. Decorin 
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works synergistically with TGF-β to inhibit myoblast differentiation and modulate myoblast 
proliferation (Mecham, 2011). Decorin can also interact with IGF-1 and myostatin (Miura et 
al., 2006). 
 
ECM Regulation  
 
As mentioned earlier, the extracellular matrix is very complex because it is composed of 
several different proteins that are involved with several processes that assist in wound healing 
and repair. As such, the ECM is tightly regulated by several factors including mechanical 
stress, inflammatory proteins, growth factors, and specialized proteases. The following 
cytokines are secreted by fibroblasts and other cells to regulate collagen turnover: IL-1α,β, IL-
6, and TNF-α. IL-1 is pro-inflammatory cytokine that has been implicated as an activator of 
MMPs to degrade collagen synthesis (Unemori et al., 1994). IL-1β is secreted by fibroblast 
upon mechanical loading to the tissue (Shimizu et al., 1994). IL-1β can also stimulate other 
signals involved with collagen turnover including MMP-1, MMP-3, IL-6, and COX-2 
(Tsuzaki et al., 2003). It has been suggested that inflammatory cytokines may also regulate 
ECM proteins through tissue inhibitors of matrix metalloproteinases (TIMPs) (Y. Y. Li, 
McTiernan, & Feldman, 1999). Li and colleagues have found that stimulation of IL-1β will 
increase TIMP-1 and suppress TIMP-3 mRNA expression and proteins in cardiac myocytes 
(Y. Y. Li et al., 1999). 
IL-6 is a pleiotropic cytokine that also promotes collagen degradation. Fibroblast cells will 
secrete IL-6 during tension to muscle and tendons (Kjaer, 2004). It has been suggested that 
pro-inflammatory cytokines also regulate MMP activity. In osteoblasts stimulated with either 
IL-1 or IL-6 induced MMP-2, MMP-3, and MMP-13 (Kusano et al., 1998). Interestingly, the 
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experiments performed by Kusano et al. reported that the increase in MMP mRNA was 
markedly enhanced by IL-1 but only moderately by IL-6 (Kusano et al., 1998). These results 
may suggest that regulation of MMPs is cytokine specific. Similar to IL-1 and IL-6, TNF-α is 
a pro-inflammatory cytokine secreted by macrophages and fibroblast cells that will also 
promote collagen degradation. It has been reported in cardiac fibroblast that the stimulation of 
TNF-α will induce MMP-3 activity (Siwik, Chang, & Colucci, 2000). This is supported by Li 
and colleagues that found TNF-α stimulation will downregulated TIMP-3 activity, an 
inhibitor of MMPs (Y. Y. Li et al., 1999).  
Perhaps more understood than inflammatory regulation of ECM proteins, growth factors 
are major regulators of ECM turnover and remodeling. TGF-β has been regarded as a master 
regulator and transcription factor of collagen I and III. TGF-β is secreted by macrophages and 
platelets that will assist in the regulation of ECM proteins and fibroblast activity. In vitro 
studies have demonstrated fold increases of collagen I and III in response to cardiac fibroblast 
in media supplemented with TGF-β (Butt & Bishop, 1997; Siwik et al., 2000). TGF-β will 
upregulate collagen genes transcription via Smad proteins (S. J. Chen et al., 1999; Ge et al., 
2012) and can also be upregulated independent of Smad signaling (Hocevar, Brown, & Howe, 
1999). TGF-β will also upregulate several other matrix proteins including aggrecan and 
biglycan  (Kjaer, 2004). TGF-β can also stimulate TIMPs that will reduce collagen 
degradation by inhibiting MMPs. The combination of TGF-β with mechanical loading has 
been shown to activate other growth factors such as connective growth factor (CTGF). 
CTGF’s role is prominent in wound healing specifically scar formation but is not very well 
understood skeletal muscle (Leask, Holmes, & Abraham, 2002). 
Fibroblast growth factor (FGF) is another essential stimulator of fibroblast activity that are 
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involved in collagen synthesis and perform other functions vital to ECM remodeling (i.e. 
fibroblast proliferation) (Harwood, Grant, & Jackson, 1976). Similar to TGF-β, FGF can also 
be activated by mechanical load and injury (Clarke & Feeback, 1996). It has been theorized 
that FGF may also play a role in intracellular communication from the conversion of 
mechanotransduction to biochemical signaling (Kjaer, 2004). Finally, Insulin-like Growth 
Factor (IGF-1) has been shown to increase collagen synthesis by stimulating fibroblast 
activity in vitro and in vivo (Butt & Bishop, 1997; Wilson, Rattray, Thomas, Moreland, & 
Schulster, 1995). However, IGF-1 itself can become inactivated through MMPs or pro-
inflammatory cytokines. Pro-inflammatory cytokines will also increase IGF-BP1 that will 
bind to IGF-1 and inactivate this growth factor (Samstein et al., 1996).  
Another essential regulator of collagen turnover are highly specialized proteases that are 
referred to as matrix metalloproteinases (MMPs). MMPs were first discovered in tadpoles in 
1962 and identified as zinc-dependent endopeptidases that operate as zymogens (inactive 
enzyme precursor) (Gross & Lapiere, 1962). MMPs are unique proteases that are members of 
the metzincin group, because they have a Met residue and zinc ion at the active site (Bode, 
Gomis-Ruth, & Stockler, 1993; Page-McCaw, Ewald, & Werb, 2007; Stocker et al., 1995). 
The latent form of MMPs will have a peptide (also known as pro-domain) that blocks the 
active or catalytic site of the protein (Libby & Lee, 2000; Page-McCaw et al., 2007). The pro-
domain will need to be cleaved, which can occur autocatalytically or heterocatalytically 
through the use of other active MMPs (Libby & Lee, 2000). Thus, the latent and active form 
of MMPs vary in size. There are over 20 known MMPs that degrade collagen and other ECM 
proteins (Table 1-2) (Page-McCaw et al., 2007). MMPs also participate in a variety of 
functions that promotes skeletal muscle regeneration including myoblast proliferation, 
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differentiation, and migration (Carmeli, Moas, Reznick, & Coleman, 2004; Lei, Leong, Smith, 
& Barton, 2013; Page-McCaw et al., 2007; Schiaffino & Partridge, 2008; Urso, Wang, 
Zambraski, & Liang, 2012). 
  









MMP2 Gelatinase A/ 72kDa gelatinase 
MMP9 Gelatinase B/ 92kDa gelatinase 
MMP12 Macrophage metalloelastase 
MMP7 Matrilysin/ Uterine 
MMP26 Matrilysin-2/ Endometase 
MMP14 MT1-MMP 





MMP25 MT6-MMP/ Leukolysin 










MMP22 MMP23B TM type II 
 
Table 1-2. MMPs function, localization and domain structure Adapted from Matrix 
metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and 
negative regulators in tumor cell adhesion by D. Bourboulia, and W. G. Stetler-Stevenson, 
2010, Seminars in cancer biology, 20, pp. 161-168. Copyright 2010 by Academic Press.  
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There have only been a few MMPs identified in skeletal muscle that serve a role in muscle 
repair and remodeling. Most notably, MMP-2 and MMP-9 have been implicated as essential 
proteases in the regenerative process, because they are highly expressed upon muscle damage 
and serve specific functions to promote repair and remodeling (Lei et al., 2013; Schiaffino & 
Partridge, 2008). Furthermore, they are unique in that they contain fibronectin type 2 repeats 
in their structure that allow collagen binding which allow these MMPs to release TGF-β from 
ECM proteins (Page-McCaw et al., 2007; Yu & Stamenkovic, 2000). MMP-2, MMP-7, 
MMP-9 are also involved with infiltration of inflammatory cells by the cleavage of ligands 
that are chemoattractants of macrophages and neutrophils (McQuibban et al., 2000; Overall, 
McQuibban, & Clark-Lewis, 2002). MMP-2 is transiently increased during injury, and is 
secreted by myoblasts amongst other cell types present in skeletal muscle (Kherif et al., 1999; 
Schiaffino & Partridge, 2008). Moreover, MMP-2 (Gelatinase-A) is responsible for the 
degradation of collagen I-V and can also degrade fibronectin, and other ECM proteins (Kherif 
et al., 1999; Page-McCaw et al., 2007). MMP-2 is constitutively active and its expression will 
peak at 7 days after muscle injury and will slowly decrease for weeks (Kherif et al., 1999; Lei 
et al., 2013). It has been reported that MMP-9 will also degrade collagen fibrils, but its 
regulation and activity suggest a different role than MMP-2. MMP-9 (Gelatinase-B) MMP-9 
is secreted and regulated predominately by inflammatory cells and expressed at very low 
levels until damage occurs in skeletal muscle (Kherif et al., 1999). MMP-9 is highly elevated 
24 hours following muscle damage and will return to basal levels around 2 weeks (Kherif et 
al., 1999). More recently, MMP-13 (Collagenase-3) has been demonstrated to assist in 
myoblast migration (Lei et al., 2013). MMP-13 is an interstitial collagenase that cleaves 
collagen I-IV and other ECM proteins (Freije et al., 1994; Leeman, Curran, & Murray, 2002). 
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MMP-13 can be activated by MMP-2, MMP-3, and MMP-14 (MT1-MMP) and can activate 
MMP-2 and MMP-9 (Lei et al., 2013). MMP-13 expression is induced 7 days following 
muscle injury and appears to peak at around 11 days (Lei et al., 2013). MMP-7 is also 
involved in skeletal muscle regeneration and skeletal muscle hypertrophy. MMP-7 is highly 
expressed by myoblasts and promotes migration of myoblasts (Caron, Asselin, Morel, & 
Tremblay, 1999). Other notable MMPs such as MT1-MMP, MMP-3, MMP-24, and MMP-25 
have been examined in skeletal muscle due to their regulation of ECM remodeling, but their 
specific role in the regenerative process has yet to be elucidated (Bernal, Hartung, & Kieseier, 
2005). 
Specific proteins named for their inhibition of MMPs, Tissue inhibitors of matrix 
metalloproteinases (TIMPs), have been identified as glycoproteins that have a high affinity for 
the active region of MMPs. The N-terminal regions of TIMPs bind with the catalytic domain 
of MMPs to inhibit their activity (Bourboulia & Stetler-Stevenson, 2010). Also, the C-
terminal region of TIMPs can interact with MMP-2 and MMP-9’s hemopexin domains to 
stabilize the inhibitor complex (Bourboulia & Stetler-Stevenson, 2010). Four TIMPs have 
been identified in mammals that can bind with all MMPs, but will have a higher affinity for 
certain MMPs (Bourboulia & Stetler-Stevenson, 2010; Mecham, 2011; Page-McCaw et al., 
2007; Schiaffino & Partridge, 2008). TIMP-1 has been identified to inhibit predominately 
MMP-1 MMP-3, MMP-7, and MMP-9 (Bourboulia & Stetler-Stevenson, 2010). TIMP-2 has 
been reported as an inhibitor of MT1-MMP and MMP-2 and is the only current TIMP known 
to also function as an activator of MMPs (i.e. MMP-2) (Bourboulia & Stetler-Stevenson, 
2010; Z. Wang, Juttermann, & Soloway, 2000). It has been reported that TIMP-1 and TIMP-2 
activity will increase following muscle damage (Hirata et al., 2003; Koskinen et al., 2001). 
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Hence, they will be involved in reducing MMP activity at certain time points of muscle 
regeneration. TIMP-3 and TIMP-4 activity, expression, and function have not been 
thoroughly examined in skeletal muscle, but their roles in MMP are being examined. Basal 
gene expression data has reported that TIMP-3 is highly expressed prenatally and will inhibit 
MMP-2 and MMP-9 (Bourboulia & Stetler-Stevenson, 2010). Whereas TIMP-4 is highly 
expressed in the brain, heart, and adipocytes and will inhibit MT1-MMP and MMP-2 
(Bourboulia & Stetler-Stevenson, 2010). Altogether, the regulation of collagen and other 
ECM proteins is sophisticated in nature and requires further examination to fully understand 
aging and pathophysiological disease. 
Overview ECM remodeling during muscle damage  
 
After exercise or administration of a myotoxin a cascade of signals will lead to optimal 
ECM repair and remodeling to best suit mammalian skeletal muscle function. Proteins and 
cells involved with ECM repair will be activated as early as a few minutes upon myotrauma. 
In exercise if mechanical load is sufficient, integrins will be activated and work as 
mechanosensors that will facilitate activation of cellular signaling pathways causing 
mecanotransduction (Ingber et al., 1994). Mechanical stress imposed on the cells will need to 
be converted to biochemical signals and it is theorized that FGF is involved with this process 
(Bishop, Butt, Dawes, & Laurent, 1998). At this point the MMP activation cascade will be 
induced first by self-activating MT1-MMP (Bonfil & Cher, 2011). The activation of MT1-
MMP will assist in the activating the rest of the proMMPs to active MMPs to start degrading 
collagen and ECM proteins and allowing the migration of mesenchymal cells. Concurrently, 
Resident inflammatory cells in skeletal muscle along with systemic inflammatory cells that 
have been successfully recruited and infiltrate the musculature will be activated (see events of 
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inflammation in skeletal muscle). Certain muscle cells and M1 macrophages will secrete the 
pro-inflammatory cytokines IL-6, IL-1, and TNF-α. In respect to ECM turnover, these 
cytokines will bind to their receptor and activate intracellular signaling pathway that will 
result in collagen degradation through MMP activation and downregulation of TIMPs. How 
these pro-inflammatory cytokines specifically activate latent MMPs is still unclear. MMP-2 
and MMP-9 will allow the release of growth factors that are bound on ECM proteins that are 
involved with myoblast proliferation and collagen synthesis. At the onset of muscle damage, 
fibronectin will be upregulated because it is has a high-affinity for denatured collagen and is 
involved in early steps of fibrillogenesis and proliferation of cells. MMP-1 will 
simultaneously be activated and will play a role in myoblast differentiation, migration, and 
collagen degradation (W. Wang, Pan, Murray, Jefferson, & Li, 2009). Furthermore, decorin 
will be upregulated to inhibit the myoblast proliferation. The MMPs involved with 
differentiation are also directly involved with myoblast migration or indirectly involved by 
activating MMPs involved in migration (MMP-9 and MMP-13) (Lo, Dalkara, & Moskowitz, 
2003). At about 14 days after muscle damage the remodeling of collagen fibrils will begin 
(Sato et al., 2003). Once new collagen is synthesized, Collagen V and XI known as nucleators 
will nucleate collagen fibrils for self-assembly (Blaschke, Eikenberry, Hulmes, Galla, & 
Bruckner, 2000; Wenstrup et al., 2004). Afterwards, ECM proteins involved with regulating 
fibril organization will regulate collagen fibrils. The organization of collagen fibrils including 
the interactions and packing of collagens are made possible by fibril-associated collagens with 
interrupted triple helix (FACIT) collagens (i.e. Collagen IX, XII, XIV, and XX) (Mecham, 
2011). Sevilla and colleagues has implicated that fibronectin is involved with fibril 
organization when observing Fibronectin-null mice with altered fibril formation (Sevilla, 
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Dalecki, & Hocking, 2010). The last documented step of fibrillogenesis is linear and lateral 
growth that is dictated by ECM regulators. SLRPs and FACITs are predominately responsible 
for fibril growth (Danielson et al., 1997). Studies involving SLRP deficient and FACIT absent 
mice have demonstrated that fibril growth is blunted (Ameye et al., 2002; Hemmavanh, Koch, 
Birk, & Espana, 2013). Thus, the ECM repair and remodeling process is intricate involving 
several process including inflammatory recruitment, infiltration, collagen biosynthesis, and 
fibrillogenesis. All of these processes are tightly regulated by growth factors and ECM 
proteins. Any alterations in expression of these ECM proteins and/or inflammatory cytokines 
may be detrimental to ECM remodeling. 
 
ECM during aging and obesity 
 
Aging and obesity are two populations with unique metabolic states and are associated 
with insulin resistance and chronic low grade inflammation. Although roughly a third of the 
world is currently overweight or obese, and a third of the global population is expected to be 
65 or older by 2040, little is known about ECM composition and remodeling in these groups 
(CDC). Moreover, virtually no research study has examined ECM composition and 
remodeling in the sarcopenic obese sub-population. As mentioned previously, aging is 
associated with many negative symptoms that cause a deficit in skeletal muscle mass. In 
regards to the ECM, collagen content appears to much higher than young adults. Brooks and 
colleagues found a 2-fold increase in hydroxyproline in old mice which is an indicator of 
collagen content (Wood et al., 2014).  Another outcome of aging is a reduction collagen 
turnover that alters the ECM (Bailey, 2001; Goldspink, Fernandes, Williams, & Wells, 1994). 
It has been reported in older adults that there is a reduction of collagen turnover and increased 
fibrosis that may suggest an imbalance in collage turnover. (Avery & Bailey, 2005; Kragstrup 
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et al., 2011). It has also been observed that fibril diameter decreases in older adults 
(Nakagawa, Majima, & Nagashima, 1994). This may be due to an upregulation of decorin 
which a major regulator of fibril diameter size. It is also known that collagen III is a small 
diameter fibril compared to collagen I that has more elastic properties. It may be possible that 
older adults will shift from collagen I to III expression. Tissue stiffness has also been 
identified in aging individuals (DeGroot et al., 2001). In younger adults that participate in 
chronic strength and power training muscle stiffness is a positive outcome from training. 
However, in older adults muscle stiffness is also observed. The muscle stiffness observed in 
younger adults is beneficial to sport and exercise performance and thus the mechanisms 
involved may differ than older adults. Muscle stiffness in older adults occurs from higher 
glycation of collagen fibrils (DeGroot et al., 2001). Glycation crosslinks are non-enzymic and 
occur when glucose reacts with collagen side-chains that form advanced glycation end 
products (AGE). This process will only occur in a low collagen turnover environment and will 
cause stiffness that is not functional for movement (Avery & Bailey, 2005, 2006). Other ECM 
proteins that play major roles in ECM remodeling such as fibronectin and decorin have not 
been thoroughly examined and require more attention. It is also important to mention that 
sarcopenia leads to muscle frailty and increased susceptibility to injury. Because ECM is 
involved with passive tension and force transmission, it is likely that alterations in the ECM is 
at least partially responsible for these conditions in older adults. 
There have been a couple reports that have discovered changes an ECM composition 
and remodeling in obese individuals as well. Hwang et al. examined an increase ECM gene 
expression in human skeletal muscle when increasing plasma lipids through infusion. 
Specifically, they found an increase in collagen I-VI, CTGF, fibronectin-1, MMP-2, MMP-11, 
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MMP-28, and TIMP-1 compared to leaner individuals (Hwang et al., 2010). In confirmation, 
Berria and colleagues reported an increase in hydroxyproline as well as collagen I and III in 
human skeletal muscle (Berria et al., 2006). More recently, it has been reported that 
fibrillogenesis and adipogenesis originate from common mesenchymal progenitors in skeletal 
muscle (Joe et al., 2010; Uezumi et al., 2011). Both PGFRα and fibroadipogenic cells have 
the ability to promote fibrosis and increase adipocytes in muscle tissue and have an increase 
concentration in obese individuals. Thus aging and obese have unique consequences that alter 
ECM composition and remodeling which may reduce the regenerative capacity and integrity 
of skeletal muscle tissue. Sarcopenic obesity must be examined to understand how the 
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SPECIFIC AIMS AND HYPOTHESES  
 
Specific Aim #1. To examine basal markers of regenerative capacity in skeletal muscle 
in C57BL/6 sarcopenic obese mice.  
Experiment #1. Experiment 1 tested the hypothesis that skeletal muscle mass and cross-
sectional area is reduced in sarcopenic obese mice. Muscle weight to tibia length and cross-
sectional area was measured to examine skeletal muscle mass in the gastrocnemius, tibialis 
anterior, and soleus. 
Experiment #2. Experiment 2 tested the hypothesis that myogenic transcription factors are 
depressed in sarcopenic obese mice at basal levels. RNA expression of MRFs were measured 
to examine composition in the gastrocnemius, tibialis anterior, and soleus. 
Experiment #3. Experiment 3 tested the hypothesis that inflammatory signaling is reduced 
in sarcopenic obese mice. Protein and RNA expression of muscle cytokines were measured 
to examine composition in the gastrocnemius, tibialis anterior, and soleus. 
Experiment #4. Experiment 4 tested the hypothesis that ECM promotes are upregulated in 
sarcopenic obese mice at basal levels. This was completed through examination of RNA 
expression of collagen I, collagen III, and proteins involved with collagen turnover in the 
gastrocnemius, tibialis anterior, and soleus. 
Specific aim #2. To examine monocytes/neutrophils activity in the muscle in 
sarcopenic obese mice during muscle regeneration. 
Experiment #1 Experiment #1 tested the hypothesis that there is a reduction of adhesion 
molecules in the tibialis anterior muscle. We induced muscle damage with through a 
myotoxin injection, bupivacaine. RNA expression of ICAM-1 etc. was examined as an 
indirect measure of activity.  
Experiment #2. Experiment 2 tested the hypothesis that there is a reduction of muscle 
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cytokines at the onset of muscle regeneration. RNA expression and protein levels of IL-6, 
TNF-α, STAT3, etc. will be examined as an indirect measure of activity. 
Specific aim #3.  To examine how sarcopenic obesity alters ECM remodeling during 
skeletal muscle regeneration. 
Experiment #1. Experiment 1 tested the hypothesis that collagen content is greater in 
sacropenic obese mice. This will be accomplished by examining stains of collagen I and 
collagen III. 
Experiment #2. Experiment 2 tested the hypothesis that ECM proteins and promoters of 
collagen are blunted in sarcopenic obese mice at the onset of muscle regeneration. The 
expression of RNA of collagen I, collagen III, fibronectin 1, and TGF-β were examined. 
Experiment #3. Experiment 3 tested the hypothesis that MMPs are exacerbated in sacropenic 
obese mice at the onset of muscle regeneration as a result of reduced TIMP-1 mRNA 
abundance. The expression of RNA of MMP-2, MMP-9, TIMP-1 were examined.
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WORKING MODEL   
The skeletal muscle regeneration 
process involves the coordination of 
the inflammatory response, activation 
of MRFs, and ECM remodeling. 
Several of these factors will be 
involved with regulating other aspects 
within muscle regeneration thus the 
repair process is tightly regulated. Because skeletal muscle is a coordinated response, changes 
in signaling in any of these factors may negatively influence the regenerative capacity of 
skeletal muscle tissue and result in sub-optimal muscle regeneration. For example, the absence 
of IL-6 will have impaired ECM remodeling and a decrease in myoblast proliferation and 
differentiation resulting in sub-optimal regeneration. 
It has been demonstrated that changes in muscle morphology and metabolic state can 
alter cellular signaling pathways involved with muscle regeneration. A previous study from 
our laboratory demonstrated changes in mice on a high-fat diet i.e. reduction of MRFs and 
cytokines at basal levels. These changes could influence regenerative capacity potential and 
favor muscle mass loss. Sarcopenia which is the loss of muscle mass due to aging, has a 
reduced regenerative capacity. The mechanisms involved with sarcopenia are not completely 
understood, but inflammation, MRF inactivity, and protein turnover has been implicated. As a 
result fibrosis and sub-optimal muscle regeneration are outcomes following muscle injury in 
older adults. These two co-morbidities both have sub-optimal regeneration and may work 
synergistically to negatively impact the regenerative process. 
Figure 2-1. Potential alterations in sarcopenic 
obesity 
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PRELIMINARY STUDIES  
The specific aims that were created for this dissertation stem from preliminary data from our 
lab. In our initial assessment of diet-induced obese mice, there was an increase in muscle 
weight and tibialis anterior weight relative to tibia length (Figure 2-2) (L. A. Brown et al., 
2015). This was not observed in the diet-induced obese mice (Figure 2-2) (L. A. Brown et 
al., 2015). This data suggested that muscle regeneration was impaired or possibly delayed in 








Figure 2-2. Skeletal muscle in 4 month old lean and obese mice 28 days following 
myotoxin-induced muscle damage. (A) tibialis anterior muscle weight, (B) tibialis anterior 
muscle weight to tibia length 
 
Following this study, old obese mice were obtained and muscle weights and tibia length 
were taken from both old 21 days following muscle damage. There was no difference 
between the injured and uninjured old obese mice (Figure 2-3) (L. A. Brown et al., 2015). 






A.       B.  
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Figure 2-3. Skeletal muscle in 22-24 month old obese mice 21 days following myotoxin-
induced muscle damage. (A) tibialis anterior muscle weight, (B) tibialis anterior muscle 
weight to tibia length. Abbreviation DIO = Diet-induced obesity 
 
Inflammation, MRFs, and the ECM were examined to further investigate whether skeletal 
muscle regeneration was impaired in these populations. The young obese mice had an 80% 
reduction of IL-6 expression in the TA compared to the young lean mice (Figure 2-4) 








Figure 2-4. IL-6 mRNA abundance in 4 month old lean and obese uninjured mice.  
 
A few days following muscle damage the young obese and lean mice had a similar response 
for upregulating IL-6 (data not shown). However, western blot analysis showed a blunted 
response of STAT3 in obese mice (Figure 2-5) (L. A. Brown et al., 2015). 
 




Figure 2-5. P-STAT3/STAT3 protein in 4 month old lean and obese mice 3 days following 
myotoxin-induced muscle damage. (A) lean, (B) obese. 
 
 
TNF-α expression was altered in obese mice as well. Upon skeletal muscle damage, TNF-α 
expression is upregulated because it is needed for skeletal muscle regeneration. Upregulation 
of TNF-α was blunted in obese mice 3 days following myotoxin-induced muscle damage 
(Figure 2-6) (L. A. Brown et al., 2015). 
 
 
Figure 2-6. TNF-α mRNA abundance in 4 month old lean and obese mice 3 days following 
myotoxin-induced muscle damage. 
 
 
Our lab also observed changes with basal MRF expression in young obese mice. Obese mice 
had more than a 20% reduction of MyoD expression compared to the lean control (Figure 2-7) 
(L. A. Brown et al., 2015). However, there were no differences found in the obese group three 
days following injury (data not shown). 




Figure 2-7. MyoD mRNA abundance in 4 month old lean and obese uninjured mice. 
 
 
MyoD expression was also examined in the aged lean and obese mice three days following 
muscle damage. There was a trend for a reduction of MyoD expression in the obese group 
(Figure 2-8). It is important to note that the sample size was not sufficient in this experiment 
(n = 3). 
 
 
Figure 2-8. MyoD mRNA abundance in 22-24 month old lean and obese mice 3 days 
following myotoxin-induced muscle damage. 
 
 
To further investigate if muscle regeneration was altered in young obese mice, ECM 
composition was examined. Three days following muscle damage, fibronectin is upregulated 
2-5 fold greater compared to the control mice. Also, the obese mice had a significantly higher 
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expression of fibronectin compared to the lean mice (Figure 2-9).  
 
 
Figure 2-9. Fibronectin mRNA abundance in 3 month old lean and obese mice 3 days 
following myotoxin-induced muscle damage. 
 
 
We then examined the collagen ratio, which has been used as a measure of fibrosis. Collagen 
III/I was much lower in the young obese mice compared to the young lean mice (Figure 2-9). 




Figure 2-10. Collagen III/I mRNA abundance in 3 month old lean and obese mice 3 days 




RESEARCH DESIGN AND METHODS  
 
Specific Aim #1. To examine basal markers of regenerative capacity in skeletal muscle in 
C57BL/6 sarcopenic obese mice.  
Rationale. Sarcopenic obesity is a metabolic syndrome in older adults that have a BMI ≥ 30 
and leads to many diseases.  Roughly one third of older adults are classified as obese and 
this population is growing. The major symptoms involved with sarcopenic obese individuals 
are a loss of skeletal muscle due to aging and systemic chronic low-grade inflammation. The 
mechanisms that are involved with a loss of skeletal muscle has been examined in aging 
studies, but has not been explored in sarcopenic obesity. Some of the mechanisms involved 
with the loss of skeletal muscle mass are related to the regenerative capacity of skeletal 
muscle. The inflammatory response, MRFs, and ECM composition are involved with muscle 
regeneration and the reduction and/or chronic expression at basal levels and can negatively 
impact muscle metabolism and repair. Previous work in our lab has demonstrated that 
expression of inflammatory cytokines are reduced in obese individuals. This will contribute 
to altered signaling in skeletal muscle. The expression of these regulators involved with 
regenerative capacity of skeletal muscle are poorly understood in sarcopenic obese skeletal 
muscle and needs to be explored. The overall objective of these experiments is to 
characterize sarcopenic obese skeletal muscle. 
Experimental design for specific aim #1.  This aim will examine muscle morphology, 
inflammation, MRF’s, and ECM in 4 uninjured animal groups 1) young lean, 2) young 
obese, 3) aged lean, 4) aged obese. Experiment #1 will examine TA weight relative to tibia 
length and bodyweight in 3-4 mo-old and 22-24 mo-old male mice. In addition, CSA will be 
measured an all animal groups. If feasible, CSA fiber size distribution and other histological 
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markers will be measured in all animal groups. Experiment #2 will examine the MRFs MyoD 
and myogenin in TA, gastrocnemius, plantaris, and soleus of all animal groups. Experiment 
#3 will examine cytokines IL-6, TNF-α, STAT3, NF-κB in TA, gastrocnemius, plantaris, and 
soleus of all animal groups. Experiment #4 will examine ECM targets collagen I, collagen III, 
TGF-β, and fibronectin in TA, gastrocnemius, plantaris, and soleus of all animal groups. If 
feasible decorin and other ECM proteins will be measured. 
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These experiments examined basal markers of regenerative capacity in sarcopenic obese skeletal 
muscle in C57BL/6 mice. 
 
Animals.  C57BL/6 male mice (Jackson Laboratories) were housed in the University of 
Arkansas’ animal facility. The room was maintained on a 12:12 light:dark cycle with the 
light period starting at 0700. Mice were randomly assigned to either standard rodent chow 
or high fat diet (HFD, 60% kcals fat, Research Diets, New Brunswick, New Jersey). Mice 
had ad libitum access to both food and water. All mice were sacrificed at 3-4 mo-old or 22-
24 mo-old (Table 2-1). All animal experimentation was approved by the University of 




                                       Table 2-1. Animal treatment groups for specific aim #1 
 
 
Diet Age n 
Lean 3-4 mo-old 8-12 
HFD 3-4 mo-old 8-12 
Lean 22-24 mo-old 8-12 
HFD 22-24 mo-old 8-12 
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Methodology related to specific aim #1. 
 
PBS Injection.  At twelve wks of age, phosphate buffered solution (PBS) injections were 
performed as previously described (Tyrone A Washington et al., 2013). Mice were 
anesthetized with a subcutaneous injection of a cocktail containing ketamine hydrochloride (45 
mg/kg body weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body 
weight). Roughly 0.03 ml of PBS were injected in the left and right tibialis anterior muscles 
(TA). A 25-gauge, 5/8 (0.5 x 16 mm) needle was inserted along the longitudinal axis of the 
muscle, and the PBS was injected slowly as the needle was withdrawn.  
 
Muscle and Tibia Extraction.  Muscle and tibia extractions was performed as previously 
described (Tyrone A Washington et al., 2013; T. A. Washington et al., 2011). Three and 21 
days post-injection, the TA and tibias was extracted from each mouse. Mice were 
anesthetized with a subcutaneous injection of a cocktail containing ketamine hydrochloride 
(90 mg/kg body weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body 
weight). The left TA was frozen in liquid nitrogen and stored at -80°C for protein and gene 
expression analysis, the right TA was cut at the midbelly, mounted in optimum cutting 
temperature compound (OCT), and dropped in liquid nitrogen cooled isopentane. Once 
frozen, samples were be stored at -80°C for morphological analysis. The tibias were removed 
and measured with a plastic caliper (VWR, Radnor, PA, USA). Tibia measurements were 
utilized to normalize muscle weights to an estimate of total body size. 
 
Tibialis Anterior Morphology.  Cross-sectional area (CSA) was performed as previously 
described (T. A. Washington et al., 2011). Each TA muscle section (n = 8-12) was stained 
with hematoxylin and eosin, imaged with a Nikon camera (Sight DS-Vi1) mounted on an 
Olympus CKX41 inverted microscope at 20X magnification (Olympus), and analyzed with 
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Nikon NIS Elements BR software package (Nikon). Each fiber was traced and the number of 
pixels traced will be calibrated to obtain CSA of the muscle. All fibers in the cross section 
images were quantified unless the sarcolemma was not intact. Approximately 100 fibers were 
traced per sample. 
 
Western blotting.  Muscle tissues were homogenized as previously described (N. P. Greene et 
al., 2015; Perry Jr et al., 2016). Briefly, tissue were homogenized with glass homogenizers in 
0.2 mL of complete protein loading buffer containing 5- mM Trsi-HCL, pH 6.8, 1% sodium 
dodecyl sulfate (SDS), 10% glycerol, 20 mM dithiothreitol, 127 mM 2-mercaptoethanol, and 
0.01% bromophenol blue, supplemented with protease inhibitors (Roche, Nutley, NJ) and 
phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). The muscle homogenates (10-30 µg) 
were transferred to microfuge tubes, heated for 5 min at 95°C, and centrifuges in a microfuge 
for 5 min at 13,000 RPM at room temperature. Protein concentrations of each sample were 
determined using the RC/DC assay (Bio-Rad, Hercules, CA), and 40 µg of protein were 
resolved on an 8-15% SDS-polyacrylamide gel (SDS-PAGE). The gel was transferred to a to 
polyvinylidene difluoride (PVDF) membrane. Membranes were stained with Ponceau S before 
blotting to verify equal loading of the gels. Membranes were incubated in a 5% nonfat dried 
milk dissolved with Tris-buffered saline with tween (TBS-T). Primary antibodies for NF-κB, 
P-Stat3 (Tyr705), and Stat3 (Cell Signaling Technologies, Danvers, MA) were diluted 1:1,000 
to 1:5,000 in 5% milk, in TBST, and incubated at 4°C overnight. Anti-rabbit monoclonal 
secondary antibodies (Cell Signaling Technologies, Danvers, MA) were diluted 1:2,000 to 
1:5,000 in 5% milk, in TBST, and then incubated at room temperature for one hour. Enhanced 
Chemiluminescence (ECL) were performed using Fluorochem M imager (Protein Simple, 
Santa Clara, California) to visualize antibody-antigen interaction. Blotting images were 
quantified by densitometry using AlphaView software (Protein Simple). The Ponceau-stained 
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membranes were digitally scanned, and the 45-kDa actin bands will be quantified by 
densitometry and used as a protein loading correction factor for each lane. 
 
RNA Isolation, cDNA Synthesis, quantitative RT-PCR. The following procedures were 
completed as previously described (N. P. Greene et al., 2015; Tyrone A Washington et al., 
2013). RNA was extracted with Trizol reagent (Life Technologies, Grand Island, NY, USA). 
TA muscles were homogenized in Trizol. Total RNA was isolated, DNase treated and 
concentration and purity was determined by fluorometry using the Qubit 2.0 (Life 
Technologies). cDNA was reverse transcribed from 1 µg of total RNA using the Superscript 
Vilo cDNA synthesis kit (Life Technologies, Carlsbad, CA, USA). Real-time PCR was 
performed, and results were analyzed by using the StepOne Real-Time PCR system (Life 
Technologies, Applied Biosystems, Grand Island, NY). cDNA was amplified in a 25 µL 
reaction containing appropriate primer pairs and TaqMan Universal Mastermix (Applied 
Biosystems). Samples were be incubated at 95°C for 4 min, followed by 40 cycles of 
denaturation, annealing and extension at 95°C, 55°C and 72°C respectively. TaqMan 
fluorescence was measured at the end of the extension step each cycle. Fluorescence labeled 
probes for MyoD (FAM dye), myogenin (FAM dye), TNFα (FAM dye), IL-6 (FAM dye), 
ICAM-1 (FAM dye), TGF-β (FAM dye), collagen I (FAM dye), collagen III (FAM dye), 
fibronectin (FAM dye), MMP-2 (FAM dye), MMP-9 (FAM dye), TIMP-1 (FAM dye), and 
18S (VIC dye) were purchased from Applied Biosystems and quantified with TaqMan 
Universal mastermix. Cycle threshold (Ct) was determined, and the ΔCt value was calculated 
as the difference between the Ct value and the 18s Ct value. Final quantification of gene 
expression was calculated using the ΔΔCT method Ct = [ΔCt(calibrator) – ΔCt(sample)]. 
Relative quantification was calculated as 20-ΔΔCt. Melt curve analysis was performed at the 
end of the PCR run to verify no primer dimers were formed. 
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Statistical analysis. All data was analyzed using Statistical Package for the Social Sciences 
(SPSS version 22.0, Armonk, NY). Results were reported as mean ± SEM. A two-way ANOVA 
was performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables. When a significant interaction was detected, differences among 
individual means were assessed with Fisher’s LSD post-hoc analysis. Statistical significance was 
set at P ≤ 0.05. The χ2 analysis was used to detect differences in the proportion of small fibers (< 




Hypothesis #1.  Skeletal muscle mass and cross-sectional area will be reduced in sarcopenic 
obese mice as measured by relative weight data and CSA size. 
Hypothesis #2.  Myogenic regulatory factors will be reduced in sarcopenic obese mice, as 
measured by mRNA abundance. 
Hypothesis #3. Inflammatory cytokines will be reduced in sarcopenic obese mice, as measured 
by mRNA abundance and protein. 





It is possible that there will be no changes in mRNA abundance and protein of sarcopenic 
obese mice compared to the lean and young control mice. Although it has been observed that 
aging and obesity alter inflammation, MRFs, and ECM; the two co-morbidities may counteract 




The study uses C57BL/6 mice that are 22-24 month old mice, which would be equivalent to 
63-69 years old in humans. Moreover, to induce obesity mice are given a diet that consists of 
60% fat to mimic obese humans. Although these methods are used to create a sarcopenic obese 
model in mice these results cannot be directly applied to humans because of the slight 





Specific aim #2.  To examine monocytes/neutrophils activity in the muscle in sarcopenic 
obese mice during muscle regeneration. 
 
Rationale.  Aging, obesity, and muscle pathologies are associated with systemic low-grade 
inflammation. It has been reported that some muscle pathologies also exhibit chronic 
inflammation in skeletal muscle. It was under the assumption in the literature that aging and 
obesity would exhibit chronic inflammation in skeletal muscle as well. Our lab has recently 
demonstrated that inflammatory cytokines are blunted in obese mice at the onset of muscle 
regeneration. In support of our findings, a study examining obese mice found a reduction of 
macrophages in obese mice following skeletal muscle injury. Thus, the reduction of 
macrophages and secreted cytokines may be due to reduced monocyte recruitment and 
infiltration to the muscle. Adhesion molecules are essential to macrophage infiltration from 
the blood into the skeletal muscle following muscle injury. It is possible that the reduced 
expression of adhesion molecules may result in less infiltration of macrophages and result in 
reduced cytokine expression. Moreover, it has not yet been examined if sarcopenic obese 
skeletal muscle has a reduction of cytokines and macrophage infiltration following muscle 
damage. The overall purpose of this aim is to determine whether cytokines in skeletal 
muscle is altered in sarcopenic obese mice at the onset of skeletal muscle regeneration 
and if these changes are associated with phagocyte infiltration
57  
 
Experimental design for Specific Aim #2. 
 
This aim examined macrophage activity as defined by macrophage recruitment and secretion 
of cytokines. Macrophage activity will be examined in 8 animal groups (Table 2-2, Table 2-
3). Experiment #1 examined the adhesion molecule ICAM-1 in TA of all animal groups. 
Experiment #3 examined ECM targets inflammatory cytokines IL-6 and TNF-α and 









These experiments examined macrophage activity in the TA of sarcopenic obese mice during 
muscle regeneration. 
Animals. The same mice mentioned in specific aim #1 were randomly assigned in 8 groups 
(Table 2-2, Table 2-3). During the myotoxin-induced muscle damage protocol, each 
mouse was administered bupivacaine (experimental) or PBS (control) in the TA. TA 
extraction will take place at either 3 or 21 days following injection. All animal 
experimentation were approved by the University of Arkansas’ Institutional Animal Care 




                          Table 2-2. Young animal treatment groups for specific aim #2-3 
 
Timepoint Diet Treatment n 
3 Day Lean Uninjured 5-6 
3 Day Lean Injured 5-6 
3 Day HFD Uninjured 5-8 
3 Day HFD Injured 5-8 
21 Day Lean Uninjured 5-6 
21 Day Lean Injured 5-6 
21 Day HFD Uninjured 5-8 





                           Table 2-3. Old animal treatment groups for specific aim #2-3 
 
Timepoint Diet Treatment n 
3 Day Lean Uninjured 7-8 
3 Day Lean Injured 7-8 
3 Day HFD Uninjured 5-6 
3 Day HFD Injured 5-6 
21 Day Lean Uninjured 7-8 
21 Day Lean Injured 7-8 
21 Day HFD Uninjured 5-6 
21 Day HFD Injured 5-6 
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Methodology related to specific aim #2. 
 
Bupivaine Injection. At twelve wks of age, bupivacaine (Hospira, Lake Forest, IL) injections 
were performed as previously described (L. A. Brown et al., 2015; T. A. Washington et al., 
2011). Mice were anesthetized with a subcutaneous injection of a cocktail containing ketamine 
hydrochloride (45 mg/kg body weight), xylazine (3 mg/kg body weight), and acepromazine (1 
mg/kg body weight). Muscle damage were induced by injecting 0.03ml of 0.75% bupivacaine 
(Marcaine) in the left and right tibialis anterior muscles (TA). A 25-gauge, 5/8 (0.5 x 16 mm) 
needle was inserted along the longitudinal axis of the muscle, and the bupivacaine was injected 
slowly as the needle was withdrawn. The control group was injected with 0.03 ml of PBS. 
Muscle and Tibia Extraction. Muscle and tibia extractions was performed as previously 
described (Tyrone A Washington et al., 2013; T. A. Washington et al., 2011). Three and 21 
days post-injection, the TA and tibias was extracted from each mouse. Mice were 
anesthetized with a subcutaneous injection of a cocktail containing ketamine hydrochloride 
(90 mg/kg body weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body 
weight). The left TA was frozen in liquid nitrogen and stored at -80°C for protein and gene 
expression analysis, the right TA was cut at the midbelly, mounted in optimum cutting 
temperature compound (OCT), and dropped in liquid nitrogen cooled isopentane. Once 
frozen, samples were be stored at -80°C for morphological analysis. The tibias were removed 
and measured with a plastic caliper (VWR, Radnor, PA, USA). Tibia measurements were 
utilized to normalize muscle weights to an estimate of total body size. 
Tibialis Anterior Morphology.  Cross-sectional area (CSA) was performed as previously 
described (Washington et al., 2011). Each TA muscle section (n = 8-12) was stained with 
hematoxylin and eosin, imaged with a Nikon camera (Sight DS-Vi1) mounted on an Olympus 
CKX41 inverted microscope at 20X magnification (Olympus), and analyzed with Nikon NIS 
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Elements BR software package (Nikon). Each fiber was traced and the number of pixels traced 
will be calibrated to obtain CSA of the muscle. All fibers in the cross section images were 
quantified unless the sarcolemma was not intact. Approximately 100 fibers were traced per 
sample. 
Western Blotting. Muscle tissues were homogenized as previously described (N. P. Greene et 
al., 2015; Perry Jr et al., 2016).Briefly, tissue were homogenized with glass homogenizers in 
0.2 mL of complete protein loading buffer containing 5- mM Trsi-HCL, pH 6.8, 1% sodium 
dodecyl sulfate (SDS), 10% glycerol, 20 mM dithiothreitol, 127 mM 2-mercaptoethanol, and 
0.01% bromophenol blue, supplemented with protease inhibitors (Roche, Nutley, NJ) and 
phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). The muscle homogenates (10-30 µg) 
were transferred to microfuge tubes, heated for 5 min at 95°C, and centrifuges in a microfuge 
for 5 min at 13,000 RPM at room temperature. Protein concentrations of each sample were 
determined using the RC/DC assay (Bio-Rad, Hercules, CA), and 40 µg of protein were 
resolved on an 8-15% SDS-polyacrylamide gel (SDS-PAGE). The gel was transferred to a to 
polyvinylidene difluoride (PVDF) membrane. Membranes were stained with Ponceau S before 
blotting to verify equal loading of the gels. Membranes were incubated in a 5% nonfat dried 
milk dissolved with Tris-buffered saline with tween (TBS-T). Primary antibodies for NF-κB, 
P-Stat3 (Tyr705), and Stat3 (Cell Signaling Technologies, Danvers, MA) were diluted 1:1,000 
to 1:5,000 in 5% milk, in TBST, and incubated at 4°C overnight. Anti-rabbit monoclonal 
secondary antibodies (Cell Signaling Technologies, Danvers, MA) were diluted 1:2,000 to 
1:5,000 in 5% milk, in TBST, and then incubated at room temperature for one hour. Enhanced 
Chemiluminescence (ECL) were performed using Fluorochem M imager (Protein Simple, 
Santa Clara, California) to visualize antibody-antigen interaction. Blotting images were 
quantified by densitometry using AlphaView software (Protein Simple). The Ponceau-stained 
62  
membranes were digitally scanned, and the 45-kDa actin bands will be quantified by 
densitometry and used as a protein loading correction factor for each lane. 
RNA Isolation, cDNA synthesis, and quantitative RT-PCR. The following procedures were 
completed as previously described (N. P. Greene et al., 2015; Nicholas P Greene et al., 2014; 
Tyrone A Washington et al., 2013). RNA was extracted with Trizol reagent (Life 
Technologies, Grand Island, NY, USA). TA muscles were homogenized in Trizol. Total 
RNA was isolated, DNase treated and concentration and purity was determined by 
fluorometry using the Qubit 2.0 (Life Technologies). cDNA was reverse transcribed from 1 
µg of total RNA using the Superscript Vilo cDNA synthesis kit (Life Technologies, Carlsbad, 
CA, USA). Real-time PCR was performed, and results were analyzed by using the StepOne 
Real-Time PCR system (Life Technologies, Applied Biosystems, Grand Island, NY). cDNA 
was amplified in a 25 µL reaction containing appropriate primer pairs and TaqMan Universal 
Mastermix (Applied Biosystems). Samples were be incubated at 95°C for 4 min, followed by 
40 cycles of denaturation, annealing and extension at 95°C, 55°C and 72°C respectively. 
TaqMan fluorescence was measured at the end of the extension step each cycle. Fluorescence 
labeled probes for TNF-α (FAM dye), IL-6 (FAM dye), ICAM-1 (FAM dye), and 18S (VIC 
dye) were purchased from Applied Biosystems and quantified with TaqMan Universal 
mastermix. Cycle threshold (Ct) was determined, and the ΔCt value was calculated as the 
difference between the Ct value and the 18s Ct value. Final quantification of gene expression 
will be calculated using the ΔΔCT method Ct = [ΔCt(calibrator) – ΔCt(sample)]. Relative 
quantification will be calculated as 20-ΔΔCt. Melt curve analysis was performed at the end of 




Statistical analysis. All data was analyzed using Statistical Package for the Social Sciences 
(SPSS version 22.0, Armonk, NY). Results was reported as mean ± SEM. A two-way ANOVA 
was performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables for 3 and 21 days post-bupivacaine injection. When a 
significant interaction is detected, differences among individual means was assessed with 
Fisher’s LSD post-hoc analysis. The χ2 analysis was used to detect differences in the proportion 
of small fibers (< 400 µm2) and large fibers (> 900 µm2) between treatment groups. Statistical 




Hypothesis #1.  There will be a reduction in macrophage infiltration in sarcopenic obese 
muscle at the onset of skeletal muscle regeneration, as measured by ICAM-1 mRNA 
abundance.  
Hypothesis #2.  There will be a reduction in cytokines in sarcopenic obese skeletal muscle at 





It is possible that there will be no changes in mRNA abundance and protein of sarcopenic obese 
mice compared to the lean and young control mice. Although it has been observed that aging 
and obesity are associated with systemic low-grade inflammation these changes to 




This study uses myotoxin-induced muscle damage that mimics traumatic eccentric damage 
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observed in exercise. Because these methods are used to isolate the regenerative process in mice 
these results cannot be directly compared to studies involving exercise models because of the 
lack of mechanical movement and involvement of whole-body metabolism. Moreover, the 
experimental design in this study does not distinguish between resident and non-resident 




Specific aim #3.  To examine how sarcopenic obesity alters ECM remodeling during 
skeletal muscle regeneration 
 
Rationale. An important step involved with skeletal muscle regeneration is ECM 
remodeling. The ECM will interact with muscle cells and release growth factors necessary to 
promote regeneration. Moreover, resident macrophages are localized within the ECM. 
Alterations in ECM and its regulation have been reported in disease and traumatic (type II) 
injury during muscle damage. As a result optimal muscle regeneration was not achieved in 
these individuals. Previously, our lab demonstrated that skeletal muscle in obese mice 
regenerates sub-optimally. In support, preliminary data examining obese mice 3 days 
following muscle damage had an increase in collagen III/I, which is an indicator of fibrosis. 
It is known in the literature that fibrosis is one of the negative outcomes of regenerating 
muscle fibers in aging mice. The ECM remodeling process in sarcopenic obese mice is not 
known and needs to be further explored. The purpose of this aim was to examine how 
sarcopenic obesity alters ECM remodeling during skeletal muscle regeneration. 
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Experimental design for specific aim #3. 
 
This aim examined components of the ECM and its regulation both to understand how 
sarcopenic obesity may alter ECM remodeling. Experiment #1 visually examined ECM 
morphology by collagen I and collagen III staining in the TA cross-section. Experiment #2 
examined ECM proteins collagen I, collagen III, and fibronectin in the TA of all animal 
groups. Experiment #3 examined the regulation of ECM as measured by TGF-β, MMP-2, 
MMP-9 and TIMP-1.  
 




These experiments examined collagen and its regulation in sarcopenic obese mice during 
muscle regeneration. 
 
Animals.  Tissues were used from the animal experiments described in specific aim 
 





Immunofluorescence. Immunostaining for collagen I and III were performed as previously 
described (Kim, Kasukonis, Brown, Washington, & Wolchok, 2016). Each TA muscle cross-
section was cut at 10 µm (n = 4-7) using the cryostat and placed on a slide. First, slides were 
permeabilized in 0.1% 10X Triton then rinsed in PBS. Then slides were blocked in PBS with 
4% goat serum and 0.05% sodium azide for 30 minutes at room temperature. Afterwards, 
slides were incubated on primary antibodies for 3 hours at room temperature; rabbit-
polyclonal anti-collagen I IgG (1:500, Sigma Aldrich, St. Louis, MO), rabbit-polyclonal  anti-
collagen III (1:500, Sigma Aldrich, St. Louis, MO). Slides were then washed with PBS and 
incubated in Alexa Fluor 488 (1:500, Life Technologies Carlsbad, CA). Images of the slide 
were acquired with a Nikon camera (Sight DS-Vi1) mounted on an Olympus CKX41 inverted 
microscope at 20X magnification (Olympus), and analyzed with MATLAB. Total ECM area 
was determined by dividing the number of green pixels by the total number of pixels in the 
image.  
RNA Isolation, cDNA synthesis, and quantitative RT-PCR. The following procedures were 
completed as previously described (Nicholas P Greene et al., 2014; Tyrone A Washington et 
al., 2013). RNA was extracted with Trizol reagent (Life Technologies, Grand Island, NY, 
USA). TA muscles were homogenized in Trizol. Total RNA was isolated, DNase treated and 
concentration and purity was determined by fluorometry using the Qubit 2.0 (Life 
Technologies). cDNA was reverse transcribed from 1 µg of total RNA using the Superscript 
Vilo cDNA synthesis kit (Life Technologies, Carlsbad, CA, USA). Real-time PCR was 
performed, and results were analyzed by using the StepOne Real-Time PCR system (Life 
Technologies, Applied Biosystems, Grand Island, NY). cDNA was amplified in a 25 µL 
reaction containing appropriate primer pairs and TaqMan Universal Mastermix (Applied 
Biosystems). Samples were be incubated at 95°C for 4 min, followed by 40 cycles of 
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denaturation, annealing and extension at 95°C, 55°C and 72°C respectively. TaqMan 
fluorescence was measured at the end of the extension step each cycle. Fluorescence labeled 
probes for collagen I (FAM dye), collagen III (FAM dye), fibronectin (FAM dye), TGF-β 
(FAM dye), MMP-2 (FAM dye), MMP-9 (FAM dye), TIMP-1 (FAM dye), and 18S (VIC 
dye) were purchased from Applied Biosystems and quantified with TaqMan Universal 
mastermix. Cycle threshold (Ct) were determined, and the ΔCt value was calculated as the 
difference between the Ct value and the 18s Ct value. Final quantification of gene expression 
was calculated using the ΔΔCT method Ct = [ΔCt(calibrator) – ΔCt(sample)]. Relative 
quantification was calculated as 20-ΔΔCt. Melt curve analysis was performed at the end of 
the PCR run to verify no primer dimers were formed 
Statistical analysis. All data was analyzed using Statistical Package for the Social Sciences 
(SPSS version 22.0, Armonk, NY). Results were reported as mean ± SEM. A two-way ANOVA 
was performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables for 3 and 21 days post-bupivacaine injection. When a 
significant interaction is detected, differences among individual means were assessed with 






Hypothesis #1.  Collagen fibrils content will not change in sarcopenic obese mice at the onset 
of skeletal muscle regeneration as visually inspected by collagen staining. 
Hypothesis #2.  ECM promoters are blunted in sarcopenic obese mice at the onset of skeletal 
muscle regeneration, as measured by collagen I, collagen III, TGF-β, and fibronectin mRNA 
abundance. 
Hypothesis #3.  MMP mRNA abundance is greater in sarcopenic obese mice at the onset of 






It is possible that there will be no changes in mRNA abundance and protein of sarcopenic 
obese mice compared to the lean and young control mice. Although it has been observed that 
aging and obesity are associated with ECM protein and ECM regulation, these changes to the 
ECM may not exist within the combination of the two co-morbidities during skeletal muscle 





This study uses myotoxin-induced muscle damage that mimics traumatic eccentric damage 
observed in exercise. Because these methods are used to isolate the regenerative process in 
mice these results cannot be directly compared to studies involving exercise models because of 







Basal level markers of skeletal muscle regenerative capacity are altered in sarcopenic obese 
mice skeletal muscle 
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AIM: Currently, in the United States sarcopenic obesity is growing at an alarming rate. 
This is a major concern because sarcopenic obese individuals are associated with insulin-
resistance, chronic low-grade inflammation, and reduced muscle quality and integrity. Previous 
studies examining either aging or obesity have reported a reduction in cross-sectional area in 
both groups and have implicated alterations in ECM and inflammatory signaling as a major 
culprit. It has not been examined if the combination of these two-comorbidities will further 
reduce muscle mass and regenerative potential. The purpose of this study was to determine how 
Sarcopenic obesity alters inflammatory signaling and extracellular remodeling in mouse skeletal 
muscle. METHODS: Twenty-four male C57BL6/J mice (4 weeks old) were randomly assigned 
to either a high fat diet (HFD, 60% fat) or normal chow for either 8 weeks or 21-23 months. At 
3-4 months or 22-24 months the TA, soleus, and gastrocnemius were excised. RESULTS: Mean 
cross-sectional area was reduced by 26% in aged HFD mice compared to the aged lean mice. 
Aged mice had nearly 2-fold collagen III content than young mice. P-STAT3/STAT3 was 
reduced by 82% in the aged HFD mice compared to the aged lean mice in the TA. NF-κB was 5-
fold greater in the aged HFD mice compared to the aged lean mice in the TA. MMP-2 was 
reduced by more than 40% in the aged HFD mice compared to the aged lean mice in all muscles. 
CONCLUSION: Sarcopenic obese mice have reduced cross-sectional area than aged lean mice 
which may be linked to markers of muscle fibrosis and basal alterations an inflammatory 
signaling. 
 






Sarcopenic obesity is a growing concern to several health organizations due to the 
increase in health risk and healthcare cost. The age-related progressive decline in muscle mass 
and excessive adipose tissue are associated with numerous health risks that can ultimately 
lead to increase mortality (Lynch, 2011; Stenholm et al., 2008). Obese and sarcopenic 
individuals are subjected to a reduction of quality in vital organs and tissues including skeletal 
muscle which is needed for mobility, energy metabolism, and acts as a reservoir for essential 
growth factors and amino acids needed for survival (Biolo, Fleming, Maggi, & Wolfe, 1995; 
Stump, Henriksen, Wei, & Sowers, 2006). Specifically, older adults that suffer from 
sarcopenia will lose 30-50% muscle mass along with reductions that contribute to muscle 
frailty (Cesari et al., 2005; Fried et al., 2001). Obesity has also recently been implicated in 
reductions in muscle mass and muscle fibrosis which may negatively impact muscle function 
(Drake, Alway, Hollander, & Williamson, 2010; Hu et al., 2010; Uezumi et al., 2011). The 
combination of these two co-morbidities could potentially accelerate the decay of muscle 
tissue. 
Skeletal muscle tissue integrity can be compromised when signaling pathways and 
regulators of myogenesis are irreversibly impaired. Several myopathies, metabolic disease and 
severe injury have implicated repression or chronic elevation of myogenic regulatory factors 
(MRFs) that are involved in myoblast proliferation and differentiation (Kim et al., 2016; Luz, 
Marques, & Santo Neto, 2002; Megeney, Kablar, Garrett, Anderson, & Rudnicki, 1996). A 
reduction of MRFs have been reported in myopathies and aging at basal levels which may 
implicate reduced regenerative potential of the muscle fibers (Thornell, 2011; Verdijk et al., 




young HFD mice skeletal muscle (L. A. Brown et al., 2015).  
Skeletal muscle function is also essential in muscle quality and is compromised in 
aging and obese individuals. The extracellular matrix (ECM) is one component surrounding 
the muscle fiber and fiber bundles that are involved in passive tension and force transmission 
(Gillies & Lieber, 2011; Kjaer, 2004). In skeletal muscle the fibril collagens I and III are 
predominant and are more resilient to stress than other ECM proteins. Muscle fibrosis has 
been documented in aging as well as muscle stiffness (DeGroot et al., 2001). Insulin resistant 
populations such as diabetics and elder populations are more susceptible to muscle stiffness 
and thus obese individuals may have alterations in ECM content (Song & Schmidt, 2012). 
The ECM also serves as reservoir for inflammatory proteins that regulate muscle mass and are 
involved in muscle function. 
There are several key inflammatory proteins such as phagocytes that are involved with 
the regulation of muscle mass. Monocytes in the blood stream will be recruited by secreted 
ICAM-1 adhesion molecules to facilitate phagocyte infiltration into the muscle ECM. (Abbas, 
Lichtman, & Pillai, 2011; Dearth et al., 2013; Schiaffino & Partridge, 2008).  This process 
will allow these non-resident macrophages to secrete cytokines involved in muscle repair 
(Abbas et al., 2011; Schiaffino & Partridge, 2008). It has been observed that populations that 
are associated with insulin resistance such as obesity and aging will also exhibit chronic 
elevation of pro-inflammatory cytokines at basal levels that can eventually lead to muscle 
atrophy over time (Petersen & Pedersen, 2005). In aging individuals the chronic expression of 
the inflammatory TNF-α will activate NF-κB that once activated may lead to apoptosis. On 
the contrary there have been findings in reduced macrophages and inflammatory cytokines in 




Whether the differences in inflammatory proteins and signaling will positively or negatively 
impact sarcopenic individuals has yet to be determined.  
Both sarcopenia and obesity have been investigated in skeletal muscle research 
extensively, yet these two co-morbidities have not been thoroughly examined together in how 
key proteins involved with repair may influence muscle quality and integrity. Thus, the 
purpose of this study is to examine how sarcopenic obesity alters basal levels of inflammation 
and ECM proteins in mice. We hypothesized that the combination of aging and obesity will 







Animals and Housing 
 Twelve young adult C57BL/6 male mice (n=12) and twelve aged C57BL/6 male mice 
(n=12) were purchased from Jackson Laboratories. Animals were housed in the University of 
Arkansas Central Laboratory Animal Facility. Young and aged mice were randomly fed a 
normal chow (lean; 17% kcals fat Research Diets, New Brunswick, New Jersey) or a high fat 
diet (HFD; 60% kcals fat, Research Diets, New Brunswick, New Jersey). The following four 
groups were formed: 1) young lean (n = 6); 2) young obese (n = 6); 3) aged lean (n = 6); 4) 
aged obese (n = 6). All procedures were approved by the University of Arkansas Institutional 
Animal Care and Use Committee (IACUC).  
Muscle and Tibia Extraction  
At either 3-4 mo or 22-24 mo of age, muscle and tibia extractions were performed as 
previously described (Tyrone A Washington et al., 2013; T. A. Washington et al., 2011). The 
gastrocnemius, soleus, TA, and tibias were extracted while the mice were anesthetized with a 
subcutaneous injection of a cocktail containing ketamine hydrochloride (90 mg/kg body 
weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body weight). The left 
TA was snap frozen in liquid nitrogen and stored at -80°C for protein and gene expression 
analysis, the right TA was cut at the midbelly, mounted in optimum cutting temperature 
compound (OCT), and then dropped in liquid nitrogen cooled isopentane. Once frozen, 
samples were stored at -80°C for morphological analysis. After the muscles was dissected out, 
the tibia was removed and measured with a plastic caliper (VWR, Radnor, PA, USA). Tibia 





Morphological Analysis  
Fiber distribution and cross-sectional area (CSA) were performed as previously 
described (L. A. Brown et al., 2015; T. A. Washington et al., 2011). Each gastrocnemius 
muscle section (n = 6) was stained with hematoxylin and eosin, imaged with a Nikon camera 
(Sight DS-Vi1) mounted on an Olympus CKX41 inverted microscope at 20X magnification 
(Olympus), and analyzed with Nikon NIS Elements BR software package (Nikon). Each fiber 
was traced with a mouse and the number of pixels traced was calibrated to obtain CSA of the 
muscle. All fibers in the cross section images were quantified unless the sarcolemma was not 
intact. Approximately 100 fibers were traced per sample. Immunostaining for collagen I and 
III were performed as previously described (Kim et al., 2016). Each TA muscle cross-section 
was cut at 10 µm (n = 4-7) using the cryostat and placed on a slide. First, slides were 
permeabilized in 0.1% 10X Triton then rinsed in PBS. Then slides were blocked in PBS with 
4% goat serum and 0.05% sodium azide for 30 minutes at room temperature. Afterwards, 
slides were incubated on primary antibodies for 3 hours at room temperature; rabbit-
polyclonal anti-collagen I IgG (1:500, Sigma Aldrich, St. Louis, MO), rabbit-polyclonal  anti-
collagen III (1:500, Sigma Aldrich, St. Louis, MO). Slides were then washed with PBS and 
incubated in Alexa Fluor 488 (1:500, Life Technologies Carlsbad, CA). Images of the slide 
were acquired with a Nikon camera (Sight DS-Vi1) mounted on an Olympus CKX41 inverted 
microscope at 20X magnification (Olympus, Tokyo, Japan), and analyzed with MATLAB. 
Total ECM area was determined by dividing the number of green pixels by the total number 






Western blotting  
Muscle tissues were homogenized as previously described (Lee et al., 2016). 
Approximately 10-40 mg of gastrocnemius, soleus, and TA was homogenized in glass dounce 
type homogenizers in 0.30 ml of complete protein loading buffer (50 mM Tris·HCl, pH 6.8, 
1% sodium dodecyl sulfate (SDS), 10% glycerol, 20 mM dithiothreitol, 127 mM 2-
mercaptoethanol, and 0.01% bromophenol blue supplemented with protease inhibitors 
(Roche) and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). After homogenization, 
samples were transferred to sterile 1.5mL microcentrifuge tubes, heated for 5 minutes at 95°C 
to denature protein and then centrifuged for 5 minutes at 13,000 rpm.  Protein concentrations 
were determined using a commercially available RC/DC assay kit. Muscle homogenate (40 
µg) was fractionated in 10% SDS-polyacrylamide gels. Gels were transferred to 
polyvinylidene difluoride (PVDF) membranes. Membranes were stained with Ponceau S 
before blotting to verify equal loading of the gels. Membranes were blocked in 5% milk, in 
Tris-buffered saline with 0.1% Tween-20 (TBST), for 2 hours. Primary antibodies for P-Stat3 
(Tyr705), Stat3 (Cell Signaling Technologies, Danvers, MA), and NF-κB p65 (Santa Cruz, 
Dallas, TX) were diluted 1:1000 to 1:2000 in 5% milk, in TBST, and incubated at 
4°C overnight. Anti-rabbit and Anti-mouse monoclonal secondary antibodies (Cell Signaling 
Technologies, Danvers, MA) were diluted 1:2,000 in 5% milk, in TBST, and then incubated 
at room temperature for one hour. Enhanced Chemiluminescence (ECL) was performed using 
Fluorochem M imager (Protein Simple, Santa Clara, California) to visualize antibody-antigen 
interaction. Blotting images were quantified by densitometry using AlphaView software 




actin bands were quantified by densitometry and used as a protein loading correction factor 
for each lane.  
RNA Isolation, cDNA synthesis, and quantitative RT-PCR 
The following procedures were completed as previously described (L. A. Brown et al., 
2015; Nicholas P Greene et al., 2014; Tyrone A Washington et al., 2013). RNA was extracted 
with Trizol reagent (Life Technologies, Grand Island, NY, USA). TA muscles were 
homogenized in Trizol. Total RNA was isolated, DNase treated and purity and concentrations 
were determined using 260/280nm ratios read on a BioTek Take3 microvolume microplate 
with a BioTek PowerWave XC microplate reader (BioTek Instruments Inc., Winooski, VT). 
cDNA was reverse transcribed from 1 µg of total RNA using the Superscript Vilo cDNA 
synthesis kit (Life Technologies, Carlsbad, CA, USA). Real-time PCR was performed, and 
results were analyzed by using the StepOne Real-Time PCR system (Life Technologies, 
Applied Biosystems, Grand Island, NY). cDNA was amplified in a 25 µL reaction containing 
appropriate primer pairs and TaqMan Universal Mastermix (Applied Biosystems). Samples 
were incubated at 95°C for 4 min, followed by 40 cycles of denaturation, annealing and 
extension at 95°C, 55°C and 72°C respectively. TaqMan fluorescence was measured at the 
end of the extension step each cycle. Fluorescence labeled probes for MyoD (FAM dye), 
myogenin (FAM dye), TNFα (FAM dye), IL-6 (FAM dye), Collagen I (FAM dye), Collagen 
III (FAM dye), Fibronectin (FAM dye), MMP-2 (FAM dye), MMP-9 (FAM dye), TGF-β 
(FAM dye), TIMP-1 (FAM dye), and 18S (FAM dye) were purchased from Applied 
Biosystems and quantified with TaqMan Universal mastermix. Cycle threshold (Ct) was 
determined, and the ΔCt value was calculated as the difference between the Ct value and the 




Ct = [ΔCt(calibrator) – ΔCt(sample)]. Relative quantification was then calculated as 20-ΔΔCt. 
Melt curve analysis was performed at the end of the PCR run to verify no primer dimers were 
formed. 
Statistical Analysis  
All data was analyzed using Statistical Package for the Social Sciences (SPSS version 
22.0, Armonk, NY). Results are reported as mean ± SEM. A two-way ANOVA was 
performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables for 3 and 21 days post-bupivacaine injection. When a 
significant interaction was detected, differences among individual means were assessed with 
Fisher’s LSD post-hoc analysis. The χ2 analysis was used to detect differences in the 
proportion of small fibers (< 400 µm2) and large fibers (> 900 µm2) between treatment groups. 






Animal weight characteristics and muscle morphology 
 Body weight in the young HFD mice was 24% greater than young lean mice (Table 1). 
Body weight in the aged HFD mice was 35% greater than aged lean mice (Table 1). TA 
muscle weight relative to tibia length in the in the young HFD mice was 4% greater compared 
to the lean mice. TA muscle weight was reduced by 8% in the aged HFD mice compared to 
the aged lean mice. Soleus muscle weight relative to tibia length in the in the young HFD 
mice was 16% greater in compared to the lean mice. In the aged mice there was no difference 
in soleus muscle weight relative to tibia length in the HFD mice compared to the lean mice. 
Gastrocnemius muscle weight relative to tibia length in the in the young HFD mice was 9% 
greater in compared to the lean mice. Gastrocnemius muscle weight was reduced by 6% in the 
aged HFD mice compared to the aged lean mice. 
In the young mice, gastrocnemius mean cross-sectional area was 17% smaller in the 
HFD mice compared to the lean mice (Fig. 1B). In the aged mice, gastrocnemius mean cross-
sectional area was 26% smaller in the HFD mice compared to the lean mice (Fig. 1B). In the 
young mice there were 21% (Fig. 1C) more small (< 400 µm2) fibers in the HFD group 
compared to the lean group in the gastrocnemius. Also, in the young mice there were 75% 
(Fig. 1C) less large fibers (> 900 µm2) in the HFD group compared to the lean group. In the 
aged mice there were 3-fold (Fig. 1D) more small (< 400 µm2) fibers in the HFD group 
compared to the lean group in the gastrocnemius. Also, in the aged mice there were 74% (Fig. 
1D) less large fibers (> 900 µm2) in the HFD group compared to the lean group in the 
gastrocnemius. There was no difference in collagen I content in in the gastrocnemius in all 




groups compared to the young groups in the gastrocnemius (Fig. 2D). 
MRF gene expression 
 There was no difference of MyoD mRNA abundance in the TA in all groups (Fig. 
3A). There was a main effect of diet with a decrease of MyoD mRNA abundance in the HFD 
groups compared to the lean groups in the soleus (Fig. 3B). There was a main effect of diet 
with an increase of MyoD mRNA abundance in the HFD groups compared to the lean groups 
in the gastrocnemius (Fig. 3C). There was a main effect of age with an increase of MyoD 
mRNA abundance in the aged groups compared to the young groups in the gastrocnemius 
(Fig. 3C). There was a main effect of diet with a decrease of myogenin mRNA abundance in 
the HFD groups compared to the lean groups in the TA (Fig. 3D). There was no difference of 
myogenin mRNA abundance in the soleus in all groups (Fig. 3E). In the young mice, 
myogenin mRNA abundance was not different in the HFD group compared to the lean group 
in the gastrocnemius (Fig. 3F). In the aged mice, myogenin mRNA abundance was not 
different in the HFD group compared to the lean group in the gastrocnemius (Fig. 3F).  
Inflammation gene expression 
There was no difference of IL-6 mRNA abundance in the TA in all groups (P = 0.05, 
Fig. 4A). There was a main effect of age with an increase of IL-6 mRNA abundance in the 
aged groups compared to the young groups in the soleus (Fig. 4B). There was no difference of 
IL-6 mRNA abundance in the gastrocnemius in all groups (Fig. 4C). There was no difference 
of TNF-α mRNA abundance in the TA in all groups (Fig. 4D). There was a main effect of diet 
with a decrease of TNF-α mRNA abundance in the HFD groups compared to the lean groups 
in the soleus (Fig. 4E). There was a main effect of age with an increase of TNF-α mRNA 




was a significant interaction of TNF-α mRNA abundance in the gastrocnemius (Fig. 4F). 
However, in the young mice, TNF-α mRNA abundance was not different in the HFD group 
compared to the lean group in the gastrocnemius (Fig. 4F). Also, in the aged mice, TNF-α 
mRNA abundance was not different in the HFD group compared to the lean group in the 
gastrocnemius (Fig. 4F). There was a main effect of age with a decrease of ICAM-1 mRNA 
abundance in the aged groups compared to the young groups in the TA (Fig. 4G). There was a 
main effect of age with an increase of ICAM-1 mRNA abundance in the aged groups 
compared to the young groups in the soleus (Fig. 4H). There was no difference of ICAM-1 
mRNA abundance in the gastrocnemius in all groups (Fig. 4I). 
Inflammation protein expression 
 In the young mice, phosphorylated STAT3 relative to STAT3 was not different in the 
HFD group compared to the lean group in the TA (Fig. 5A). In the aged mice, phosphorylated 
STAT3 relative to STAT3 was reduced by 82% in the HFD group compared to the lean group 
in the TA (Fig. 5A). In the young mice, NF-κB was not different in the HFD group compared 
to the lean group in the TA (Fig. 5B). In the aged mice, NF-κB was 5-fold greater in the HFD 
group compared to the lean group in the TA (Fig. 5B). There was a main effect of diet with a 
decrease of phosphorylated STAT3 relative to STAT3 in the aged groups compared to the 
young groups in the TA (Fig. 5C). There was a main effect of diet with an increase of NF-κB 
in the HFD groups compared to the lean groups in the soleus (Fig. 5D). There was a main 
effect of age with an increase of NF-κB in the aged groups compared to the young groups in 
the soleus (Fig. 5D). There was no difference of phosphorylated STAT3 relative to STAT3 in 
the gastrocnemius in all groups (Fig. 5E). In the young mice, NF-κB was not different in the 




κB was 3-fold greater in the HFD group compared to the lean group in the gastrocnemius 
(Fig. 5F). 
Collagen & TGFβ gene expression 
 There was a main effect of diet with a decrease of TGF-β mRNA abundance in the 
HFD groups compared to the lean groups in the TA (Fig. 6A). There was a main effect of age 
with a decrease of TGF-β mRNA abundance in the aged groups compared to the young 
groups in the TA (Fig. 6A). There was a significant interaction of TGF-β mRNA abundance in 
the soleus (Fig. 6B). However, in the young mice, TGF-β mRNA abundance was not different 
in the HFD group compared to the lean group in the soleus (Fig. 6B). Also, in the aged mice, 
TGF-β mRNA abundance was not different in the HFD group compared to the lean group in 
the soleus (Fig. 6B). There was no difference of TGF-β mRNA abundance in the 
gastrocnemius in all groups (Fig. 6C). There was a main effect of age with a decrease of 
collagen I mRNA abundance in the aged groups compared to the young groups in the TA 
(Fig. 6D). In the young mice, collagen I mRNA abundance was 2-fold greater in the HFD 
group compared to the lean group in the soleus (Fig. 6E). In the aged mice, collagen I mRNA 
abundance was not different in the HFD group compared to the lean group in the soleus (Fig. 
6E). In the young mice, collagen I mRNA abundance was 5-fold greater in the HFD group 
compared to the lean group in the gastrocnemius (Fig. 6F). In the aged mice, collagen I 
mRNA abundance was not different in the HFD group compared to the lean group in the 
gastrocnemius (Fig. 6F). In the young mice, collagen III mRNA abundance was 2-fold greater 
in the HFD group compared to the lean group in the TA (Fig. 6G). In the aged mice, collagen 
III mRNA abundance was not different in the HFD group compared to the lean group in the 




HFD group compared to the lean group in the soleus (Fig. 6H). In the aged mice, collagen III 
mRNA abundance was not different in the HFD group compared to the lean group in the 
soleus (Fig. 6H). In the young mice, collagen III mRNA abundance was 6-fold greater in the 
HFD group compared to the lean group in the gastrocnemius (Fig. 6I). In the aged mice, 
collagen III mRNA abundance was reduced by 73% in the HFD group compared to the lean 
group in the gastrocnemius (Fig. 6I). There was a significant interaction of fibronectin 1 
mRNA abundance in the TA (Fig. 6J). However, in the young mice, fibronectin 1 mRNA 
abundance was not different in the HFD group compared to the lean group in the TA (Fig. 6J). 
Also, in the aged mice, fibronectin 1 mRNA abundance was not different in the HFD group 
compared to the lean group in the TA (Fig. 6J). In the young mice, fibronectin 1 mRNA 
abundance was not different in the HFD group compared to the lean group in the soleus (Fig. 
6K). In the aged mice, fibronectin 1 mRNA abundance was reduced by 56% in the HFD 
group compared to the lean group in the soleus (Fig. 6K). In the young mice, fibronectin 1 
mRNA abundance was 2-fold greater in the HFD group compared to the lean group in the 
gastrocnemius (Fig. 6L). In the aged mice, fibronectin 1 mRNA abundance was not different 
in the HFD group compared to the lean group in the gastrocnemius (Fig. 6L). 
MMP and TIMP gene expression 
 In the young mice, MMP-2 mRNA abundance was not different in the HFD group 
compared to the lean group in the TA (Fig. 7A). In the aged mice, MMP-2 mRNA abundance 
was decreased by 42% in the HFD group compared to the lean group in the TA (Fig. 7A). In 
the young mice, MMP-2 mRNA abundance was 2-fold greater in the HFD group compared to 
the lean group in the soleus (Fig. 7B). In the aged mice, MMP-2 mRNA abundance was 




young mice, MMP-2 mRNA abundance was 2-fold greater in the HFD group compared to the 
lean group in the gastrocnemius (Fig. 7C). In the aged mice, MMP-2 mRNA abundance was 
decreased by 45% in the HFD group compared to the lean group in the gastrocnemius (Fig. 
7C). There was a main effect of diet with a decrease of MMP-9 mRNA abundance in the HFD 
groups compared to the lean groups in the TA (Fig. 7D). There was a main effect of age with 
a decrease of MMP-9 mRNA abundance in the aged groups compared to the young groups in 
the TA (Fig. 7D). There was a main effect of diet with a decrease of MMP-9 mRNA 
abundance in the HFD groups compared to the lean groups in the soleus (Fig. 7E). There was 
a main effect of diet with a decrease of MMP-9 mRNA abundance in the HFD groups 
compared to the lean groups in the gastrocnemius (Fig. 7F). There was a significant 
interaction of TIMP-1 mRNA abundance in the TA (Fig. 7G). However, in the young mice, 
TIMP-1 mRNA abundance was not different in the HFD group compared to the lean group in 
the TA (Fig. 7G). Also, in the aged mice, TIMP-1 mRNA abundance was not different in the 
HFD group compared to the lean group in the TA (Fig. 7G). There was no difference in 
TIMP-1 mRNA abundance in in the soleus in all groups (Fig. 7H). There was no difference in 






The primary goal of this study was to examine how sarcopenic obesity alters basal 
levels of inflammation and ECM proteins in mice. We hypothesized that the combination of 
aging and obesity would further impair myogenesis, inflammatory signaling and ECM 
remodeling at rest. To our knowledge we are the first to demonstrate a reduction in mean 
CSA, greater frequency of smaller fibers, reduced P-STAT/STAT3, increase collagen III 
content, and chronically activated NF-κB expression in sarcopenic obese mice. All of these 
changes observed in sarcopenic obese indicate reduced regenerative capacity and also suggest 
further progressive decline exacerbated by the comorbidity of sarcopenic obesity. 
To determine whether sarcopenic obese mice were subjected to further exacerbated 
declines in muscle mass loss, we first examined muscle weights relative to tibia length and 
mean CSA in all animal groups. Aged HFD mice had an 8% and 6% reduction in TA and 
gastrocnemius muscle weight relative to tibia length but no change in the soleus. It has been 
reported that aging muscle is more susceptible to muscle mass losses in type II fibers than 
type I fibers which we observed in the mean-cross sectional area of aging HFD mice 
(Muscaritoli et al., 2010). Then we examined mean CSA and observed a 17% and 26% 
reduction in the young HFD and aged HFD compared to their lean counterparts, respectively. 
Next, we examined fiber distribution in both young and aged mice. The HFD mice in both 
young and aged mice had a higher frequency for smaller fibers and lower frequency of larger 
fibers suggesting that there is reduction of CSA in young HFD and aged HFD mice. Taken 
together it appears that muscle mass is much greater in sarcopenic obese mice. 
In this study we noticed that changes in MRFs were influenced by aging. In the soleus 




and colleagues had similar findings reporting higher elevated MyoD in old rats compared to  
young rats (Marsh, Criswell, Carson, & Booth, 1997). It is possible that MyoD may be 
chronically expressed to try and repair the muscle because in aging muscle there is a loss of 
motor neurons that will result in denervated muscle fibers (Hashizume, Kanda, & Burke, 
1988; Marsh et al., 1997). There were no changes reported with myogenin expression in 
skeletal muscle which is consistent with Schefer that reported no changes in myogenic 
differentiation in aging skeletal muscle in vitro (Shefer, Van de Mark, Richardson, & 
Yablonka-Reuveni, 2006). 
Next we examined inflammatory cytokines and adhesion molecules in skeletal muscle. 
There were no differences in IL-6 expression except for an increase of IL-6 in the soleus of 
aged mice. There was also an increase of ICAM-1 in the soleus of aged mice. ICAM-1 is an 
adhesion that recruits naïve macrophages from circulation to the site of injury (Abbas et al., 
2011). It is possible that slow twitch muscle fibers might be more susceptible to macrophage 
infiltration to facilitate muscle repair an aging muscle. It is important to note that the soleus 
was the only hindlimb muscle fiber that did not result in a decrease muscle weight relative to 
tibia length and therefore the IL-6 could be playing a preservative role in aging type I muscle 
fibers. This would be supported by aging literature that has demonstrated more pronounced 
reductions in type II fibers (Muscaritoli et al., 2010). On the contrary, the downstream target 
of IL-6, STAT3, was downregulated in aging mice. It has been confirmed that IL-6 can be 
alternatively activated by other intracellular proteins resulting apoptosis signaling observed an 
inflammatory diseases (Kishimoto, 2006). Thus more investigation is required to determine if 
IL-6 is playing a beneficial or negative role in slow twitch muscle fibers. Interestingly, there 




indicate less macrophage infiltration and thus less removal of damaged muscle fibers. Hence, 
there may be a differential response of IL-6 signaling in different muscle fiber types. 
 It has been a major assumption that pro-inflammatory cytokines are chronically 
activated in populations that are associated with systemic low grade inflammation. This study 
found no differences in TNF-α expression in either the TA or gastrocnemius. However, in the 
soleus there was a decrease of TNF-α expression in the HFD mice and an increase in TNF-α 
expression in the aged mice. The increase in TNF-α corroborates with the findings of 
increased IL-6 and ICAM-1 expression in the soleus and advocates a greater population of 
macrophages in aging soleus muscle. Because there was an increase of TNF-α expression in 
aged soleus muscle we investigated the downstream target NF-κB. We reported a main effect 
of HFD and aging to increase NF-κB expression in the soleus and 3-5 fold changes in aged 
HFD TA and gastrocnemius muscle. Moreover, there were no changes of TNF-α expression 
in the TA and gastrocnemius aging muscle. It has been demonstrated that NF-κB can be 
chronically activated independent of TNF-α and will cause atrophy in cancer cachexia (He et 
al., 2013). These findings may provide an explanation of the further decline in sarcopenic 
obese muscle mass and should be further investigated. 
Muscle fibrosis has also been observed in both aging and obese populations and can 
negatively impact regenerative capacity. In the gastrocnemius we observed no changes of 
collagen I content, but almost 2-fold greater collagen III in aged mice. It appears that excess 
collagen exhibited in aging gastrocnemius is predominately collagen III (Wood et al., 2014). 
Collagen III is different in structure in collagen I that it is more elastic and may suggest a 
higher susceptibility to injury in older adults.  Gene expression was also investigated and 




mice was reduced collagen III gene expression in the gastrocnemius and fibronectin 1 in 
soleus at basal levels. These findings did not match the excessive collagen III content 
witnessed in aging muscle and require more attention. It is possible that MMPs are still being 
activated in aging mice even though aging reduces favors low collagen turnover. Because 
MMP activity was not directly measured, further investigation is required. 
Altogether, aging HFD mice have reduced regenerative capacity and further 
progressive muscle mass loss at rest. This was evident in the aging and aging HFD muscle 
because there were reductions in muscle mass, CSA, impaired inflammatory signaling and 
altered ECM remodeling. Interestingly, it does appear that type II muscle are more negatively 
impacted and should be targeted for future therapeutic strategies to preserve muscle in 











Tibia anterior weight, soleus weight, gastrocnemius weight, bodyweight, tibia anterior relative to tibia 
length, soleus relative to tibia length, gastrocnemius relative to tibia length, in male C57BL/6 mice.  
Treatment TA (mg) Soleus (mg) Gastrocnemius 
(mg) 
Bodyweight (g) TA/TL (mg 
mm -1) 
Soleus/TL 
(mg mm -1) 
Gastrocnemius/TL 
(mg mm -1) 
Young         
   Lean 55.07 ± 1.41 9.67 ± 0.22 149.33 ± 3.32 28.91 ± 0.45 3.18 ± 0.09  0.56 ± 0.01 8.61 ± 0.23 
   HFD 56.90 ± 0.86 11.58 ± 0.18# 162.38 ± 2.49# 38.14 ± 0.64# 3.31 ± 0.05# 0.67 ± 0.01# 9.44 ± 0.14# 
Aged        
   Lean 52.03 ± 8.34 10.29 ± 0.47 152.44 ± 4.99 35.14 ± 2.09 2.83 ± 0.11 0.56 ± 0.02 8.29 ± 0.28 
   HFD 46.78 ± 1.16$ 9.83 ± 0.51 140.51 ± 3.82$ 53.70 ± 2.48$ 2.59 ± 0.07$ 0.54 ± 0.03 7.76 ± 0.17$ 
Values are means ± SEM. Note. BW = bodyweight, TL = tibia length. Significant difference from the 














Figure 1. Tibialis anterior mean cross sectional area and fiber distribution (A) 
Representative H&E staining of muscle cross section of young lean (a), young HFD (b), aged 
lean (c), and aged HFD (d); (B) Mean cross-sectional area of the tibialis anterior in young 
lean and HFD mice. (C) Myofiber distribution in young lean and young HFD mice (D) 
Myofiber distribution in young lean and young HFD mice. Frequency histograms and the 
frequency of fibers < 400 µm2 and > 900 µm2 were compared by a χ2 analysis as previously 
described (Washington et al., 2011). Values are reported in the frequency percentage of a 
given fiber size (µm2). Differences between two groups distinguished by *, P ≤ 0.05. 
Figure 2. Immunofluorescent staining of collagen on the tibialis anterior muscle. (A) 
Representative collagen I staining of muscle cross section of young lean (a), young HFD (b), 
aged lean (c), and aged HFD (d); (B) Collagen I content percentage in young and aged mice. 
(C) Representative  collagen III staining of muscle cross section of young lean (a), young 
HFD (b), aged lean (c), and aged HFD (d); (D) Collagen III content percentage in young and 
aged mice. Main effects of age distinguished by ‡. 
Figure 3. Myogenic regulatory factors in young and aged mice in the TA, soleus, and 
gastrocnemius. (A-C) MyoD mRNA abundance. (D-F) Myogenin mRNA abundance. All data 
was normalized to the young lean. Main effects of diet distinguished by † and age by ‡. 
Significant differences between young lean and young HFD and aged lean and aged HFD 
distinguished by #. P ≤ 0.05. 
Figure 4. Inflammatory cytokines and ICAM-1 mRNA Abundance in young and aged 
mice in the TA, soleus and gastrocnemius. (A-C) IL-6 mRNA abundance. (D-F) TNF-α 




lean. Main effects of diet distinguished by † and age by ‡. Significant differences between 
young lean and young HFD and aged lean and aged HFD distinguished by #. P ≤ 0.05. 
Figure 5. P-STAT3/STAT3 and NF-κB65 protein in young and aged mice in the TA, 
soleus, and gastrocnemius. (A) P-STAT3/STAT3 in the TA; (B) NF-κB65 in the TA. (C) P-
STAT3/STAT3 in the soleus; (D) NF-κB65 in the soleus. (E) P-STAT3/STAT3 in the 
gastrocnemius; (F) NF-κB65 in the gastrocnemius. Main effects of diet distinguished by † and 
age by ‡. Significant differences between young lean and young HFD and aged lean and aged 
HFD distinguished by #. P ≤ 0.05. Abbreviations: YL, young lean; YH, young high fat diet; 
AL, aged lean; AH, aged high fat diet. 
Figure 6. Collagen and promoters of collagen in young and aged mice in the TA, 
soleus and gastrocnemius. (A-C) TGF-β mRNA abundance. (D-F) Collagen I mRNA 
abundance. (G-I) Collagen III mRNA abundance (J-L) Fibronectin 1 mRNA abundance All 
data was normalized to the young lean. Main effects of diet distinguished by † and age by ‡. 
Significant differences between young lean and young HFD and aged lean and aged HFD 
distinguished by #. P ≤ 0.05. 
Figure 7. MMPs and TIMP-1 mRNA Abundance in young and aged mice in the TA, 
soleus and gastrocnemius. (A-C) MMP-2 mRNA abundance. (D-F) MMP-9 mRNA 
abundance. (G-I) TIMP-1 mRNA abundance All data was normalized to the young lean. Main 
effects of diet distinguished by † and age by ‡. Significant differences between young lean 
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AIM: Sarcopenic obesity has become a major concern because older adults have become 
the fastest growing obese population in North America. Sarcopenic obese individuals are 
associated with major health concerns along with increased risk of disability and will result in 
reduce quality of life. Aging and obese populations are associated with reduced recovery with 
injury and systemic low-grade inflammation. The inflammatory response is a major regulator in 
muscle regeneration which is needed for repair. The regenerative process is also dependent on 
myogenic regulatory factors (MRFs) for optimal muscle growth. The purpose of this study was 
to determine how sarcopenic obesity alters MRFs and inflammatory signaling during muscle 
regeneration in mice. METHODS: One hundred two male C57BL6/J mice (4 weeks old) were 
randomly assigned to either a high fat diet (HFD, 60% fat) or normal chow. Both young mice (12 
weeks) and aged mice (22-24 months old) were injected with either PBS (control) or bupivacaine 
(myotoxin). The TA was excised 3 or 21 days after injection. RESULTS: The aged lean injured 
mice had 9% greater mean cross-sectional area than the control mice 21 days following muscle 
damage but no changes were observed in aged HFD injured mice. There were no reported 
changes in MRF gene expression in the aged HFD mice 3 and 21 days post-injection. There was 
a main effect of diet to increase NF-κB in the aging HFD mice 3 days following muscle damage. 
NF-κB was 3-fold greater in the aged HFD injured mice compared to the uninjured mice 21 days 
following muscle damage. CONCLUSION: Sarcopenic obese mice had reduced regenerative 
capacity partially due to impaired inflammatory signaling.  
 





Currently, close to 40% of Americans 65 years of age and older are obese (CDC). The 
majority of these older adults also suffer from an age-related decline in muscle mass known as 
sarcopenia (Rosenberg, 1989). These individuals would be considered sarcopenic obese which 
is defined as a metabolic syndrome in which there is excess adipose tissue along with an age-
related decline of muscle mass (Choi, 2013; Lim et al., 2010; Lynch, 2011; Rosenberg, 1989). 
This is alarming because little is known about the symptoms and associated health risks 
involved with this sub-population. It has been identified that both aging and obesity are 
associated with chronic systemic low-grade inflammation. Nevertheless, chronic 
inflammatory signaling negatively impacts numerous physiological processes involved with 
recovery including skeletal muscle regeneration, which is needed for optimal muscle repair 
(Hu et al., 2010; Nguyen et al., 2011).  
Skeletal muscle regeneration is essential for the repair of damaged muscle fibers. It 
involves the coordination of inflammatory signaling, satellite cell activation, and extracellular 
matrix (ECM) remodeling for optimal muscle growth and repair. Similar to damage to other 
tissues and organs muscle damage evokes an inflammatory response to aid in the recovery 
process. In fact, the inflammatory response has been regarded as one of the earliest responses 
after the muscle has been damaged (Abbas et al., 2011; Schiaffino & Partridge, 2008). This is 
because inflammatory cells are involved in the removal of necrotic muscle tissue as well as 
regulating myogenic regulatory factors (MRFs) that involved in myoblast proliferation and 
differentiation that is necessary in the early stages of skeletal muscle regeneration (S. E. Chen 
et al., 2005; Toth et al., 2011).  
After muscle damage occurs, phagocytes circulating in the bloodstream will be 
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recruited to infiltrate the endothelial wall into the skeletal muscle ECM. Upon arrival, 
phagocytes will engulf damaged tissue and secrete several cytokines such as TNF-α and IL-6 
to assist in myoblast proliferation and differentiation. The expression of pro-inflammatory 
cytokines will be elevated for several days peaking at around 48-72 hours following muscle 
damage and reach basal levels a few weeks later (Hirata et al., 2003). In addition, resident 
macrophages located in the ECM of skeletal muscle tissue will secrete cytokines that will 
facilitate the influx of phagocytes to the site of muscle injury. 
Recruitment of phagocytes contribute to muscle growth and is a part of the muscle 
regeneration process. The adhesion molecule, ICAM-1, is partially responsible for phagocyte 
recruitment and infiltration within various tissues (Abbas et al., 2011). Dearth and colleagues 
examined an overload muscle model and discovered that ICAM-1 expression was increased 
by more than 10 fold in wild-type mice 3 days following muscle overload-induced damage 
(Dearth et al., 2013). Furthermore, the percentage of regenerating fibers, as measured by Pax7 
protein, were 3.5 fold higher in the wild-type mice compared to the ICAM -/- mice a week 
following muscle overload (Dearth et al., 2013). The role of pro-inflammatory cytokines and 
their relationship to the recruitment and infiltration has also been investigated in skeletal 
muscle. Cultured C2C12 treated cells treated with TNF-α induced ICAM-1 in primary 
myoblasts (Dearth et al., 2013). Furthermore, Zhang et al. examined macrophage recruitment 
in IL-6 knockout mice following cardiotoxin-induced muscle damage and observed a decrease 
in chemokines involved with macrophage infiltration days after muscle damage along with 
smaller myofibers two weeks following muscle damage (Zhang et al., 2013). 
It has been observed in aging and pathophysiological disease that the alteration of 
inflammatory cytokines can delay or impair the muscle regeneration process (Cesari et al., 
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2005). Recently, we examined diet-induced obese mice and discovered reduced IL-6 at basal 
levels and a blunted response TNF-α mRNA abundance at the onset of muscle regeneration 
(L. A. Brown et al., 2015). The obese mice also had no change in cross-sectional area and a 
reduction in skeletal muscle weight relative to tibia length 28 days following muscle damage 
(L. A. Brown et al., 2015). In the aging literature there have been a few reports finding that 
either older adults are not able to induce a pro-inflammatory response at the onset muscle 
regeneration or that there is no difference pro-inflammatory cytokine expression compared to 
young adults (Hamada et al., 2005; Pedersen et al., 2004). Thus, aging and obesity leads to 
chronic systemic low-grade inflammation, reduced inflammatory cytokines in skeletal muscle, 
and the inability to secrete a substantial amount of inflammatory cytokines during muscle 
regeneration. Whether this is the case for sarcopenic obese mice has yet to be explored. 
Therefore the purpose of this study was to investigate how sarcopenic obesity alters 
inflammatory processes during skeletal muscle regeneration. We hypothesized that impaired 






Animals and Housing 
 One hundred two C57BL/6 mice were purchased from Jackson Laboratories. Animals 
were housed in the University of Arkansas Central Laboratory Animal Facility. The overall 
study consisted of 2 separate animal experiments in young adult (3-4 mo) and aged mice (22-
24 mo). Experiment 1 examined immunohistochemistry and protein expression, and gene 
expression 3 days post-bupivacaine injection. Experiment 2 examined immunohistochemistry, 
muscle morphology, protein expression, and gene expression 21 days post-bupivacaine 
injection. For experiment 1 and 2 mice were randomly assigned to one of eight groups at 4 
weeks of age: 1) young lean uninjured (n = 5); 2) young lean injured (n = 6); 3) young obese 
uninjured (n = 5-8); 4) young obese injured (n = 6-8); 5) aged lean uninjured (n = 7-8); 6) 
aged lean injured (n = 7-8); 7) aged obese uninjured (n = 5-6); 8) aged obese injured (n = 6). 
Mice were fed normal chow (normal; 17% kcals fat Research Diets, New Brunswick, New 
Jersey) or a high fat diet (HFD; 60% kcals fat, Research Diets, New Brunswick, New Jersey) 
until they were euthanized. All procedures were approved by the University of Arkansas 
Institutional Animal Care and Use Committee (IACUC).  
Muscle and Tibia Extraction  
At either 3-4 mo or 22-24 mo of age, muscle and tibia extractions were performed as 
previously described (Tyrone A Washington et al., 2013; T. A. Washington et al., 2011). The 
TA and tibias were extracted while the mice were anesthetized with a subcutaneous injection 
of a cocktail containing ketamine hydrochloride (90 mg/kg body weight), xylazine (3 mg/kg 
body weight), and acepromazine (1 mg/kg body weight). The left TA was snap frozen in 
liquid nitrogen and stored at -80°C for protein and gene expression analysis, the right TA was 
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cut at the midbelly, mounted in optimum cutting temperature compound (OCT), and then 
dropped in liquid nitrogen cooled isopentane. Once frozen, samples were stored at -80°C for 
morphological analysis. After the muscles was dissected out, the tibia was removed and 
measured with a plastic caliper (VWR, Radnor, PA, USA). Tibia measurements were utilized 
to normalize muscle weights to an estimate of total body size. 
Bupivacaine Injection 
At 3 mo or 22-23 mo of age, bupivacaine (Hospira, Lake Forest, IL) injections were 
performed as previously described (Washington et al., 2013). Mice were anesthetized with a 
subcutaneous injection of a cocktail containing ketamine hydrochloride (45 mg/kg body 
weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body weight). Muscle 
damage was induced by injecting 0.03ml of 0.75% bupivacaine (Marcaine) in the left and 
right tibialis anterior muscles (TA). A 25-gauge, 5/8 (0.5 x 16 mm) needle was inserted along 
the longitudinal axis of the muscle, and the bupivacaine was injected slowly as the needle was 
withdrawn. The control group was injected with 0.03 ml of phosphate buffered saline (PBS). 
Morphological Analysis  
Fiber distribution and cross-sectional area (CSA) were performed as previously 
described (Brown et al., 2016; Washington et al., 2011). Each TA muscle section (n = 6) was 
stained with hematoxylin and eosin, imaged with a Nikon camera (Sight DS-Vi1) mounted on 
an Olympus CKX41 inverted microscope at 20X magnification (Olympus), and analyzed with 
Nikon NIS Elements BR software package (Nikon). Each fiber was traced with a mouse and 
the number of pixels traced was calibrated to obtain CSA of the muscle. All fibers in the cross 
section images were quantified unless the sarcolemma was not intact. Approximately 100 
fibers were traced per sample. 
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Western blotting  
Muscle tissues were homogenized as previously described (Lee et al., 2016). 
Approximately 10-40 mg of gastrocnemius, soleus, and TA was homogenized in glass dounce 
type homogenizers in 0.30 ml of complete protein loading buffer (50 mM Tris·HCl, pH 6.8, 
1% sodium dodecyl sulfate (SDS), 10% glycerol, 20 mM dithiothreitol, 127 mM 2-
mercaptoethanol, and 0.01% bromophenol blue supplemented with protease inhibitors 
(Roche) and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). After homogenization, 
samples were transferred to sterile 1.5mL microcentrifuge tubes, heated for 5 minutes at 95°C 
to denature protein and then centrifuged for 5 minutes at 13,000 rpm.  Protein concentrations 
were determined using a commercially available RC/DC assay kit. Muscle homogenate (40 
µg) was fractionated in 10% SDS-polyacrylamide gels. Gels were transferred to 
polyvinylidene difluoride (PVDF) membranes. Membranes were stained with Ponceau S 
before blotting to verify equal loading of the gels. Membranes were blocked in 5% milk, in 
Tris-buffered saline with 0.1% Tween-20 (TBST), for 2 hours. Primary antibodies for P-Stat3 
(Tyr705), Stat3 (Cell Signaling Technologies, Danvers, MA), and NF-κB p65 (Santa Cruz, 
Dallas, TX) were diluted 1:1000 to 1:2000 in 5% milk, in TBST, and incubated at 
4°C overnight. Anti-rabbit and Anti-mouse monoclonal secondary antibodies (Cell Signaling 
Technologies, Danvers, MA) were diluted 1:2,000 in 5% milk, in TBST, and then incubated 
at room temperature for one hour. Enhanced Chemiluminescence (ECL) was performed using 
Fluorochem M imager (Protein Simple, Santa Clara, California) to visualize antibody-antigen 
interaction. Blotting images were quantified by densitometry using AlphaView software 
(Protein Simple). The Ponceau-stained membranes were digitally scanned, and the 45-kDa 
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actin bands were quantified by densitometry and used as a protein loading correction factor 
for each lane.  
RNA Isolation, cDNA synthesis, and quantitative RT-PCR 
The following procedures were completed as previously described (N. P. Greene et al., 
2015; Nicholas P Greene et al., 2014; Tyrone A Washington et al., 2013). RNA was extracted 
with Trizol reagent (Life Technologies, Grand Island, NY, USA). TA muscles were 
homogenized in Trizol. Total RNA was isolated, DNase treated and purity and concentrations 
were determined using 260/280nm ratios read on a BioTek Take3 microvolume microplate 
with a BioTek PowerWave XC microplate reader (BioTek Instruments Inc., Winooski, VT). 
cDNA was reverse transcribed from 1 µg of total RNA using the Superscript Vilo cDNA 
synthesis kit (Life Technologies, Carlsbad, CA, USA). Real-time PCR was performed, and 
results were analyzed by using the StepOne Real-Time PCR system (Life Technologies, 
Applied Biosystems, Grand Island, NY). cDNA was amplified in a 25 µL reaction containing 
appropriate primer pairs and TaqMan Universal Mastermix (Applied Biosystems). Samples 
were incubated at 95°C for 4 min, followed by 40 cycles of denaturation, annealing and 
extension at 95°C, 55°C and 72°C respectively. TaqMan fluorescence was measured at the 
end of the extension step each cycle. Fluorescence labeled probes for TNFα (FAM dye), IL-6 
(FAM dye), ICAM-1 (FAM dye), and 18S (FAM dye) were purchased from Applied 
Biosystems and quantified with TaqMan Universal mastermix. Cycle threshold (Ct) was 
determined, and the ΔCt value was calculated as the difference between the Ct value and the 
18S Ct value. Final quantification of gene expression was calculated using the ΔΔCT method 
Ct = [ΔCt(calibrator) – ΔCt(sample)]. Relative quantification was then calculated as 20-ΔΔCt. 
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Melt curve analysis was performed at the end of the PCR run to verify no primer dimers were 
formed. 
Statistical Analysis  
All data was analyzed using Statistical Package for the Social Sciences (SPSS version 
22.0, Armonk, NY). Results are reported as mean ± SEM. Pre-planned comparisons between 
lean and obese uninjured mice were conducted using Student’s t-tests. For these analyses, lean 
and obese uninjured were pooled from the 3 and 21 day time-points. A two-way ANOVA was 
performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables for 3 and 21 days post-bupivacaine injection. When a 
significant interaction was detected, differences among individual means were assessed with 
Fisher’s LSD post-hoc analysis. The χ2 analysis was used to detect differences in the 
proportion of small fibers (< 400 µm2) and large fibers (> 900 µm2) between treatment groups. 






Animal weight characteristics and muscle morphology 
Body weight in the young HFD mice was 21% greater than young lean mice (Table 1). 
Body weight in the aged HFD mice was 38% greater than aged lean mice (Table 2). In the 
young mice there was no difference in muscle weight relative to tibia length 3 days post-
bupivacaine injection (Table 1). In the aged mice there was no difference in muscle weight 
relative to tibia length 3 days post-bupivacaine injection (Table 2). In the young mice there 
was no difference in muscle weight relative to tibia length 21 days post-bupivacaine injection 
(Table 1). In the aged mice there was no difference in muscle weight relative to tibia length 21 
days post-bupivacaine injection (Table 2). 
In the young lean mice, mean cross-sectional area was 20% greater in the injured 
group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 1B). In the 
young HFD mice, mean cross-sectional area was not different in the injured group compared 
to the uninjured group 21 days post-bupivacaine injection (Fig. 1B). In the young lean mice 
there were 89% less small (< 400 µm2) fibers in the injured group compared to the uninjured 
group (Fig. 1C). Also, in the young lean mice there were 7% more large fibers (> 900 µm2) in 
the injured group compared to the uninjured group (Fig. 1C). No differences were seen 
between the uninjured and injured young HFD mice for distribution of myofibers 21 days 
post-bupivacaine injection (Fig. 1D). In the aged lean mice, mean cross-sectional area was 9% 
greater in the injured group compared to the uninjured group 21 days post-bupivacaine 
injection (Fig. 1F). In the aged HFD mice, mean cross-sectional area was not different in the 
injured group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 1F). 
In the aged lean mice there were 32% less small (< 400 µm2) fibers in the injured group 
 
129  
compared to the uninjured group (Fig. 1G). Also, in the aged lean mice there were no 
differences seen between large fibers in the injured group compared to the uninjured group 21 
days post-bupivacaine injection. No differences were seen between the uninjured and injured 
aged HFD mice for distribution of myofibers 21 days post-bupivacaine injection (Fig. 1H). 
MRF gene expression 
In the young lean mice, MyoD mRNA abundance was not different in the injured 
group compared to the uninjured group 3 days post-bupivacaine injection (Fig. 2A). In the 
young HFD mice MyoD mRNA abundance was not different in the injured group compared 
to the uninjured group 3 days post-bupivacaine injection (Fig. 2A). There was a main effect of 
diet with a decrease of MyoD mRNA abundance in the young HFD group compared to the 
lean group 21 days post-bupivacaine injection (Fig. 2B). In the aged lean mice MyoD mRNA 
abundance was not different in the injured group compared to the uninjured group 3 days 
post-bupivacaine injection (Fig. 2C). In the aged HFD mice MyoD mRNA abundance was not 
different in the injured group compared to the uninjured group 3 days post-bupivacaine 
injection (Fig. 2C). In the aged lean mice, MyoD mRNA abundance was reduced by 76% 
(Fig. 2D) in the injured group compared to the uninjured group 21 days post-bupivacaine 
injection. In the aged HFD mice MyoD mRNA abundance was not different in the injured 
group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 2D). In the 
young lean mice, myogenin mRNA abundance was 6-fold greater (Fig. 2E) in the injured 
group compared to the uninjured group 3 days post-bupivacaine injection. In the young HFD 
mice myogenin mRNA abundance was not different in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection (Fig. 2E). There was a main effect of diet 
with a decrease of myogenin mRNA abundance in the young HFD group compared to the 
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young lean group 21 days post-bupivacaine injection (Fig. 2F). In the aged lean mice, 
myogenin mRNA abundance was not different in the injured group compared to the uninjured 
group 3 days post-bupivacaine injection (Fig. 2G). In the aged HFD mice, myogenin mRNA 
abundance was not different in the injured group compared to the uninjured group 3 days 
post-bupivacaine injection (Fig. 2G). In the aged lean mice, myogenin mRNA abundance was 
reduced by 70% (Fig. 2H) in the injured group compared to the uninjured group 21 days post-
bupivacaine injection. In the aged HFD mice myogenin mRNA abundance was not different 
in the injured group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 
2H). 
ICAM 1 gene expression 
 In the young lean mice, ICAM-1 mRNA abundance was not different in the 
injured group compared to the uninjured group 3 days post-bupivacaine injection (Fig. 3A). In 
the young HFD mice, ICAM-1 mRNA abundance was not different in the injured group 
compared to the uninjured group 3 days post-bupivacaine injection (Fig. 3A). There was a 
main effect of diet with a decrease of ICAM-1 mRNA abundance in the young HFD group 
compared to the young lean group 21 days post-bupivacaine injection (Fig. 3B). In the aged 
lean mice, ICAM-1 mRNA abundance was not different in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection (Fig. 3C). In the aged HFD mice ICAM-1 
mRNA abundance was not different in the injured group compared to the uninjured group 3 
days post-bupivacaine injection (Fig. 3C). There was a main effect of diet with a decrease of 
ICAM-1 mRNA abundance in the aged HFD group compared to the aged lean group 21 days 




In the young lean mice, IL-6 mRNA abundance was 5-fold greater in the injured group 
compared to the uninjured group 3 days post-bupivacaine injection (Fig. 4A). In the young 
HFD mice, IL-6 mRNA abundance was not different in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection (Fig. 4A). In the young lean mice, IL-6 
mRNA abundance was 3-fold greater in the injured group compared to the uninjured group 21 
days post-bupivacaine injection (Fig. 4B). In the young HFD mice, IL-6 mRNA abundance 
was not different in the injured group compared to the uninjured group 21 days post-
bupivacaine injection (Fig. 4B). There was a main effect of diet with an increase of 
phosphorylated STAT3 relative to STAT3 in the young HFD group compared to the young 
lean group 3 days post-bupivacaine injection (Fig. 4C). There was a main effect of diet with 
an increase of phosphorylated STAT3 relative to STAT3 in the young HFD group compared 
to the young lean group 21 days post-bupivacaine injection (Fig. 4D). 
In the aged lean mice, IL-6 mRNA abundance was not different in the injured group 
compared to the uninjured group 3 days post-bupivacaine injection (Fig. 5A). In the aged 
HFD mice, IL-6 mRNA abundance was 3-fold greater 3 days post bupivacaine injection (Fig. 
5A). In the aged lean mice, IL-6 mRNA abundance was not different in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 5B). In the aged 
HFD mice, IL-6 mRNA abundance was not different in the injured group compared to the 
uninjured group 21 days post-bupivacaine injection (Fig. 5B). There was a main effect of diet 
with a decrease of phosphorylated STAT3 relative to STAT3 in the aged HFD group 
compared to the aged lean group 3 days post-bupivacaine injection (Fig. 5C). In the aged lean 
mice, phosphorylated STAT3 relative to STAT3was not different in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 5D). In the aged 
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HFD mice, phosphorylated STAT3 relative to STAT3 was not different in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 5D). 
TNF-α/NF-κB signaling 
There was a main effect of injury with an increase of TNF-α mRNA abundance in the 
young injured group compared to the young uninjured group 3 days post-bupivacaine 
injection (Fig. 6A). There was a main effect of diet with a decrease of TNF-α mRNA 
abundance in the young HFD group compared to the young lean group 21 days post-
bupivacaine injection (Fig. 6B). There was no difference of NF-κB in all groups 3 days post-
bupivacaine injection (Fig. 6C). There was a main effect of diet with an increase of NF-κB in 
the young HFD group compared to the young lean group 21 days post-bupivacaine injection 
(Fig. 6D). 
In the aged lean mice, TNF-α mRNA abundance was not different in the injured group 
compared to the uninjured group 3 days post-bupivacaine injection (Fig. 7A). In the aged 
HFD mice, TNF-α mRNA abundance was not different in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection (Fig. 7A). There was a main effect of diet 
with a decrease of TNF-α mRNA abundance in the aged HFD group compared to the aged 
lean group 21 days post-bupivacaine injection (Fig. 7B). There was a main effect of diet with 
an increase of NF-κB in the aged HFD group compared to the aged lean group 3 days post-
bupivacaine injection (Fig. 7C). In the aged lean mice, NF-κB was not different in the injured 
group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 7D). In the 
aged HFD mice, NF-κB was 3-fold greater (Fig. 7D) in the injured group compared to the 





The primary goal of this study was to examine how sarcopenic obesity alters 
myogenic and inflammatory signaling in skeletal muscle following injured. We hypothesized 
that sarcopenic obese mice would have impaired muscle regeneration due to the inability to 
upregulate inflammatory cytokines at the onset of muscle damage. In addition, we expected to 
observe a blunted response in ICAM-1 expression following muscle injury. To our knowledge 
we are the first to demonstrate no changes in frequency of cross-sectional area fiber size 21 
days following muscle damage in HFD mice. We also witnessed reduced STAT3 at the onset 
muscle regeneration and upregulated NF-κB in the early and late stages of muscle 
regeneration in HFD mice. These alterations within inflammatory signaling would suggest 
sub-optimal muscle regeneration in aged HFD mice.  
There were no differences when examining the TA muscle weight relative to tibia 
length in the aged lean and aged HFD mice. However, 21 days following myotoxin-induced 
damage, mean CSA slightly shifted towards the right in the aged lean mice but not in the aged 
HFD mice. A previous study from our laboratory demonstrated a right shift towards large 
fibers in young lean mice but not in young HFD mice indicating delayed muscle regeneration 
(L. A. Brown et al., 2015). We observed a similar pattern in the aged lean and aged HFD 
mice. Also, 21 days following muscle damage we observed a 20% and 9% increase in young 
lean and aged lean mice, respectively but no changes in the HFD mice. These data would 
suggest that there is a delayed or sub-optimal regenerative response in the aged HFD mice. 
 Next we examined expression of MRFs in all animal groups. To our surprise there was 
no differences with the upregulation of MyoD in both the young and aged mice at the onset of 
muscle regeneration. A previous study reported that MyoD was upregulated 5 days after 
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muscle injury for myoblast proliferation (Marsh et al., 1997). The difference in MyoD 
expression in this study compared to our study may be due to high variance reported in gene 
expression. As expected young mice upregulated myogenin at the onset of regeneration but 
young HFD and aging mice had the inability to upregulate myogenin. Myogenin is an 
essential transcription factor for myoblast differentiation. Unlike our findings Marsh and 
colleagues found a 2.5-fold upregulation of myogenin in aged rats (Marsh et al., 1997). In 
their study they normalized myogenin expression to muscle weight which may could 
potentially explain the slight increase they found an expression due to a smaller muscle 
weight in old rats (Marsh et al., 1997). It has been reported in numerous studies that aging 
skeletal muscle has a reduced satellite pool and senescent cells that may contribute to reduced 
activity in muscle cells involved with muscle repair an aging lean and HFD mice 
(Chakkalakal, Jones, Basson, & Brack, 2012; Ciciliot & Schiaffino, 2010; Conboy et al., 
2005). 
 In young mice and old mice we did not observe any changes in ICAM-1 expression 
following injury at the early stages of injury. Dearth and colleagues found a 2-fold 
upregulation of ICAM-1 in 3 days after overload in mice (Dearth et al., 2013). Monocyte 
recruitment is one of the first processes that will occur following tissue injury which can 
facilitate macrophage recruitment within minutes following tissue damage (Kharraz et al., 
2013). It is possible that we did not see an upregulation of ICAM-1 in any group because the 
3 day time point is too late to detect differences in a myotoxin-induced muscle damage model. 
In the late stages of muscle regeneration there was a reduced expression of ICAM-1 in the 
HFD mice. Activated inflammatory proteins involved with repair will typically get inhibited 
before returning to basal levels. The reduction of ICAM-1 may indicate a delayed 
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regenerative response in HFD mice. 
 In this study we noticed that the young lean and aged HFD mice were able to activate 
IL-6 at the onset of muscle regeneration whereas the young HFD and aged lean mice could 
not induce IL-6. The young HFD and aged lean mice both exhibit altered inflammatory 
cytokines and sub-optimal regeneration (L. A. Brown et al., 2015; Chakkalakal et al., 2012). 
The young HFD mice also had a greater P-STAT3/STAT3 expression 3 and 21 days 
following muscle injury that may be partially responsible for sub-optimal regeneration in this 
population. However, the aged HFD mice induced IL-6, but had a severe reduction in STAT3 
expression. IL-6 can classically activate STAT3 for anti-inflammatory effects or alternatively 
signal pathways responsible for apoptosis seen in inflammatory diseases (Kishimoto, 2006). 
The lack of STAT3 activation in aged HFD may suggest that IL-6 is signaling pathways that 
may negatively impact muscle regeneration.  
 TNF-α was also examined because of it has a regulatory role in myoblast 
differentiation. We observed a similar response for young lean and HFD to upregulate TNF-α 
3 days following injury. This was different from our previous study that found a blunted 
response in TNF-α (L. A. Brown et al., 2015). The differences in diet of the control animal 
groups between studies (lean diet 10% fat v. normal chow) could be responsible for 
highlighting the changes in HFD mice in the previous study. There was also a main effect of 
diet to increase NF-κB 3 days following muscle damage and it remained elevated in the HFD 
group 21 days following muscle recovery. TNF-α/NF-κB signaling is necessary to carry out 
apoptosis of damaged muscle fibers (S. E. Chen et al., 2005). However, chronic expression 
can lead to muscle atrophy that may be responsible in the reduction of CSA seen in our study. 
Interestingly, the aging mice were unable to upregulate TNF-α. However, we did observe a 
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main effect of diet to increase in NF-κB expression at the onset of muscle regeneration and a 
3-fold greater response in the aged HFD mice. It has been demonstrated that NF-κB can be 
chronically activated independent of TNF-α and will cause atrophy in cancer cachexia (He et 
al., 2013). It appears that NF-kB could be the major contributor to muscle loss in sarcopenic 
obesity. 
 Overall, sarcopenic obesity has a sub-optimal regenerative response to muscle injury. 
This appears to be partially due to the inability to activate STAT3 and inactivate NF-κB 
during muscle regeneration. The aged mice also demonstrated a blunted response in myogenin 
which may be associated with changes in inflammatory signaling. The reductions of 






Table 1  
 
Animal post-bodyweight, tibia anterior muscle wet weight, tibia length, muscle relative to 
tibia length, and muscle relative to bodyweight, in young male C57BL/6 mice with and 
without muscle damage  
Values are means ± SEM. Main effects of treatment distinguished by † and diet by ‡, P ≤ 
0.05. 
Treatment Bodyweight (g) Muscle wet wt 
(mg) 
Tibia (mm) Muscle/BW 
(mg g -1)  
Muscle/TL 
(mg mm -1) 
3D Lean       
   Uninjured 27.84 ± 0.44 51.27 ± 1.08 17.56 ± 0.08  1.84 ± 0.03 2.92 ± 0.07 
Injured 28.12 ± 0.74 53.23 ± 1.93 17.01 ± 0.23† 1.90 ± 0.07 3.13 ± 0.08 
3D HFD      
   Uninjured 38.68 ± 1.48‡ 57.08 ± 2.12 17.58 ± 0.20 1.49 ± 0.10‡ 3.25 ± 0.13 
   Injured 34.63 ± 1.98‡ 53.96 ± 2.30 17.10 ± 0.26† 1.57 ± 0.08‡ 3.15 ± 0.10 
21D Lean      
   Uninjured 29.98 ± 0.37 58.87 ± 0.77 17.15 ± 0.12 1.96 ± 0.01 3.43 ± 0.04 
   Injured 30.30 ± 0.86 59.05 ± 1.86 17.20 ± 0.09 1.95 ± 0.04 3.43 ± 0.11 
21D HFD      
   Uninjured 39.83 ± 1.22‡ 56.10 ± 2.43 17.60 ± 0.25 1.41 ± 0.08‡ 3.19 ± 0.16‡ 




Table 2  
Animal post-bodyweight, tibia anterior muscle wet weight, tibia length, muscle relative to 
tibia length, and muscle relative to bodyweight, in aged male C57BL/6 mice with and without 
muscle damage  
Treatment Bodyweight (g) Muscle wet wt 
(mg) 
Tibia (mm) Muscle/BW 
(mg g -1)  
Muscle/TL 
(mg mm -1) 
3D Lean       
   Uninjured 34.10 ± 2.62 48.44 ± 1.01 18.50 ± 0.18  1.46 ± 0.08 2.60 ± 0.05 
Injured 32.59 ± 0.70 55.52 ± 1.59 18.18 ± 0.14† 1.71 ± 0.06 3.06 ± 0.10 
3D HFD      
   Uninjured 58.87 ± 2.17‡ 46.48 ± 1.42 18.32 ± 0.14 0.79 ± 0.04‡ 2.54 ± 0.09 
   Injured 56.47 ± 4.36‡ 45.40 ± 1.76 18.68 ± 0.07† 0.84 ± 0.09‡ 2.43 ± 0.09 
21D Lean      
   Uninjured 32.34 ± 0.69 55.92 ± 0.87 17.80 ± 0.07 1.73 ± 0.04 3.14 ± 0.05 
   Injured 32.73 ± 0.93 54.36 ± 1.26 17.98 ± 0.10‡ 1.66 ± 0.02 3.02 ± 0.06 
21D HFD      
   Uninjured 46.72 ± 3.55‡ 48.24 ± 1.95‡ 17.89 ± 0.17 1.06 ± 0.10‡ 2.70 ± 0.11‡ 
   Injured 50.46 ± 4.45‡ 49.37 ± 2.37‡ 18.22 ± 0.06‡ 1.02 ± 0.12‡ 2.71 ± 0.13‡ 






Figure 1. Tibialis anterior mean cross-sectional area and fiber distribution 21 days of 
recovery after bupivacaine-induced injury. (A) Representative H&E staining of muscle cross 
section of young lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD injured (d); 
(B) Mean cross-sectional area of the tibialis anterior in young mice. (C) Myofiber distribution 
in young lean uninjured and lean injured mice (D) Myofiber distribution in young HFD 
uninjured and HFD injured mice. .(E) Representative H&E staining of muscle cross section of 
aged lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD injured (d); (F) Mean 
cross-sectional area of the tibialis anterior in aged mice. (G) Myofiber distribution in aged 
lean uninjured and lean injured mice (H) Myofiber distribution in aged HFD uninjured and 
HFD injured mice. Frequency histograms and the frequency of fibers < 400 µm2 and > 900 
µm2 were compared by a χ2 analysis as previously described (Washington et al., 2011). Values 
are reported in the frequency percentage of a given fiber size (µm2). Main effects of injury 
distinguished by † and diet by ‡. Significant differences between lean uninjured and lean 
injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Figure 2. Myogenic regulatory factors of skeletal muscle regeneration at 3 days and 21 
days of recovery after bupivacaine-induced injury. (A) MyoD mRNA abundance 3 days post-
bupivacaine injection in young lean and HFD mice. (B) MyoD mRNA abundance 21 days 
post-bupivacaine injection in young lean and HFD mice. (C) MyoD mRNA abundance 3 days 
post-bupivacaine injection in aged lean and HFD mice. (D) MyoD mRNA abundance 21 days 
post-bupivacaine injection in aged lean and HFD mice. (E) Myogenin mRNA abundance 3 
days post-bupivacaine injection in young lean and HFD mice. (F) Myogein mRNA abundance 
21 days post-bupivacaine injection in young lean and HFD mice. (G) Myogenin mRNA 
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abundance 3 days post-bupivacaine injection in aged lean and HFD mice. (H) Myogenin 
mRNA abundance 21 days post-bupivacaine injection in aged lean and HFD mice. Main 
effects of injury distinguished by † and diet by ‡. Significant differences between lean 
uninjured and lean injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Figure 3. ICAM-1 mRNA abundance of skeletal muscle regeneration at 3 days and 21 
days of recovery after bupivacaine-induced injury. (A) ICAM-1 mRNA abundance 3 days 
post-bupivacaine injection in young lean and HFD mice. (B) ICAM-1 mRNA abundance 21 
days post-bupivacaine injection in young lean and HFD mice. (C) ICAM-1 mRNA abundance 
3 days post-bupivacaine injection in aged lean and HFD mice. (D) ICAM-1 mRNA 
abundance 21 days post-bupivacaine injection in aged lean and HFD mice. Main effects of 
injury distinguished by † and diet by ‡. Significant differences between lean uninjured and 
lean injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Figure 4. IL-6 signaling of skeletal muscle regeneration at 3 days and 21 days of 
recovery after bupivacaine-induced injury. (A) IL-6 mRNA abundance 3 days post-
bupivacaine injection in young lean and HFD mice. (B) IL-6 mRNA abundance 21 days post-
bupivacaine injection in young lean and HFD mice. (C) Fold changes in P-STAT3/STAT3 
protein 3 days post-bupivacaine injection in young lean and HFD mice. (D) Fold changes in 
P-STAT3/STAT3 protein 21 days post-bupivacaine injection in young lean and HFD mice. 
Main effects of injury distinguished by † and diet by ‡. Significant differences between lean 
uninjured and lean injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Abbreviations: YLu, young lean uninjured; Yli, young lean injured; YHu, young high fat diet 
uninjured; YHi, young high fat diet injured. 
Figure 5. IL-6 signaling of skeletal muscle regeneration at 3 days and 21 days of 
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recovery after bupivacaine-induced injury. (A) IL-6 mRNA abundance 3 days post-
bupivacaine injection in aged lean and HFD mice. (B) IL-6 mRNA abundance 21 days post-
bupivacaine injection in aged lean and HFD mice. (C) Fold changes in P-STAT3/STAT3 
protein 3 days post-bupivacaine injection in aged lean and HFD mice. (D) Fold changes in P-
STAT3/STAT3 protein 21 days post-bupivacaine injection in aged lean and HFD mice. Main 
effects of injury distinguished by † and diet by ‡. Significant differences between lean 
uninjured and lean injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Abbreviations: ALu, aged lean uninjured; Ali, aged lean uninjured; AHu, aged high fat diet 
uninjured; AHi, aged high fat diet injured. 
Figure 6. TNF-α signaling of skeletal muscle regeneration at 3 days and 21 days of 
recovery after bupivacaine-induced injury. (A) TNF-α mRNA abundance 3 days post-
bupivacaine injection in young lean and HFD mice. (B) TNF-α mRNA abundance 21 days 
post-bupivacaine injection in young lean and HFD mice. (C) Fold changes in NF-κB65 
protein 3 days post-bupivacaine injection in young lean and HFD mice. (D) Fold changes in 
NF-κB65 protein 21 days post-bupivacaine injection in young lean and HFD mice. Main 
effects of injury distinguished by † and diet by ‡. Significant differences between lean 
uninjured and lean injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. 
Abbreviations: YLu, young lean uninjured; Yli, young lean injured; YHu, young high fat diet 
uninjured; YHi, young high fat diet injured.  
Figure 7. TNF-α signaling of skeletal muscle regeneration at 3 days and 21 days of 
recovery after bupivacaine-induced injury. (A) TNF-α mRNA abundance 3 days post-
bupivacaine injection in aged lean and HFD mice. (B) TNF-α mRNA abundance 21 days 
post-bupivacaine injection in aged lean and HFD mice. (C) Fold changes in NF-κB65 protein 
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3 days post-bupivacaine injection in aged lean and HFD mice. (D) Fold changes in NF-κB65 
protein 21 days post-bupivacaine injection in aged lean and HFD mice. Main effects of injury 
distinguished by † and diet by ‡. Significant differences between lean uninjured and lean 
injured and aged uninjured and aged injured distinguished by #. P ≤ 0.05. Abbreviations: ALu, 
aged lean uninjured; Ali, aged lean uninjured; AHu, aged high fat diet uninjured; AHi, aged 






















































































    Young 3D 




    Young 21D 


















     Aged 3D 




    Aged 21D 


















    Young 3D 
YLu YLi YHu YHi 
NF-κB p65 
Ponceau 
    Young 21D 

















     Aged 3D 
ALu ALi AHu AHi 
NF-κB p65 
Ponceau 
     Aged 21D 











1,2Lemuel A. Brown, 1,2Richard A. Perry, 1,2Wesley S. Haynie, 2Jacob L. Brown, 3John T. Kim, 
3Benjamin M. Kasukonis, 2Thomas A. Blackwell, 2Megan E. Rosa, 2David E. Lee, 2Nicholas P. 
Greene, 3Jeffrey C. Wolchok, and 1,2Tyrone A. Washington 
 
 
1Exercise Muscle Biology Laboratory, 2Human Performance Laboratory, Department of Health, 
Human Performance and Recreation, University of Arkansas, Fayetteville AR 72701 













Tyrone A. Washington, Ph.D. 
University of Arkansas  
Department of Health, Human Performance, and Recreation 
155 Stadium Dr. HPER 308H 
Fayetteville AR 72701 
 
Office Phone: 479-575-6693 





AIM: Sarcopenic obesity is a vastly growing population worldwide that is tied with 
several health risks. Both aging and obese individuals are tied with poor regenerative capacity 
and increased muscle fibrosis. This is alarming because sarcopenic obese individuals exhibit 
progressive muscle loss which is associated with mortality in aging. The extracellular matrix is 
essential because it assists in regenerating muscle fibers by releasing growth factors and can 
protect the musculature from high amounts of stress. The remodeling of the ECM may be 
impaired in sarcopenic obese individuals. The purpose of this study was to determine how 
obesity alters extracellular matrix remodeling (ECM) during muscle regeneration in mice. 
METHODS: One hundred two male C57BL6/J mice (4 weeks old) were randomly assigned to 
either a high fat diet (HFD, 60% fat) or normal chow. Both young mice (12 weeks) and aged 
mice (22-24 months old) were injected with either PBS or bupivacaine. The TA was excised 3 or 
21 days after injection. RESULTS: There was a main effect of injury to reduce collagen I and III 
content in aged injured mice 3 days following myotoxin induced muscle damage. There was a 
main effect of diet with a decrease of collagen I, collagen III, and MMP-9 gene expression in 
aged HFD mice 3 days following myotoxin-induced muscle damage. CONCLUSION: 
Sarcopenic obese mice had changes in collagen content and reduced ECM gene expression that 
suggests impaired ECM remodeling in sarcopenic obese mice. 
 





Currently, the worldwide estimation of adults 65 years is 605 million individuals and 
roughly a third of them are considered obese (Amarya, Singh, & Sabharwal, 2014). This is a 
major concern because older adults are the fastest growing obese population in the United 
States. Not to mention, older adults and obesity are associated with increased skeletal muscle 
fibrosis and reduced insulin sensitivity (Goldspink et al., 1994; Lim et al., 2010; Proctor et al., 
1998). As a result, older obese adults have reduced mobility and an increased risk of disability 
(Fried et al., 2001). Muscle fibrosis in obese and older adults partially stems from improper or 
sub-optimal skeletal muscle regeneration (L. A. Brown et al., 2015; Smythe et al., 2008). 
The skeletal muscle regeneration process is comprised of an inflammatory response, 
myoblast proliferation and differentiation, and extracellular matrix (ECM) remodeling that 
will work synergistically for optimal muscle growth and repair. Skeletal muscle ECM can be 
induced by mechanical stimuli and/or traumatic damage to muscle tissue, which will release 
the growth factor TGF-β that will induce anti-inflammatory cytokines over time to increase 
collagen turnover and ECM regulatory proteins necessary for ECM remodeling (Hocevar et 
al., 1999; Kjaer, 2004). Thus, ECM remodeling takes place in both the early and late stages of 
skeletal muscle regeneration. 
Skeletal muscle ECM is predominately comprised of collagen I and collagen III triple 
helix polypeptides that are activated transcriptionally during the regenerative process to 
increase collagen deposition (Kjaer, 2004; Schiaffino & Partridge, 2008). Collagen I has been 
implicated as the sturdiest collagen fibril whereas collagen III is a naïve collagen fibril that is 
more pliable and is involved in collagen I production (Kjaer, 2004; Schiaffino & Partridge, 
2008). Along with collagen, Matrix metalloproteinases (MMPs), which are zymogen 
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endopeptidases, are activated to degrade collagen for ECM remodeling and myoblast 
migration (Bourboulia & Stetler-Stevenson, 2010). In regards to muscle regeneration, MMP-2 
and MMP-9 have been implicated as essential ECM proteins because of their role in muscle 
ECM remodeling and satellite cell migration during the regenerative process (Schiaffino & 
Partridge, 2008). The family of MMPs are controlled by tissue inhibitors of MMPs (TIMPs) 
that can dock on the active region of MMPs to stop the cleavage of collagen and ECM 
promoting such as fibronectin (Bourboulia & Stetler-Stevenson, 2010). Physiological changes 
to this process such as insulin resistance can reduce alter the ECM remodeling and in worst 
cases cause aberrant signaling of a couple or several proteins that play key roles in the 
regenerative process. 
There have been a few studies examining how chronic injury, aging, and obesity may 
negatively impact ECM remodeling and the regenerative process. Ireland and colleagues 
examined ECM gene expression of Collagen I and III in chronic Achilles tendinopathy 
(Ireland et al., 2001). They observed an upregulation of both collagen I and II with an increase 
in the collagen III/I ratio (Ireland et al., 2001). These findings are consistent with other studies 
that witnessed that individuals suffering from traumatic acute or chronic injury exhibited 
fibrosis and an increase collagen III/I ratio (Ameye et al., 2002). It has been reported that both 
aging and obesity have higher collagen content in skeletal muscle tissue (Berria et al., 2006; 
Wood et al., 2014). In aging muscle collagen concentration may be 2-fold higher compared to 
young and is associated with muscle stiffness (Wood et al., 2014). Moreover, it appears that 
the increase in fibrosis is due partially to the increase in M2a macrophages present in skeletal 
muscle that will promote collage deposition (Z. Wang et al., 2000). Thus, changes in ECM 
proteins and the regulation of these proteins can impair the regenerative process. Whether 
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these changes exist in Sarcopenic obese individuals has not been demonstrated. 
Therefore the purpose of this study was to investigate how Sarcopenic obesity alters 
the skeletal muscle ECM following a damaging stimulus. We hypothesized that impaired 
muscle regeneration will be associated with an increase in skeletal muscle fibrosis. We further 







Animals and Housing 
 One hundred two C57BL/6 mice were purchased from Jackson Laboratories. Animals 
were housed in the University of Arkansas Central Laboratory Animal Facility. The overall 
study consisted of 2 separate animal experiments in young adult (3-4 mo) and aged mice (22-
24 mo). Experiment 1 examined immunohistochemistry and protein expression, and gene 
expression 3 days post-bupivacaine injection. Experiment 2 examined immunohistochemistry, 
muscle morphology, protein expression, and gene expression 21 days post-bupivacaine 
injection. For experiment 1 and 2 mice were randomly assigned to one of eight groups at 4 
weeks of age: 1) young lean uninjured (n = 5); 2) young lean injured (n = 6); 3) young obese 
uninjured (n = 5-8); 4) young obese injured (n = 6-8); 5) aged lean uninjured (n = 7-8); 6) 
aged lean injured (n = 7-8); 7) aged obese uninjured (n = 5-6); 8) aged obese injured (n = 6). 
Mice were fed normal chow (normal; 17% kcals fat Research Diets, New Brunswick, New 
Jersey) or a high fat diet (HFD; 60% kcals fat, Research Diets, New Brunswick, New Jersey) 
until they were euthanized. All procedures were approved by the University of Arkansas 
Institutional Animal Care and Use Committee (IACUC).  
Muscle and Tibia Extraction  
At either 3-4 mo or 22-24 mo of age, muscle and tibia extractions were performed as 
previously described (Tyrone A Washington et al., 2013; T. A. Washington et al., 2011). The 
TA and tibias were extracted while the mice were anesthetized with a subcutaneous injection 
of a cocktail containing ketamine hydrochloride (90 mg/kg body weight), xylazine (3 mg/kg 
body weight), and acepromazine (1 mg/kg body weight). The left TA was snap frozen in 
liquid nitrogen and stored at -80°C for protein and gene expression analysis, the right TA was 
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cut at the midbelly, mounted in optimum cutting temperature compound (OCT), and then 
dropped in liquid nitrogen cooled isopentane. Once frozen, samples were stored at -80°C for 
morphological analysis. After the muscles was dissected out, the tibia was removed and 
measured with a plastic caliper (VWR, Radnor, PA, USA). Tibia measurements were utilized 
to normalize muscle weights to an estimate of total body size. 
Bupivacaine Injection 
At 3 mo or 22-23 mo of age, bupivacaine (Hospira, Lake Forest, IL) injections were 
performed as previously described (Washington et al., 2013). Mice were anesthetized with a 
subcutaneous injection of a cocktail containing ketamine hydrochloride (45 mg/kg body 
weight), xylazine (3 mg/kg body weight), and acepromazine (1 mg/kg body weight). Muscle 
damage was induced by injecting 0.03ml of 0.75% bupivacaine (Marcaine) in the left and 
right tibialis anterior muscles (TA). A 25-gauge, 5/8 (0.5 x 16 mm) needle was inserted along 
the longitudinal axis of the muscle, and the bupivacaine was injected slowly as the needle was 
withdrawn. The control group was injected with 0.03 ml of phosphate buffered saline (PBS). 
Tissue histology and image analysis 
The following procedures were completed as previously described (Kim et al., 2016).  
Each TA muscle cross-section will was cut at 10 µm (n = 3-5) using the cryostat and placed 
on a slide. Prior to immunostaining, slides were permeabilized in 0.1% 100X triton then 
rinsed in phosphate-buffered solution (PBS, pH 7.4). Slides were then blocked in PBS 
containing 4% goat serum and 0.05% sodium azide for 1h at room temperature prior to 
incubation in primary antibodies including mouse-anti-collagen I IgG (1:500, Sigma Aldrich), 
rabbit polyclonal anti-collagen III (1:1000, Abcam), and mouse-anti-myosin IgG2B (MF-20, 
1:10, Developmental Studies Hybridoma Bank, Iowa City, IA) for 4h at 4°C. Following PBS 
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washes, slides were incubated in the appropriate corresponding Alexa Fluor 488 and 596 
(1:500, Life Technologies) labeled secondary antibodies for 30 minutes at room temperature. 
Images of the slide were acquired with a Nikon camera (Sight DS-Vi1) mounted on an 
Olympus CKX41 inverted microscope at 20X magnification (Olympus), analyzed with 
MATLAB. Total ECM area was determined by dividing the number of green pixels by the 
total number of pixels in the image. 
RNA Isolation, cDNA synthesis, and quantitative RT-PCR 
The following procedures were completed as previously described (N. P. Greene et al., 
2015; Nicholas P Greene et al., 2014; Tyrone A Washington et al., 2013). RNA was extracted 
with Trizol reagent (Life Technologies, Grand Island, NY, USA). TA muscles were 
homogenized in Trizol. Total RNA was isolated, DNase treated and purity and concentrations 
were determined using 260/280nm ratios read on a BioTek Take3 microvolume microplate 
with a BioTek PowerWave XC microplate reader (BioTek Instruments Inc., Winooski, VT). 
cDNA was reverse transcribed from 1 µg of total RNA using the Superscript Vilo cDNA 
synthesis kit (Life Technologies, Carlsbad, CA, USA). Real-time PCR was performed, and 
results were analyzed by using the StepOne Real-Time PCR system (Life Technologies, 
Applied Biosystems, Grand Island, NY). cDNA was amplified in a 25 µL reaction containing 
appropriate primer pairs and TaqMan Universal Mastermix (Applied Biosystems). Samples 
were incubated at 95°C for 4 min, followed by 40 cycles of denaturation, annealing and 
extension at 95°C, 55°C and 72°C respectively. TaqMan fluorescence was measured at the 
end of the extension step each cycle. Fluorescence labeled probes for Collagen I (FAM dye), 
Collagen III (FAM dye), Firbronectin 1 (FAM dye), MMP-2 (FAM dye), MMP-9 (FAM dye), 
TIMP-1 (FAM dye), TGF-β (FAM dye), and 18S (FAM dye) were purchased from Applied 
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Biosystems and quantified with TaqMan Universal mastermix. Cycle threshold (Ct) was 
determined, and the ΔCt value was calculated as the difference between the Ct value and the 
18S Ct value. Final quantification of gene expression was calculated using the ΔΔCT method 
Ct = [ΔCt(calibrator) – ΔCt(sample)]. Relative quantification was then calculated as 20-ΔΔCt. 
Melt curve analysis was performed at the end of the PCR run to verify no primer dimers were 
formed. 
Statistical Analysis  
All data was analyzed using Statistical Package for the Social Sciences (SPSS version 
22.0, Armonk, NY). Results are reported as mean ± SEM. Pre-planned comparisons between 
lean and obese uninjured mice were conducted using Student’s t-tests. For these analyses, lean 
and obese uninjured were pooled from the 3 and 21 day time-points. A two-way ANOVA was 
performed to analyze main effects of treatment and diet and if there were any interactions 
between the dependent variables for 3 and 21 days post-bupivacaine injection. When a 
significant interaction was detected, differences among individual means were assessed with 







 In the young mice, there was no difference in collagen I content in all groups 3 days 
post-bupivacaine injection (Fig. 1B). In the young mice, there was no difference in collagen 
III content in all groups 3 days post-bupivacaine injection (Fig. 1D). In the aged mice there 
was a main effect of diet with a decrease of collagen I content in the HFD group compared to 
the lean group 3 days post-bupivacaine injection (Fig. 1F). In the aged mice there was main 
effect of injury with a decrease in collagen I content in the injured group compared to the 
injured group 3 days post-bupivacaine injection (Fig. 2D). In the aged mice there was a main 
effect of injury with a decrease of collagen I content in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection (Fig. 1H). In the young lean mice, collagen 
I content was 17% greater in the injured group compared to the uninjured group 21 days post-
bupivacaine injection (Fig. 2B). In the young HFD lean mice, collagen I content was reduced 
by 26% in the injured group compared to the uninjured group 21 days post-bupivacaine 
injection. (Fig. 2B). In the young mice there was main effect of injury with a decrease in 
collagen III content in the injured group compared to the injured group 21 days post-
bupivacaine injection (Fig. 2D). In the aged lean mice, collagen I content was reduced by 22% 
in the injured group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 
2F). In the aged HFD mice there was no difference in collagen I content in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 2F). In the aged 
mice there was no difference in collagen III content in all groups 21 days post-bupivacaine 
injection (Fig. 2H). 
Collagen gene expression 
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There was a main effect of injury with an increase of collagen I mRNA abundance in 
the young injured group compared to the young uninjured group 3 days post-bupivacaine 
injection (Fig. 3A). There was a main effect of diet with a decrease of collagen I mRNA 
abundance in the young HFD group compared to the young lean group 21 days post-
bupivacaine injection (Fig. 3B). There was a main effect of diet with a decrease of collagen I 
mRNA abundance in the aged HFD group compared to the aged lean group 3 days post-
bupivacaine injection (Fig. 3C). There was a main effect of diet with a decrease of collagen I 
mRNA abundance in the aged HFD group compared to the aged lean group 21 days post-
bupivacaine injection (Fig. 3D). There was a main effect of injury with an increase of 
collagen III mRNA abundance in the young injured group compared to the young uninjured 
group 3 days post-bupivacaine injection (Fig. 3E). In the young lean mice collagen III mRNA 
abundance was not different in the injured group compared to the uninjured group 21 days 
post-bupivacaine injection (Fig. 3F). In the young HFD mice collagen III mRNA abundance 
was not different in the injured group compared to the uninjured group 21 days post-
bupivacaine injection (Fig. 3F). There was a main effect of diet with a decrease of collagen III 
mRNA abundance in the aged HFD group compared to the aged lean group 3 days post-
bupivacaine injection (Fig. 3G). In the aged lean mice collagen III mRNA abundance was not 
different in the injured group compared to the uninjured group 21 days post-bupivacaine 
injection (Fig. 3H). In the aged HFD mice collagen III mRNA abundance was not different in 
the injured group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 
3H). 
Collagen promoter gene expression 
 
172  
There was a main effect of injury with an increase of fibronectin 1 mRNA abundance 
in the young injured group compared to the young uninjured group 3 days post-bupivacaine 
injection (Fig. 4A). There was a main effect of diet with a decrease of fibronectin 1 mRNA 
abundance in the young HFD group compared to the young lean group 21 days post-
bupivacaine injection (Fig. 4B). There was a main effect of injury with an increase of 
fibronectin 1 mRNA abundance in the aged injured group compared to the aged uninjured 
group 3 days post-bupivacaine injection (Fig. 4C). There was a main effect of diet with a 
decrease of fibronectin 1 mRNA abundance in the aged injured group compared to the young 
uninjured group 21 days post-bupivacaine injection (Fig. 4D). There was a main effect of 
injury with an increase of TGF-β mRNA abundance in the young injured group compared to 
the young uninjured group 3 days post-bupivacaine injection (Fig. 4E). In the young lean 
mice, TGF-β mRNA abundance was not different in the injured group compared to the 
uninjured group 21 days post-bupivacaine injection (Fig. 4F). In the young HFD mice, TGF-β 
mRNA abundance was not different in the injured group compared to the uninjured group 21 
days post-bupivacaine injection (Fig. 4F). In the aged lean mice, TGF-β mRNA abundance 
was not different in the injured group compared to the uninjured group 3 days post-
bupivacaine injection (Fig. 4G). In the aged HFD mice, TGF-β mRNA abundance was not 
different in the injured group compared to the uninjured group 3 days post-bupivacaine 
injection (Fig. 4G). In the aged lean mice, TGF-β mRNA abundance was not different in the 
injured group compared to the uninjured group 21 days post-bupivacaine injection (Fig. 4H). 
In the aged HFD mice, TGF-β mRNA abundance was not different in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 4H). 
MMPs and TIMP gene expression 
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In the young lean mice, MMP-2 mRNA abundance was not different in the injured 
group compared to the uninjured group 3 days post-bupivacaine injection (Fig. 5A). In the 
young HFD mice, MMP-2 mRNA abundance was not different in the injured group compared 
to the uninjured group 3 days post-bupivacaine injection (Fig. 5A). There was a main effect of 
diet with a decrease of MMP-2 mRNA abundance in the young HFD group compared to the 
young lean group 21 days post-bupivacaine injection (Fig. 5B). In the aged lean mice, MMP-2 
mRNA abundance was not different in the injured group compared to the uninjured group 3 
days post-bupivacaine injection (Fig. 5C). In the aged HFD mice, MMP-2 mRNA abundance 
was not different in the injured group compared to the uninjured group 3 days post-
bupivacaine injection (Fig. 5C). There was a main effect of diet with a decrease of MMP-2 
mRNA abundance in the young HFD group compared to the young lean group 21 days post-
bupivacaine injection (Fig. 5D). In the young lean mice, MMP-9 mRNA abundance was not 
different in the injured group compared to the uninjured group 3 days post-bupivacaine 
injection (Fig. 5E). In the young HFD mice, MMP-9 mRNA abundance was not different in 
the injured group compared to the uninjured group 3 days post-bupivacaine injection (Fig. 
5E). In the young lean mice MMP-9 mRNA abundance was not different in the injured group 
compared to the uninjured group 21 days post-bupivacaine injection (Fig. 5F). In the young 
HFD mice MMP-9 mRNA abundance was not different in the injured group compared to the 
uninjured group 21 days post-bupivacaine injection (Fig. 5F). There was a main effect of diet 
with a decrease of MMP-9 mRNA abundance in the aged HFD group compared to the aged 
lean group 21 days post-bupivacaine injection (Fig. 5G). There was a main effect of diet with 
a decrease of MMP-9 mRNA abundance in the aged HFD group compared to the aged lean 
group 21 days post-bupivacaine injection (Fig. 5H). There was a main effect of injury with a 
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decrease of MMP-9 mRNA abundance in the aged injured group compared to the aged 
uninjured group 21 days post-bupivacaine injection (Fig. 5H). In the young lean mice, TIMP-
1 mRNA abundance was 28-fold greater (Fig. 5I) in the injured group compared to the 
uninjured group 3 days post-bupivacaine injection. In the young HFD mice TIMP-1 mRNA 
abundance was not different in the injured group compared to the uninjured group 3 days 
post-bupivacaine injection (Fig. 5I). There was a main effect of diet with a decrease of TIMP-
1 mRNA abundance in the young HFD group compared to the young lean group 21 days post-
bupivacaine injection (Fig. 5J). There was a main effect of injury with an increase of TIMP-1 
mRNA abundance in the aged injured group compared to the aged uninjured group 3 days 
post-bupivacaine injection (Fig. 5K). In the aged lean mice, TIMP-1 mRNA abundance was 
reduced by 47% (Fig. 5L) in the injured group compared to the uninjured group 21 days post-
bupivacaine injection. In the aged HFD mice TIMP-1 mRNA abundance was not different in 







The primary goal of this study was to examine how sarcopenic obesity alters 
extracellular matrix remodeling in skeletal muscle following injured. We hypothesized that 
there would be no change in collagen I content due to inactivity of senescent muscle cells to 
upregulate collagen following muscle damage. In addition, we expected to observe excessive 
MMP activity due to reductions of TIMP-1 activity. To our knowledge we are the first to 
demonstrate reductions in collagen I content in sarcopenic obese mice and reduced collagen, 
MMP, and fibronectin gene expression at the early and late stages of muscle injury.  
Following muscle damage there appears to be several changes in collagen content due 
to sarcopenic obesity. We witnessed reductions in collagen I and III content 3 days following 
myotoxin injection. Aging is associated with muscle fibrosis due to excessive MMP activity 
and reduced collagen turnover (Kragstrup et al., 2011; Uezumi et al., 2011; Unsold, Bremen, 
Didie, Hasenfuss, & Schafer, 2014). However, we did not observe any changes in MMP-2 
expression and a decrease in MMP-9 expression. Even though MMP expression did not 
appear to be upregulated in the sarcopenic obese group it is still likely that MMP activity is 
occurring much earlier than 3 days after muscle damage which would explain the 
downregulation of MMP-9 and changes in collagen which has a long half-life. Moreover the 
reduction of collagen III in sarcopenic obese mice could reduce the elastic properties of the 
muscle fiber and thus increasing susceptibility to traumatic injury following muscle recovery.  
This study also demonstrated alterations in collagen RNA expression in sarcopenic 
obese mice. Collagen I was reduced in aging HFD mice 3 days following damage and was 
still reduced 21 days following muscle damage. The reduction of collagen I expression is 
 
176  
supported by previous literature that reported slow turnover in mature collagen (Avery & 
Bailey, 2005, 2006). The reduction of collagen I expression may indicate reduction in 
collagen turnover. Furthermore, these animals may be more susceptible towards increased 
muscle stiffness because advanced glycation of end products (AGE) occur in a low collagen 
turnover environment (Avery & Bailey, 2005, 2006; DeGroot et al., 2001). AGE would also 
be more likely to occur in sarcopenic obese individuals because the process favors an insulin 
resistant environment as well (DeGroot et al., 2001; Song & Schmidt, 2012). Collagen III had 
a similar fate and was reduced in aged HFD mice at the onset of muscle damage. It has been 
suggested that collagen III is necessary for the development of collagen I. Without the 
development of new collagen I, the sarcopenic obese muscle would be more susceptible to 
muscle stiffness via AGE which occurs more so in mature collagen and aging mice (DeGroot 
et al., 2001; Wood et al., 2014).  
 Both TGF-β and fibronectin are involved in promoting collagen synthesis during the 
muscle regeneration process. Our results showed a pronounced elevation of fibronectin 3 days 
following injury in the aged mice followed by a decrease 21 days after muscle damage. The 
aging mice had a similar response in fibronectin demonstrating that fibronectin may not cause 
the decrease in collagen observed in aging. This would also indicate that fibrillogenesis 
remodeling may not be altered in aging mice. In this study we did not observe any changes in 
TGF-β at the onset of muscle regeneration in aging mice. TGF-β is typically upregulated a 
few days following muscle damage and will be upregulated for a few weeks to promote 
collagen synthesis (Clarke & Feeback, 1996; Kjaer, 2004). Our results would implicate TGF-
β being partially responsible for altered collagen gene expression in aged mice. Hence, no 
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changes in TGF-β and a reduction in collagen content may elude to an imbalance in collagen 
turnover. 
 MMPs and Tissue inhibitors of MMPs (TIMPs) are also regulators of collagen and 
play a role in collagen turnover. Previously mentioned, MMP-2 and MMP-9 are reduced in 
aged HFD mice at the onset of muscle regeneration. In support with our findings, TIMP-1 
gene expression was upregulated following 3 days following muscle damage in aged HFD 
mice. However, TIMP-1 returned to basal levels in aged HFD mice at 21 days which would 
suggest a different regulator to inhibit MMP expression at the later stages of regeneration.  
Altogether, these findings illustrate a disruption of ECM remodeling in sarcopenic 
obesity through the inability of aging muscle to upregulate key ECM proteins. We have 
identified that HFD mice have reduced collagen and MMP gene expression and an 
upregulation of fibronectin and TIMP-1 that demonstrates the reductions of collagen content 
observed may be influenced by increased MMP activity immediately following muscle 
damage or the influence of other ECM related proteins that promote collagen degradation. 
Future studies need to focus on elucidating the disruption of ECM gene expression and 






Figure 1. Immunofluorescent staining of skeletal muscle regeneration at 3 days of 
recovery after bupivacaine-induced injury. (A) Representative collagen I staining of muscle 
cross section of young lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD 
injured (d). (B) Quantified collagen I content percentage in young lean and HFD mice. (C) 
Representative collagen III staining of muscle cross section of young lean uninjured (a), lean 
injured (b), HFD uninjured (c), and HFD injured (d). (D) Quantified collagen III content 
percentage in young lean and HFD mice. (E) Representative collagen I staining of muscle 
cross section of aged lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD injured 
(d). (F) Quantified collagen I content percentage in aged lean and HFD mice. (G) 
Representative collagen III staining of muscle cross section of aged lean uninjured (a), lean 
injured (b), HFD uninjured (c), and HFD injured (d). (H) Quantified collagen III content 
percentage in aged lean and HFD mice. Main effects of injury distinguished by † and diet by 
‡. Significant differences between lean uninjured and lean injured and aged uninjured and 
aged injured distinguished by #. P ≤ 0.05. 
Figure 2. Immunofluorescent staining of skeletal muscle regeneration at 21 days of 
recovery after bupivacaine-induced injury. (A) Representative collagen I staining of muscle 
cross section of young lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD 
injured (d). (B) Quantified collagen I content percentage in young lean and HFD mice. (C) 
Representative collagen III staining of muscle cross section of young lean uninjured (a), lean 
injured (b), HFD uninjured (c), and HFD injured (d). (D) Quantified collagen III content 
percentage in young lean and HFD mice. (E) Representative collagen I staining of muscle 
cross section of aged lean uninjured (a), lean injured (b), HFD uninjured (c), and HFD injured 
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(d). (F) Quantified collagen I content percentage in aged lean and HFD mice. (G) 
Representative collagen III staining of muscle cross section of aged lean uninjured (a), lean 
injured (b), HFD uninjured (c), and HFD injured (d). (H) Quantified collagen III content 
percentage in aged lean and HFD mice. Main effects of injury distinguished by † and diet by 
‡. Significant differences between lean uninjured and lean injured and aged uninjured and 
aged injured distinguished by #. P ≤ 0.05. 
Figure 3. Collagen mRNA abundance of skeletal muscle regeneration at 3 days and 21 
days of recovery after bupivacaine-induced injury. (A) Collagen I mRNA abundance 3 days 
post-bupivacaine injection in young lean and HFD mice. (B) Collagen I mRNA abundance 21 
days post-bupivacaine injection in young lean and HFD mice. (C) Collagen I mRNA 
abundance 3 days post-bupivacaine injection in aged lean and HFD mice. (D) Collagen I 
mRNA abundance 21 days post-bupivacaine injection in aged lean and HFD mice. (E) 
Collagen III mRNA abundance 3 days post-bupivacaine injection in young lean and HFD 
mice. (F) Collagen III mRNA abundance 21 days post-bupivacaine injection in young lean 
and HFD mice. (G) Collagen III mRNA abundance 3 days post-bupivacaine injection in aged 
lean and HFD mice. (H) Collagen III mRNA abundance 21 days post-bupivacaine injection in 
aged lean and HFD mice. Main effects of injury distinguished by † and diet by ‡. Significant 
differences between lean uninjured and lean injured and aged uninjured and aged injured 
distinguished by #. P ≤ 0.05. 
Figure 4. Fibronectin 1 and TGF-β mRNA abundance of skeletal muscle regeneration 
at 3 days and 21 days of recovery after bupivacaine-induced injury. (A) Fibronectin 1 mRNA 
abundance 3 days post-bupivacaine injection in young lean and HFD mice. (B) Fibronectin 1 
mRNA abundance 21 days post-bupivacaine injection in young lean and HFD mice. (C) 
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Fibronectin 1 mRNA abundance 3 days post-bupivacaine injection in aged lean and HFD 
mice. (D) Fibronectin 1 mRNA abundance 21 days post-bupivacaine injection in aged lean 
and HFD mice. (E) TGF-β mRNA abundance 3 days post-bupivacaine injection in young lean 
and HFD mice. (F) TGF-β mRNA abundance 21 days post-bupivacaine injection in young 
lean and HFD mice. (G) TGF-β mRNA abundance 3 days post-bupivacaine injection in aged 
lean and HFD mice. (H) TGF-β mRNA abundance 21 days post-bupivacaine injection in aged 
lean and HFD mice. Main effects of injury distinguished by † and diet by ‡. Significant 
differences between lean uninjured and lean injured and aged uninjured and aged injured 
distinguished by #. P ≤ 0.05. 
Figure 5. MMP and TIMP mRNA abundance of skeletal muscle regeneration at 3 days 
and 21 days of recovery after bupivacaine-induced injury. (A) MMP-2 mRNA abundance 3 
days post-bupivacaine injection in young lean and HFD mice. (B) MMP-2 mRNA abundance 
21 days post-bupivacaine injection in young lean and HFD mice. (C) MMP-2 mRNA 
abundance 3 days post-bupivacaine injection in aged lean and HFD mice. (D) MMP-2 mRNA 
abundance 21 days post-bupivacaine injection in aged lean and HFD mice. (E) MMP-9 
mRNA abundance 3 days post-bupivacaine injection in young lean and HFD mice. (F) MMP-
9 mRNA abundance 21 days post-bupivacaine injection in young lean and HFD mice. (G) 
MMP-9 mRNA abundance 3 days post-bupivacaine injection in aged lean and HFD mice. (H) 
MMP-9 mRNA abundance 21 days post-bupivacaine injection in aged lean and HFD mice. (I) 
TIMP-1 mRNA abundance 3 days post-bupivacaine injection in young lean and HFD mice. 
(J) TIMP-1 mRNA abundance 21 days post-bupivacaine injection in young lean and HFD 
mice. (K) TIMP-1 mRNA abundance 3 days post-bupivacaine injection in aged lean and HFD 
mice. (L) TIMP-1 mRNA abundance 21 days post-bupivacaine injection in aged lean and 
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HFD mice. Main effects of injury distinguished by † and diet by ‡. Significant differences 
between lean uninjured and lean injured and aged uninjured and aged injured distinguished by 































































































































































 The overall purpose of this project was to determine how sarcopenic obesity alters 
regenerative capacity and the early and late stages of muscle regeneration in mice. This 
project has uncovered three major findings in the sarcopenic obese population. First of all, 
sarcopenic obese muscle has a further reduced capacity to regenerate muscle fibers than 
sarcopenia or obesity alone. This reduction of regenerative capacity also appears to be linked 
with a more pronounced loss in skeletal muscle mass. The second major finding was that 
sarcopenic obese mice had impaired inflammatory signaling. The experiments performed 
suggest that the role of TNF-α in repair and recovery is lost, whereas IL-6 signaling may lead 
to alternative pathways that result into sub-optimal regeneration. Finally, this project has 
demonstrated that ECM remodeling is negatively influenced by the combination of aging and 
obesity. Altogether, these findings have identified a relatively new population that is 
susceptible to major losses in muscle and diminished muscle regeneration. 
 
Regenerative capacity is reduced in sarcopenic obese mice 
 When skeletal muscle is introduced to a mechanical stimuli, the muscle fiber will 
activate several processes that are tightly regulated and coordinated for optimal growth. Any 
changes to one of these processes can cause alterations to repair and recovery to the whole 
muscle but should eventually return back to normal after muscle repair is completed. In 
degenerative models such as pathophysiological diseases, the muscle fiber will have 
alterations of these processes at rest that will influence muscle quality over time and reduce 
the ability for musculature to repair when muscle damage occurs (Argiles et al., 2009; Cai et 
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al., 2004; Coletti, Moresi, Adamo, Molinaro, & Sassoon, 2005; He et al., 2013). The first aim 
of this project identified three major processes that influence regenerative potential or 
capacity; myogenesis, the inflammatory response, and ECM remodeling. Each process had 
drastic changes in sarcopenic obese mice which ultimately led to muscle mass loss. The major 
finding in the first set of experiments is that aging HFD mice have reduced muscle weights 
and cross-sectional area. The further progressive loss in muscle mass may have to do with 
alterations in all of these processes involved in muscle regeneration. Both resident 
macrophages and Satellite cells (SC) are located at the basement membrane of skeletal muscle 
at rest (Schiaffino & Partridge, 2008). Changes within the microenvironment can influence 
the ability of these proteins to proper function. We observed excessive increases of collagen 
III content in aged mice but no changes or reductions in collagen gene expression and 
inducers and inhibitors of collagen synthesis and degradation. It is very likely that sarcopenic 
obese individuals have lower collagen turnover than either obesity or aging. Low collagen 
turnover cultivates muscle stiffness by AGE because crosslinking will occur in an 
environments with 1) lower collagen turnover, 2) reduced insulin sensitivity and 3) mature 
collagen (Avery & Bailey, 2005, 2006; DeGroot et al., 2001). The constant degrading and 
synthesis of collagen observed in healthy adult muscle assists in the movement of SC cells to 
migrate to the site of muscle injury and can be regulated by inflammatory cytokines. There 
were also basal changes of MyoD and myogenin which could be tied with the increase in 
collagen III content in aging mice, because progenitor cells are localized in the ECM and 
ECM proteins are involved in SC migration. Collagen turnover is traditionally induced by 
anti-inflammatory cytokines and inhibited by pro-inflammatory cytokines. Not many changes 
were seen in TGF-β but there were changes in IL-6 and NF-κB. IL-6 when secreted can 
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activate its downstream target STAT3 which will have anti-inflammatory effects. There was a 
reduction of STAT3 which may explain why there were no changes in TGF-β and in turn no 
changes or reductions in collagen gene expression. Perhaps, what was more interesting was 
the elevation of NF-κB observed in aged HFD mice. NF-κB is usually signaled through TNF-
α and can lead to apoptosis in damaged muscle tissue (He et al., 2013). NF-κB appeared to be 
elevated independent of TNF-α. Chronic elevation of inflammatory cytokines has been 
implicated in myopathies and may be the major mechanism involved in age-related muscle 
loss (Cai et al., 2004; He et al., 2013). Thus, regenerative capacity in sarcopenic obesity is 
reduced and should be more associated with metabolic diseases and myopathies than healthy 
populations. Any potential treatment to improve regenerative capacity in sarcopenic obesity 
should be aimed to target the altered genes involved in the regenerative process. 
 
Inflammatory signaling is impaired in sarcopenic obesity 
 The inflammatory response has a major regulatory role in skeletal muscle regeneration 
including assisting in myoblast proliferation, differentiation, collagen remodeling, and 
removal of damaged tissues and recruitment of other inflammatory proteins to overall assist in 
optimal regeneration. Hence, inflammatory signaling has been examined extensively within 
the field of muscle regeneration. Because inflammatory signaling has a diverse role in skeletal 
muscle regeneration, other regenerative processes can be altered and can result in sub-optimal 
muscle repair. The second set of experiments focused solely on muscle morphology, MRFs 
and inflammation, but it is very likely that impaired signaling observed in sarcopenic obese 
mice influenced other areas of muscle regeneration as well.  
 This project reported a significant reduction not only in young HFD mice but aged 
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HFD mice which makes this study novel. Furthermore, there were no changes in fiber 
distribution in aged HFD mice 21 following muscle injury. These results were similar to a 
previous study investigated in our laboratory demonstrating young HFD had a delayed muscle 
regeneration response and it was due to impaired signaling. In our first aim we did not see any 
changes with basal IL-6 in TA which supports the expected increase of IL-6 following muscle 
damage. However, IL-6 appears to be targeting downstream targets other than STAT3 that 
can be detrimental to the regenerative process. IL-6 serves many functions in skeletal muscle 
such as promoting MMP activity, assisting in myoblast proliferation, attracting other 
inflammatory cytokines to the site of injury. Thus, it is necessary for future studies to 
determine how alternative signaling is specifically impacting sarcopenic obese mice. The 
other major finding in aim #2 was impaired TNF-α/NF-κB signaling. TNF-α had a similar 
response to young lean mice in both the early and late stages of muscle regeneration however, 
NF-κB was upregulated in all muscles examined for this project. Mentioned earlier, NF-κB 
may be acting independent of TNF-α to induce apoptosis (He et al., 2013). It is important to 
note that both aging and obesity are associated with muscle fibrosis. The chronic expression 
of NF-κB observed in aged HFD mice and upregulation during muscle damage may be 
compensatory effect to inhibit excess collagen deposition and thus reduce muscle fibrosis. It 
has been reported that NF-κB can inhibit collagen I. Furthermore, other inhibitors of collagen 
synthesis do not appear to upregulated following damage. Thus, impaired signaling will 
contribute sub-optimal regeneration and may influence other aspects of muscle regeneration.  
 
ECM is impaired in sarcopenic obesity 
 The ECM serves two major functions within skeletal muscle. 1) the ECM will serve as 
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a reservoir of growth factors and proteins that assist in muscle repair and 2) also supportive 
structure that will resist tension and compressive force (Kjaer, 2004). One of the major 
findings reported in the last set of experiments was reduced collagen content in aged mice at 
the onset of muscle regeneration. The MMP gene expression did not support collagen 
degradation but it is important to note that MMP gene expression is not always directly 
related to MMP activity. Furthermore, the rate of collagen synthesis is much lower which 
could be possibly due to the upregulation of NF-κB. Thus, there could be an imbalance in 
collage turnover favoring collagen degradation in aging mice. In the first set of experiments 
we observed a high percentage of collagen in the aged mice compared to the lean mice. 
During ECM remodeling collagen will release growth factors that will increase collagen 
turnover. Because there was no increase in collagen turnover it is likely that other factors are 
involved that may interfere with the remodeling process.  
Compared to the other processes in skeletal muscle regeneration, the ECM has a more 
functional role with force transmission and to resist compressive forces. The reduction of 
thicker collagen, collagen I, could make the muscle more susceptible to injury while muscle 
regeneration is still occurring. The aging muscle also had excessive collagen III content which 
is a more flexible collagen that could contribute to muscle weakness observed in aging. 
Overall, the alterations in aged HFD mice were similar to lean mice meaning ECM 
remodeling may not be further impaired in sarcopenic obese individuals. This may also 
suggest that ECM remodeling could be more tightly regulated than the other regenerative 
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